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Abstract
With persistent and chronic use of alcohol and drugs, structural and functional changes occur
in the brain, contributing to the development and maintenance of substance use disorder (SUD).
The cyclic nature of addiction is increasingly understood in a neuroscientific framework.
Influential theories describe allostatic changes that occur over time as the initial highly
rewarding effects of substances subsequently lead to reduced capacity of prefrontal brain
regions to exert effective self-regulation, while an increasingly reactive amygdala-striatum
system becomes progressively more vulnerable to substance-cues, stress, negative affect, and
compulsive substance use (Koob & Volkow, 2016; Noël, Brevers, & Bechara, 2013; Volkow
& Morales, 2015). The resulting cognitive deficits are one of the most commonly reported risk
factors for dropout from addiction treatment (Brorson, Ajo Arnevik, Rand-Hendriksen, &
Duckert, 2013). Recently it has been proposed that interventions designed to improve cognition
may bolster SUD treatment outcomes and increase the likelihood of long-term recovery from
addiction (Verdejo-García, 2016). This thesis aimed to investigate the potential for
neuropsychological screening and cognitive training interventions to improve SUD treatment
outcomes. The first study of this thesis (Chapter 2) assessed cognitive functioning in an SUD
sample in residential treatment (N = 128), with findings indicating that almost half (43.8%)
were identified as cognitively impaired, compared to 16.2% of controls (N = 37). History of
head injury was a significant determinant of cognitive impairment and cognitive impairment
was associated with higher levels of psychological distress. Study two evaluated a cognitive
remediation intervention developed to specifically target executive dysfunction and delivered
within residential SUD treatment – in an all-female sample inclusive of those with
comorbidities including psychiatric diagnoses and history of head injury (Chapter 3). A threemonth follow-up was included to assess outcomes over time (Chapter 4). Lastly, the
relationships between executive functions (EFs) and emotion regulation were investigated
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(Chapter 5), given the proposed links between EFs and self-regulation capacity (Hofmann,
Schmeichel, & Baddeley, 2012), and the significant role of emotion dysregulation in the
aetiology and maintenance of SUDs (Wilcox, Pommy, & Adinoff, 2016). Findings regarding
the evaluation of the intervention indicated that the cognitive remediation group (CR; N = 16)
improved in an inhibition task, inventory-based assessment of EFs, self-reported impulsivity
and self-control, and quality of life, relative to controls, who participated in treatment as usual
(TAU; N = 17). Three-month follow-up outcomes of the intervention indicated no significant
differences between the CR (N = 12) and TAU (N = 12) groups with regard to quality of life
and self-reported self-control, cravings, and likelihood of relapse. The CR group demonstrated
sustained improvements in inventory-based assessment of EFs and a higher rate of treatment
completion (37.5%) compared to the TAU group (5.9%), however, treatment completion may
have been confounded by the unexpectedly longer duration of treatment at baseline observed
in the CR vs. TAU group. Investigation of relationships between EFs and emotion regulation
at baseline in the entire sample (N = 50) indicated that task-switching, inventory-based
assessment of EFs, and personality disorder indicators uniquely predicted emotion regulation
difficulties. Mediation analysis found a significant indirect effect of task-switching
performance on emotion regulation difficulties, through personality disorder indicators. Taken
together, these findings provide preliminary evidence for the use of cognitive remediation to
improve cognition in a residential SUD sample, including those with the often-excluded
comorbidities of psychiatric diagnoses and history of head injury. These findings have utility
in informing the continued development and evaluation of novel cognitive remediation
interventions for SUD populations.
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CHAPTER 1: CRITICAL OVERVIEW

2

1.1.

SUBSTANCE USE: HISTORY, IMPACT, AND TREATMENT
Our relationship with psychoactive substances can be traced to the beginning of

recorded human history, when our ancestors discovered the process of fermenting fruit
and grain to create intoxicating beverages (Nathan, Conrad, & Skinstad, 2016).
Culturally, this relationship has been complex and has involved the use of psychoactive
substances in religious ceremonies, medicinally, and in a socially acceptable manner by
the general population (Crocq, 2007). Substance use is now highly prevalent for primarily
recreational purposes: The United Nations Office on Drugs and Crime (2016) estimates
that 247 million adults (aged 15 to 64 years) used at least one drug in 2014, with
approximately 29 million people meeting criteria for a substance use disorder (SUD), and
roughly 207,400 drug-related deaths. The World Health Organisation (2016) reports that
in 2012 approximately 3.3 million deaths (i.e., 5.9% of all global deaths) were attributable
to alcohol consumption. The consequences of the widespread misuse of psychoactive
substances are far-reaching, with significant harm to individuals, families, and
communities, as well as economic burden resulting from attempts to alleviate these
problems. A variety of SUD treatments exist, including detoxification programs,
outpatient interventions (e.g., targeted group or individual psychotherapies), harm
reduction services, methadone maintenance therapy, and inpatient modalities (e.g.,
residential rehabilitation programs).

1.2.

THERAPEUTIC COMMUNITIES FOR SUBSTANCE USE DISORDER
Therapeutic communities (TCs) are a type of residential rehabilitation program.

They typically involve a duration of residence of between 4 to 12 months and they utilise
a “recovery-oriented” approach. TC’s aim to produce positive change in the domains of
“substance use, legal, employment, and psychological well-being” for people with
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alcohol or other substance use disorders (Vanderplasschen et al., 2013, p. 20), with
residents often meeting criteria for multiple SUDs and additional medical, social, and
psychiatric comorbidities (Fernández-Calderón, Fernández, Ruiz-Curado, VerdejoGarcía, & Lozano, 2015). The key distinguishing feature of TCs is “the purposive use of
the peer community to facilitate social and psychological change in individuals” (De
Leon, 2003, p. 18).

1.3.

THEORIES OF ADDICTION
Treatment approaches for SUD have been influenced by our understanding of

addiction, which has evolved over time and has often been fraught with shifts between
polar positions, as summarised by the questions posed by Crocq (2007, p. 355): “Is
addiction a sin or a disease; should treatment be moral or medical; is addiction caused by
the substance, the individual’s vulnerability and psychology, or social factors; should
substances be regulated or freely available?”
Research in the field of addiction has generally utilised symptoms that reflect the
consequences of substance use (e.g., impaired occupational or interpersonal functioning)
to diagnose SUD, as a comprehensive understanding of the underlying mechanisms of
addiction (e.g., locating biomarkers to distinguish SUD) has not yet been accomplished
(DeVito, Carroll, & Sofuoglu, 2016). The issues that arise as a result of using presenting
symptoms as the basis for establishing a diagnosis have been documented in the broader
field of mental health (Cuthbert & Insel, 2013); namely, this kind of nosology may hinder
the discovery of aetiological factors that could guide accurate diagnostic classification,
the delivery of effective treatment, and appropriate methods to monitor treatment
outcomes.
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Currently, an array of heterogeneous theories of addiction exist and implicate
various combinations of neurobiological, genetic, sociocultural, behavioural, and
psychological factors involved in the onset and maintenance of addiction (for a review
see Ouzir & Errami, 2016). This multiplicity of addiction theories can be understood in
light of the evolving social and cultural context of substance use over time, as well as the
scientific and technological developments in characterising psychiatric disorders that
have occurred. A literature search at the turn of the 21st century found an abundance of
theories and models of addiction that could be roughly classified into five distinct groups:
behavioural/social theories, biological theories, theories of individual susceptibility,
theories focussing on environmental factors, and theories of recovery/relapse (West,
2001). Broadly speaking, these theories tend to locate the mechanisms of addiction within
biological processes, the psychoactive constituents of substances, individual
psychological factors, and/or the social/cultural environment, with varying levels of
integration of these components across theories.
While a range of theories and models of addiction have been proposed, recent
findings have converged on common mechanisms through which the progression from
substance use to addiction unfolds, with a number of authors proposing similar theories
(e.g., Feil et al., 2010; George & Koob, 2010; Hester, Lubman, & Yücel, 2010; Koob,
2015; Koob & Volkow, 2016; Noël, Brevers, & Bechara, 2013; Volkow & Morales,
2015). The transition from initial substance use to the cycle of addiction is believed to
unfold

in

three

stages:

binge/intoxication,

withdrawal/negative

affect,

and

preoccupation/anticipation (i.e., cravings), with allostatic changes in hedonic set point
occurring during this process (George & Koob, 2010). The construct of craving has
played a significant role in addiction research, and has been investigated using a diverse
range of models that can be classified under four broad categories: conditioning-based,
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cognitive, psychobiological, and motivation models (Skinner & Aubin, 2010) – with
craving generally defined as “a desire of any intensity to consume a substance” (Skinner
& Aubin, 2010, p. 620).
Typically, initial experimentation with alcohol or drugs is under voluntary control
and is associated with the acutely rewarding effects of these substances, which are driven
by mechanisms at the brain circuit- and cell-level, involving surges of dopamine release
in the nucleus accumbens (Volkow & Morales, 2015). Individuals may be susceptible to
continued use of alcohol and drugs for a number of reasons, including sociocultural
factors, pre-existing vulnerabilities, and environmental stress. With continued use, greater
quantities may be consumed due to habituation of intoxicating effects and resultant
dependence. This stage is thought to involve neuroadaptations related to repeated
exposure to substance-cues (Volkow & Morales, 2015), and the neuroplastic changes
serve to increase sensitivity to substance-cues, reduce sensitivity to non-drug rewards,
compromise self-regulatory abilities, and increase sensitivity to environmental stress and
negative affect (Koob & Volkow, 2016). The mechanism through which substance-cues
trigger cravings and increase the likelihood of substance consumption is thought to
involve glutamatergic inputs from the amygdala, ventral prefrontal cortex, and ventral
hippocampus to striatal projections that are associated with increased dopamine
signalling and release in the nucleus accumbens and dorsal striatum. With repeated
substance use, however, the ventromedial prefrontal cortex becomes hypofunctional in
the absence of substance use or related cues (Volkow & Morales, 2015). Addicted
individuals may experience physical and psychological symptoms of withdrawal (e.g.,
cravings) if substance use is reduced or discontinued, and relapse to substance use may
occur in order to reduce these aversive symptoms, perpetuating the cyclic nature of SUD
(Koob, 2015).
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Neuroscience theories of addiction have been informed by research investigating
the neurocognitive mechanisms involved in the onset and maintenance of addiction
(Bechara, 2005; Goldstein et al., 2009; Goldstein & Volkow, 2011; Kwako, Momenan,
Litten, Koob, & Goldman, 2016; Miquel et al., 2016; Naqvi & Bechara, 2009; Noël et al.,
2013; Verdejo-García & Bechara, 2009; Verdejo-García, Lawrence, & Clark, 2008).
Broadly speaking, these findings highlight the role of three interacting neural systems: an
impulsive amygdala-striatum system, a reflective prefrontal cortex system, and the role
of the insula in translating the body’s interoceptive signals into subjective feelings of
craving (Noël et al., 2013). The cyclic nature of addiction is understood in the context of
chronic use resulting in aberrant neurocognitive changes, with the reflective system
reduced in its capacity to effect self-control, the impulsive system more reactive to states
and cues that trigger compulsive substance use, and an associated increase in the strength
of cravings and difficulties in their effective regulation.
While amygdala-striatum and prefrontal cortex systems, as well as the insula,
have been the main focus of neurocognitive addiction research, it has been proposed that
data-driven neuroscientific approaches (i.e., neuroimaging and/or genetic studies without
a priori hypotheses; e.g., Huys, Deserno, Obermayer, Schlagenhauf, & Heinz, 2016) may
aid the discovery of other brain regions or genes implicated in the onset, maintenance,
and treatment of addiction (DeVito et al., 2016). As an example of an alternate brain
region potentially implicated in addiction, Miquel and colleagues (2016) assert that the
cerebellum may play a key role in the neuroscience of addiction, given evidence
suggesting that drugs of abuse affect cerebellar functioning, its relationship to drugrelated memory cues, and contribution to functions involving the reflective prefrontal
cortex system. A further line of research has investigated the mechanisms of addiction at
the level of neurocircuitry, investigating complex relationships between cell-specific and
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synapse-specific processes that are implicated in addiction, with a particular focus on the
role of dopaminergic and glutamatergic neurotransmission in the striatum (Yager, Garcia,
Wunsch, & Ferguson, 2015).
These research developments promote neuroscience-based approaches to SUD
diagnosis and treatment, and may facilitate the use of neuroimaging methods to detect
potential biomarkers for addiction (e.g., Kwako et al., 2016), aiding in resolving some of
the pitfalls associated with using the presenting symptoms of SUD to establish diagnosis.
Despite the benefits associated with the use of biomarkers to guide clinical practice
(Huys, Maia, & Frank, 2016; Perlis, 2011), the translation of these findings has
progressed slowly and inconsistently (Franken & van de Wetering, 2015; Kwako et al.,
2016).

1.4.

BARRIERS TO EFFECTIVE TREATMENT
There are a variety of treatment approaches targeting SUD, yet significant barriers

to long-term recovery from addiction are commonly encountered during the treatment
process. Addictions are conceptualised as “chronic relapsing disorders” (Brandon,
Vidrine, & Litvin, 2007, p. 269), with high rates of relapse reported in the literature (Hunt,
Barnett, & Branch, 1971; Kirshenbaum, Olsen, & Bickel, 2009; Polivy & Herman, 2002).
For this reason, relapse prevention is a core component of SUD treatment (Hendershot,
Witkiewitz, George, & Marlatt, 2011). Multiple theories of relapse have been
documented, including learning theories, trait and individual-difference theories, and
self-regulatory theories (Brandon et al., 2007). Of these relapse theories, Marlatt and
Gordon’s (1985) cognitive-behavioural model of relapse has been the most influential in
the field of addiction treatment. This theory proposes that relapse occurs under high-risk
situations and involves a reduction in effective coping behaviour, leading to both reduced
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self-efficacy and increased incentive salience of substance use. These conditions may
lead the individual to engage in a lapse (i.e., a momentary rather than sustained return to
substance use), which Marlatt and Gordon’s model delineates from full-blown relapse. In
the event of a lapse, an individual’s cognitions and self-attributions influence the
likelihood of progression to relapse, with cognitive dissonance potentially leading to
dichotomous thinking (e.g., a shift from complete control vs. complete loss of control)
and an increase in the likelihood of relapse. A revised and expanded version of this
influential cognitive-behavioural model of relapse was subsequently developed, with
particular emphasis placed on the complexities and dynamic processes surrounding
relapse (Witkiewitz & Marlatt, 2004). The updated model considers the role of both intraand inter-personal processes in relapse, along with a distinction between distal and
proximal risk factors, and a greater focus on the temporal relationships between risk
factors.
While relapse is an important concept in the delivery of effective SUD treatment,
a further potential barrier to long-term recovery concerns the high rates of dropout from
treatment programs. The dropout rate in inpatient SUD treatment settings has been
estimated to be as high as 57% (Deane, Wootton, Hsu, & Kelly, 2012) and treatment
retention has been identified as an important factor in recovery from SUD (Brorson, Ajo
Arnevik, Rand-Hendriksen, & Duckert, 2013; Stark, 1992). For this reason, establishing
an understanding of factors associated with treatment completion and, conversely, early
dropout has been a research priority. Brorson and colleagues (2013) conducted a
systematic review of risk factors for dropout from addiction treatment, which included
122 studies from 1992 to 2013, involving 199,331 participants. The most consistently
reported risk factors were cognitive deficits, personality disorder, low treatment alliance,
and younger age.
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1.4.1. COGNITIVE DEFICITS
While the immediate effects of intoxication may produce acute behavioural and
cognitive changes, frequent and chronic substance use results in persistent alterations in
brain function, structure, and cognition as detected by neuroimaging and
neuropsychological assessment (Baldacchino, Balfour, Passetti, Humphris, & Matthews,
2012; Broyd, van Hell, Beale, Yücel, & Solowij, 2016; Caplan, Epstein, Quinn, Stevens,
& Stern, 2007; Ersche & Sahakian, 2007; Hart, Marvin, Silver, & Smith, 2012;
Lorenzetti, Fornito, Yücel, Solowij, & Lubman, 2014; Oscar-Berman & Marinković,
2007). As well as substance-specific effects, substance use may lead to broad changes in
cognition irrespective of the type of substance used; namely increased impulsivity and
deficits in episodic memory, decision-making, and inhibitory control (FernándezSerrano, Pérez-García, & Verdejo-García, 2011; Yücel & Lubman, 2007).
Deficits in behavioural inhibition are commonly observed in SUD, and may be
related to the onset and maintenance of the disorder (Smith, Mattick, Jamadar, & Iredale,
2014). These effects may be substance-specific, however, as they are commonly observed
in cocaine, methamphetamine, MDMA, tobacco, and alcohol users, but not consistently
in opioid or cannabis users. Higher levels of impulsivity, as assessed by delay discounting
tasks, which investigate the value assigned to future rewards as a function of temporal
delay, are also commonly observed in SUD populations and may be particularly
heightened in polysubstance users (Moody, Franck, Hatz, & Bickel, 2016).
Though cognitive deficits are commonly observed in chronic substance use,
findings indicate recovery of functioning in specific cognitive domains with abstinence,
with varying effects depending on the type of substance used (Schulte et al., 2014). For
example, with sustained abstinence, improvements in inhibition, verbal short-term
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memory, visuospatial abilities, and cognitive flexibly occur following cocaine
dependence; improvements in working memory, episodic memory, and sustained
attention following methamphetamine dependence; and selective attention following
heroin dependence (Schulte et al., 2014).
In addition to the cognitive deficits associated with chronic use of psychoactive
substances, additional comorbidities (pre-existing or substance-related) may also
contribute to impaired cognition in SUD populations; for example, neurodevelopmental
disorders (e.g., Molina & Pelham Jr., 2014), neurological conditions (e.g., Wang et al.,
2015), dementias (e.g., Kalapatapu et al., 2016), and traumatic brain injury (TBI). TBIs
refer to “a physiologically significant disruption of brain function resulting from the
application of external physical force” (Silver, McAllister, & Arciniegas, 2009, p. 653)
and frequently co-occur with SUD. SUD and TBI share a bidirectional relationship and
create significant challenges in the treatment process (Weil, Corrigan, & Karelina, 2016).
Of note, premorbid impairments in cognition may precede and be associated with
the development of SUD. In parallel with the association between low childhood IQ and
subsequent increased risk of certain adult mental disorders (Koenen et al., 2009), some
studies suggest a link between low premorbid IQ and the development of SUD (Chen,
Lawlor, Duggan, Hardy, & Eaton, 2006; Mahoney, Kalechstein, De Marco, Newton, &
De La Garza, 2017; Mortensen, Sørensen, Jensen, Reinisch, & Mednick, 2005).
Significantly, the recovery of cognitive functions associated with abstinence may be
related to premorbid functioning (Schulte et al., 2014).
Substance use during adolescence presents a unique risk regarding the
development of cognitive deficits in terms of the effects of psychoactive substances on
the developing brain. During this period of neuromaturation, adolescents are both more
likely to engage in substance use and also more vulnerable to the resulting detrimental
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effects on the brain (Conrod & Nikolaou, 2016). Persistent cognitive deficits in capacities
such as executive function may arise, representing a failure in the normal
neuromaturational process (Lubman, Cheetham, & Yücel, 2015; Lubman & Yücel, 2008;
Lubman, Yücel, & Hall, 2007).

1.4.1.1.

Executive dysfunction

The study of executive functions (EFs) has a long history, involving contributions
from several disciplines (e.g., neuropsychology, cognitive psychology, cognitive
neuroscience). For this reason, multiple models of EFs and respective forms of
assessment exist (Snyder, Miyake, & Hankin, 2015). Aside from theoretical differences
in the study of EFs, some epistemological issues have also been raised with regards to
paradigmatic differences between the disciplines noted above and the ensuing difficulties
that may arise in attempting to translate findings from the context of one discipline to
another (Labra-Spröhnle, 2016).
Traditionally, the role of EFs in human behaviour and cognition were explored
within neuropsychological studies of patients with frontal lobe damage, with the
observation that although several cognitive abilities remained intact, these patients
demonstrated personality changes and difficulties with goal-directed behaviour (Miyake
et al., 2000). A widely accepted conceptualisation of EFs within the field of clinical
neuropsychology

recognises

four

broad

behavioural

components:

volition,

planning/decision making, purposive action, and effective performance (Lezak,
Howieson, Bigler, & Tranel, 2012, p. 666). Various detailed neuropsychological models
and assessment methods for the study of EFs exist (for a review of models for adult
populations see Chan, Shum, Toulopoulou, & Chen, 2008).
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Within cognitive psychology, an influential model associated with EFs is
Baddeley’s (1986) multi-component working memory model, with the central executive
component postulated to control and integrate cognitive processes, including the activity
of the two other components, the phonological loop and the visuospatial sketchpad. A
key theoretical concern as the study of EFs progressed in both cognitive psychology and
neuropsychology, was the extent to which EFs could be considered as unitary in nature;
linked to a common, underlying mechanism (Miyake et al., 2000). Subsequently, a
prominent theory of EFs, known as the unity/diversity framework (Miyake & Friedman,
2012; Miyake et al., 2000), identified three core cognitive abilities linked to EFs and
moderately correlated, yet distinct: “updating (constant monitoring and rapid
addition/deletion of working memory contents), shifting (switching flexibly between
tasks or mental sets), and inhibition (deliberate overriding of dominant or prepotent
responses)” (Miyake & Friedman, 2012, p. 9).
In the study of EFs, cognitive neuroscience research has utilised neuroimaging
methods to identify the key brain regions and networks that may be implicated. A wealth
of research has examined the neural substrates of EFs, with multiple studies indicating
consistent involvement of frontal and parietal brain regions across a number of EF tasks,
but also some distinct brain regions associated with specific EF tasks (Friedman &
Miyake, 2017). For example, a review of the neural correlates of task-switching (i.e.,
effectively switching between multiple tasks) suggests that the inferior frontal junction
and posterior parietal cortex are consistently implicated (Kim, Cilles, Johnson, & Gold,
2012). Other studies have examined the role of cognitive control (i.e., the process of
regulating cognition and behaviour to reach internally represented goals) in EFs. For
example, the dual mechanisms of control framework (Braver, 2012), postulates that two
key modes are involved in cognitive control: proactive control and reactive control. The
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neural basis of proactive control is thought to involve sustained and anticipatory
maintenance of goal-related information within the lateral prefrontal cortex, whereas
reactive control involves this brain region and also a wider brain network, in the transient
detection of stimuli that may interfere with goal-pursuit.
Along with the general impairments in cognition observed in SUD populations
described above, findings indicate that specific impairment of EFs is commonly
associated with chronic substance use, and is implicated in the maintenance of the
disorder (Blume & Marlatt, 2009; Fernández-Serrano, Pérez-García, Perales, & VerdejoGarcía, 2010; Fernández-Serrano, Pérez-García, Río-Valle, & Verdejo-García, 2010;
Gierski et al., 2013; Hester et al., 2010; Moreno-López et al., 2012; Perry et al., 2011). It
is proposed that EF deficits may impede the process of addiction treatment, as the
cognitive abilities required for optimal treatment engagement and benefit may be
compromised (Blume & Marlatt, 2009). For these reasons, EF deficits may play a key
role in determining treatment outcomes and long-term abstinence. For example, a recent
systematic review examined the role of EF deficits in SUD treatment outcomes and found
that reward-based decision-making was linked to relapse, while general cognition was
associated with adherence to treatment (Domínguez-Salas, Díaz-Batanero, LozanoRojas, & Verdejo-García, 2016). Given the prevalence and impact of EFs on the process
of SUD treatment and long-term recovery from addiction, it is proposed that the
development of interventions to improve EFs may increase the likelihood of individuals
engaging with and benefitting from treatment, while capitalising on the neuroplasticity of
the brain and potential recovery of cognitive abilities associated with abstinence
(Copersino, 2017; Manning, Verdejo-García, & Lubman, 2017).
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1.4.2. COMORBID PSYCHIATRIC DISORDERS
Along with the general deficits in cognition and specific impairment of EFs
commonly observed in SUD populations that may interfere with SUD treatment,
psychiatric disorders also frequently co-occur with SUDs and impede the treatment
process (Baingana, al'Absi, Becker, & Pringle, 2015; Baker, Thornton, Hiles, Hides, &
Lubman, 2012; Burns & Teesson, 2002; Grant et al., 2015; Grant et al., 2016; Grant et
al., 2004; Lubman, Allen, Rogers, Cementon, & Bonomo, 2007). These include major
depressive disorder, dysthymia, bipolar I, generalised anxiety disorder, panic disorder,
social phobia, posttraumatic stress disorder, and antisocial, schizotypal, and borderline
personality disorders (Grant et al., 2015; Grant et al., 2016). As well as adding complexity
to the process of treatment (Flynn & Brown, 2008; McGovern, Xie, Segal, Siembab, &
Drake, 2006), comorbid psychiatric and SU disorders are associated with poorer
treatment outcomes (González-Saiz, Vergara-Moragues, Verdejo-García, FernándezCalderón, & Lozano, 2014; Melchior, Prokofyeva, Younès, Surkan, & Martins, 2014).
Comorbid personality disorder, in particular, is highly prevalent within SUD
populations (Bowden-Jones et al., 2004; Grant et al., 2015; Grant et al., 2016; Tomko,
Trull, Wood, & Sher, 2014) and has been identified as one of the most consistently
reported risk factors for early dropout from SUD treatment (Brorson et al., 2013). The
clinical and aetiological complexities surrounding comorbid personality disorder and
SUD have been documented (Lee, Cameron, & Jenner, 2015; McMain & Ellery, 2008;
Pennay et al., 2011; Trull, Sher, Minks-Brown, Durbin, & Burr, 2000; Verheul, 2001).
For example, comorbid personality disorders and SUDs are associated with complex
clinical presentation and poor prognosis (McMain & Ellery, 2008). Additionally, there is
significant overlap between aetiological factors involved in both disorders (Trull et al.,
2000).
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Borderline personality disorder (BPD) is estimated to occur in up to 65% of those
in SUD treatment (Trull et al., 2000). Trull and colleagues (2000) proposed a theoretical
model recognising the significant role played by emotion regulation deficits and increased
impulsivity in the aetiology of both BPD and SUD. This model recognises the interaction
between

neurobiological

vulnerabilities

and

family-environmental

factors

in

predisposing an individual to develop comorbid BPD and SUD.
While comorbid personality disorder, particularly BPD, and SUD are common,
may share aetiological factors, and lead to poorer addiction treatment outcomes, a
separate line of research has investigated the neurocognitive deficits specifically
associated with BPD (Fertuck, Lenzenweger, Clarkin, Hoermann, & Stanley, 2006;
Ruocco, 2005; Ruocco & Carcone, 2016; Unoka & Richman, 2016). In general, BPD
populations demonstrate global neurocognitive deficits, with the most robust evidence of
dysfunction in EFs, decision-making, and memory domains (Unoka & Richman, 2016).
Furthermore, neuroimaging techniques have identified structural and functional
abnormalities in frontomedial and temporolimbic structures and their connectivity in
BPD (Ruocco, Amirthavasagam, Choi-Kain, & McMain, 2013; Salvador et al., 2016;
Schulze, Schmahl, & Niedtfeld, 2016; van Zutphen, Siep, Jacob, Goebel, & Arntz, 2015;
Winsper et al., 2016).
SUD and personality disorder are associated with specific cognitive deficits, are
commonly comorbid, and create significant complexities in the process of addiction
treatment. Studies have also examined the neurocognitive deficits that occur in comorbid
personality disorder and SUD. For example, cognition in cocaine-dependent samples
including those with comorbid personality disorders has been investigated (Albein-Urios,
Martínez-González, Lozano-Rojas, & Verdejo-García, 2014; Albein-Urios et al., 2013).
The profile of EFs in an SUD sample with comorbid cluster B (e.g., BPD, antisocial) and
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cluster C (e.g., avoidant and obsessive-compulsive) personality disorders was explored,
with poorer outcomes in attention/inhibition and working memory found in cluster B and
cluster C groups, respectively (Albein-Urios et al., 2014). Additionally, cocainedependent participants with comorbid personality disorders, compared to those without
comorbidities, demonstrated poorer response inhibition and attention regulation, as well
as reduced grey matter of the right temporal pole (Albein-Urios et al., 2013). Further
neuroimaging research has demonstrated that readiness to change problematic substance
use in cocaine-dependent individuals is correlated with ventromedial prefrontal grey
matter and is modulated by comorbid personality disorder (Moreno-López, Albein-Urios,
Martinez-Gonzalez, Soriano-Mas, & Verdejo-García, 2014).

1.5.

SELF-REGULATION AND EXECUTIVE FUNCTIONS
The fields of social and personality psychology have studied the protective

capacity of self-regulation, broadly defined as those qualities enabling humans “to live
cooperatively, achieve important goals and maintain health throughout their life span”
(Heatherton & Wagner, 2011, p. 132). Addiction can be understood as a failure of selfregulation. A theoretical account of addiction as self-regulation failure proposes a major
distinction between underregulation and misregulation, with the former corresponding to
instances in which an individual fails to exert appropriate regulatory actions, and the latter
to the misguided or counterproductive exertion of regulatory actions (Baumeister &
Heatherton, 1996). This theory postulates that effective self-regulation entails three core
ingredients: standards, monitoring, and operating. Standards refer to the process of
establishing internalised goals and objectives, monitoring involves comparing these goals
with current actions and states, and operating refers to initiating alternative behaviours in
situations where discrepancies between goals and current behaviours are identified.
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Strength models of self-regulation posit that self-regulatory capacity is a limited resource
that is renewable over time, is affected by the strength of an impulse, and can be increased
or decreased in relation to situational factors and individual differences (Baumeister &
Heatherton, 1996). More recently, the cognitive neuroscience of addiction has aided in
refining models of self-regulation. These findings support balance models of selfregulation, in which top-down control arising from prefrontal brain regions is involved in
a dynamic relationship with subcortical brain regions involved in emotional and rewardbased responding (Heatherton & Wagner, 2011; Kelley, Wagner, & Heatherton, 2015).
Recently, the study of EFs in cognitive psychology and neuroscience has started
to converge with the study of self-regulation, which has historically been investigated in
social and personality psychology (Heatherton & Wagner, 2011; Hofmann, Schmeichel,
& Baddeley, 2012). Specifically, it has been proposed that EFs may provide a
neurocognitive basis for self-regulation and that, consequently, training of EFs may
improve self-regulation (Hofmann et al., 2012). Effective self-regulation enables
individuals to successfully navigate tempting situations in which the strength of an
impulse that conflicts with an internalised standard or goal threatens to result in a loss of
behavioural control. There are several capacities related to effective self-regulation; for
example, emotion regulation, self-control, and regulation of cravings (Hofmann et al.,
2012).
Emotions have been defined as “sets of cognitive, subjective, physiological and
motor changes that arise from an individual's conscious or non-conscious determination
that a stimulus has a positive or negative value in a particular context and with respect to
that individual's currently active goals” (Etkin, Büchel, & Gross, 2015, p. 693). Emotion
regulation, therefore, is the process of managing emotions; altering their intensity and
duration, according to our goals (Gross, 2013; Gross, Sheppes, & Urry, 2011).
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Neuroimaging studies have identified two broad types of emotion regulation: implicit and
explicit (Etkin et al., 2015). Explicit regulation is characterised by a conscious, effortful
implementation of regulation strategies and is associated with activation of regions in the
frontoparietal executive network of the brain, whereas implicit regulation is evoked
automatically, without conscious awareness, and with a neural basis of activation in the
ventral anterior cingulate and ventromedial prefrontal cortex (Etkin et al., 2015).
Emotion dysregulation is increasingly acknowledged as a transdiagnostic process
playing a central role in the onset and maintenance of diverse psychopathologies (Aldao,
Nolen-Hoeksema, & Schweizer, 2010; Broome, He, Iftikhar, Eyden, & Marwaha, 2015;
Kret & Ploeger, 2015). In the realm of addiction, emotion dysregulation is considered to
substantially influence an individual’s vulnerability to SUD, the progression from
experimentation to abuse, and the continuing maintenance of the disorder; for this reason
SUD has also been conceptualised as “a disorder of affect” (Cheetham, Allen, Yücel, &
Lubman, 2010, p. 631).
Self-control and regulation of cravings arising in the context of substance-cues
are further aspects of self-regulation that play a significant role in addiction. Deficits in
self-control are pronounced in SUD populations, associated with compulsive drugseeking behaviour, and reflect neuroadaptations in brain regions implicated in cognitive
control, particularly the anterior cingulate and adjacent prefrontal cortex (Tang, Posner,
Rothbart, & Volkow, 2015). Furthermore, the role of substance-cues and related cravings
play a significant role in the self-regulation failure inherent to addiction (Heatherton &
Wagner, 2011). It is proposed that self-control may be increased through targeted
interventions that strengthen the corresponding brain regions, to potentially reduce
problematic substance use (Tang et al., 2015).
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In light of the significant connections between EFs, associated brain regions, and
self-regulatory capacities such as emotion regulation, self-control, and regulation of
cravings arising in the context of substance-cues – and the potential to strengthen these
capacities through targeted interventions – it is plausible that individuals with SUD may
benefit from interventions designed to improve EFs and potentially boost self-regulation
capacity.

1.6.

INTERVENTIONS TO IMPROVE COGNITION
In the context of this thesis, the term cognitive training will be defined as

“behavioral treatment for cognitive impairment that targets cognitive skills and fosters
improvement through the practice of compensatory and/or restorative strategies” (Choi
& Twamley, 2013, p. 49). Interventions targeting cognition tend to utilise two broad
methods: drill and practice and strategy-based (Wykes, Huddy, Cellard, McGurk, &
Czobor, 2011). Drill and practice methods refer to repeated practice of cognitive skills
with the aim of restoring premorbid abilities whereas strategy-based approaches entail
learning compensatory strategies to minimise cognitive demands (Choi & Twamley,
2013). Cognitive remediation was borne out of the field of neuropsychology and may
utilise either drill and practice or strategy-based methods, and often includes a
combination of these approaches, with the aim of facilitating durable improvements in
cognition that generalise to functional outcomes (Wykes et al., 2011). In this thesis, the
term cognitive remediation will be used to refer to cognitive training interventions that
include strategy-based methods – alone or in combination with drill and practice methods.
Sometimes the term cognitive rehabilitation is used interchangeably with cognitive
remediation, and there is some disagreement in regards to the specificity of these broad
definitions (Bryce, Lee, Ponsford, & Rossell, 2016).
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A range of cognitive training interventions have been utilised in various clinical
populations in attempts to improve cognition and clinical outcomes. Cognitive
remediation interventions have been most notably applied in schizophrenia (e.g., Wykes
et al., 2011) and acquired brain injury (ABI) populations (e.g., Virk, Williams, Brunsdon,
Suh, & Morrow, 2015). An early meta-analysis of cognitive remediation for
schizophrenia populations yielded medium effect sizes for cognitive performance,
slightly lower effect sizes for psychosocial functioning, and small effect sizes for
symptoms (McGurk, Twamley, Sitzer, McHugo, & Mueser, 2007). A more recent metaanalysis found small to moderate effects for cognition and functioning, which were
durable and did not vary as a result of intervention characteristics (Wykes et al., 2011).
Cognitive remediation interventions also lead to reductions in the negative symptoms of
schizophrenia (Cella, Preti, Edwards, Dow, & Wykes, 2017) and significantly greater
employment and productivity outcomes for patients with schizophrenia and other severe
mental illnesses (Chan, Hirai, & Tsoi, 2015), potentially through improved
neurobiological functioning in frontal brain regions (Isaac & Januel, 2016). However, a
recent methodological critique of systematic reviews and meta-analyses of cognitive
remediation for schizophrenia found some consistent areas of methodological weakness,
including lack of protocol registration, uncertainty regarding the use of independent data
extraction procedures, and a lack of publication bias assessment, warranting the careful
interpretation of these results (Bryce, Lee, Rossell, Sloan, & Ponsford, 2016).
A systematic review and meta-analysis of cognitive remediation in ABI
populations found short-term improvements in divided attention following stroke, but no
improvements in any other domain of attention across populations (Virk et al., 2015). A
meta-analysis investigating the effects of occupation-based cognitive rehabilitation for
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traumatic brain injury found small effect sizes for cognition and activities of daily life
(Park, Maitra, & Martinez, 2015).
In contrast to cognitive remediation, another approach to cognitive training
utilises computerised training platforms, with a primary focus on the drill and practice
approach, generally to the exclusion of strategy-based methods. In this thesis, the term
computerised cognitive training will be used to refer to cognitive training interventions
that utilise drill and practice methods only. Brain training represents one such area in
which computerised cognitive training is commercially marketed as a method to improve
cognitive abilities in healthy populations (Simons et al., 2016). Although improvements
in the targeted cognitive tasks are observed, there is a lack of evidence to suggest that
transfer of these improvements to untrained but closely related tasks occurs (Owen et al.,
2010; Simons et al., 2016). A separate line of research has investigated the effects of
computerised working memory training in learning disorder and nonclinical populations,
with findings indicating only short-term benefits of training with regard to the targeted
cognitive domains and also a lack of transfer to untrained, clinically meaningful tasks
(Melby-Lervåg, Redick, & Hulme, 2016). Despite the lack of empirical evidence for the
effectiveness of brain training in healthy populations and working memory training,
preliminary evidence suggests that computerised cognitive training may be beneficial in
certain psychiatric disorder populations. For example, computerised cognitive training
has been used in major depressive disorder populations, producing moderate-large effects
for global cognition, attention, and working memory, as well as small-moderate effects
for symptom severity and daily functioning (Motter et al., 2016). Additionally,
computerised working memory training was investigated in a sample of individuals with
elevated trait anxiety, with findings suggesting improvements in attentional control, and
with some transfer effects observed (Sari, Koster, Pourtois, & Derakshan, 2015). There
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is also preliminary evidence supporting the use of cognitive training interventions (i.e.,
mixed cognitive remediation and computerised cognitive training) in eating disorder
populations (Brockmeyer et al., 2014; Brockmeyer et al., 2016; Dingemans et al., 2013;
Tchanturia, Lounes, & Holttum, 2014), schizoaffective disorders (Anaya et al., 2012),
mild cognitive impairment and dementia populations (Coyle, Traynor, & Solowij, 2015),
and borderline personality disorder (Vita et al., 2016).
While there is a lack of evidence suggesting that computerised cognitive training
produces improvements in untrained tasks in healthy populations, some studies have
found beneficial effects on untrained tasks and improvements in functioning in some
clinical populations. It is important to consider potential explanations for this
discrepancy. Recent theories of transfer implicate two key concepts: content and contexts,
and their interaction (Simons et al., 2016). Content refers to what is learnt as a result of
computerised cognitive training interventions and contexts refer to the environments in
which learning and potential future transfer of this learning occurs. The skills taught
through computerised cognitive training interventions may vary in level of specificity,
with some interventions focussing on a narrow range of highly specific skills, and others
targeting broader sets of skills. The context of learning may also vary significantly across
intervention studies in terms of knowledge domain (e.g., working memory training vs.
mixed cognitive training), physical location of the training intervention, intended
purposes of the training, and whether individuals use acquired skills individually or in the
context of other people. In this way, it may be that highly specific computerised cognitive
training interventions may result in less transfer to untrained tasks, whereas broader more
strategy-based interventions result in a greater likelihood of transfer and improved
functional outcomes (Simons et al., 2016). Differences in study design and
methodological quality may also account for the discrepancies between studies reporting
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beneficial outcomes from computerised cognitive training interventions; crucially, these
may be related to the wide variety of interventions employed (Bryce, Lee, Ponsford, et
al., 2016; Simons et al., 2016). Selection of outcome measures may also significantly
influence findings and where multiple measures of a targeted cognitive construct are
included, there may be a greater likelihood of detecting improvements in cognition
(Simons et al., 2016). Finally, the improvements in cognition and functional outcomes
displayed in computerised cognitive training for certain clinical populations vs. healthy
populations may indicate potential ceiling effects for healthy populations who
presumably demonstrate less cognitive dysfunction and problems in everyday
functioning.
In summary, evidence suggests beneficial effects of cognitive training in various
populations, most notably schizophrenia and ABI, but also preliminary evidence for
major depressive disorder, individuals with elevated trait anxiety, eating disorders,
schizoaffective disorders, mild cognitive impairment and dementia populations, and
borderline personality disorder.

1.6.1. COGNITIVE TRAINING FOR SUD
While cognitive training interventions have demonstrated beneficial effects in
other populations, only recently have these interventions been investigated as a potential
treatment for SUD populations. This is theoretically coherent in light of the significant
cognitive deficits and executive dysfunction observed in SUD populations, and their
deleterious effects on the process of treatment (Bates, Bowden, & Barry, 2002). Emerging
research has evaluated cognitive training interventions to improve cognition and selfregulation, with the ultimate goal of increasing treatment retention and facilitating longterm recovery from SUD.
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A recent review of the literature regarding cognitive training for SUD identified
studies that investigated the effects of four specific types of cognitive training
intervention: cognitive bias modification (CBM), response inhibition, working memory,
and goal-directed interventions (Verdejo-García, 2016). With regard to proposed
underlying mechanisms of these training interventions, they were classified into two
distinct classes: a bottom-up reorientation of tendencies towards impulsive behaviours
through training effects on the medial prefrontal cortex and amygdala (i.e., CBM and
response inhibition) and a top-down strengthening of EFs through training effects on the
dorsolateral and ventrolateral prefrontal cortices (i.e., working memory and goal-directed
interventions). Findings indicated that CBM resulted in decreased alcohol-approach
biases and reduced alcohol use in the long-term; response inhibition training also resulted
in reduced alcohol-approach biases and reduced alcohol use in community samples;
working memory training resulted in reduced heavy alcohol use in a community sample
partially through its effects in moderating impulsive responding; and goal-directed
approaches resulted in increased working memory capacity and cognitive control.
While these findings represent significant preliminary evidence for the
effectiveness of cognitive training for SUD, there are many gaps in this emerging area of
research. For example, there is a notable lack of studies investigating the effects of
working memory training and goal-directed approaches, and studies that examine not
only cognitive outcomes but also significant clinical outcomes (e.g., craving, quality of
life, relapse to substance use, treatment retention) are required (Verdejo-García, 2016).
Furthermore, there is a lack of studies investigating the effects of cognitive training
interventions that include participants with psychiatric comorbidities or who have a
history of head injury, both common comorbidities in SUD populations. Additionally,
there is also a lack of studies that have investigated the long-term effects of cognitive
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training for SUD through the inclusion of a longitudinal follow-up of outcomes. As the
research investigating cognitive training for SUD grows, an important objective will be
gathering further data to inform an understanding of the mechanisms through which
cognitive training interventions exert their effects (e.g., Gladwin, Wiers, & Wiers, 2017)
and also understanding the complex relationships between cognition, particularly EFs,
and self-regulation capacities.

1.7.

RESEARCH AIMS
The broad aims of this thesis were to assess cognitive functioning in an SUD

sample attending residential treatment and determine the effectiveness of a
neuropsychologically based intervention. Initially, the cognitive functioning of residents
in SUD TC treatment was explored and characterised. This served to inform the next aim
of this thesis; the implementation and evaluation of a cognitive training intervention
within this residential SUD sample. Given the impairment of EFs in SUD populations,
the proposed link between EFs and self-regulation, and preliminary evidence suggesting
a role for cognitive training interventions in improving SUD treatment outcomes, a
cognitive remediation intervention specifically targeting executive dysfunction was
developed and evaluated. With regard to the lack of studies investigating the effects of
cognitive training in SUD populations with comorbid psychiatric diagnoses and history
of head injury, participants with these comorbidities were included. Additionally, clinical
outcome measures relating to cravings, quality of life, and relapse to substance use were
included, given the lack of prior studies assessing these outcomes. Along with the aim of
evaluating a cognitive remediation intervention, an additional aim of this thesis was to
investigate the long-term effects of cognitive remediation through the inclusion of a
longitudinal follow-up study. Finally, this thesis aimed to explore the relationships
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between EFs and emotion regulation, to provide further data that may inform the
development of novel cognitive training interventions.
This thesis comprises three studies, forming four publications included as
chapters. The findings of study one are presented in Chapter 2, those of study two are
presented in Chapters 3 and 4, and those of study three in Chapter 5. Chapter 2 provides
an overview of cognitive functioning in a snapshot sample of Australian TC residents in
treatment for SUD, exploring variation with regard to demographic characteristics and
other comorbidities. This was an important starting point for this thesis, and provided
significant data regarding the prevalence and nature of cognitive impairment among
typical clients residing in Australian SUD TCs at any given time, with no exclusions.
These data, along with the findings of the existing literature presented during this chapter,
contributed to the development and implementation of a cognitive remediation
intervention in this population.
Chapter 3 is comprised of the evaluation of a novel cognitive remediation
intervention to address executive dysfunction in an SUD sample in residential therapeutic
community treatment, including those with psychiatric comorbidities and history of head
injury.
Chapter 4 contributes longitudinal data to this research area by investigating
outcomes of the cognitive remediation intervention at three-month follow-up, including
measures of self-regulation, quality of life, and clinical outcomes measures, such as
quality of life and relapse to substance use.
Given the important role of emotion dysregulation in SUD, and the proposed link
between self-regulation capacities such as emotion regulation and EFs, Chapter 5
explores the relationships between EFs and emotion regulation, with the aim of

27

elucidating ways in which specific basic EFs (i.e., working memory, task-switching,
and/or inhibition) may be related to effective emotion regulation.
Finally, Chapter 6 provides an overview and synthesis of the findings presented
in the previous chapters, clinical implications, limitations and future research directions
in the area of cognitive training for SUD populations.
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2.1.

ABSTRACT

Introduction: Retaining clients in residential alcohol and other drug (AOD) treatment is
difficult and cognitive impairment has been identified as a significant predictor of
treatment dropout. The application of extensive screening for cognitive impairment is
cost-prohibitive for most AOD treatment services. The current study aimed to explore
cognitive functioning and impairment-associated factors in a typical sample of residential
AOD clients using a free brief screening tool that could be utilised by front-line AOD
services.
Methods: Residents of an AOD therapeutic community (n = 128) and a non-substance
using control group (n = 37) were administered a brief cognitive screening measure, the
Montreal Cognitive Assessment (MoCA). MoCA total and domain scores were compared
between these groups and within the AOD group examined in association with primary
substance of misuse, severity of dependence, gender, psychological distress, and history
of head injury.
Results: Almost half (43.8%) of the AOD sample were identified as cognitively impaired,
compared to 16.2% of the control group. Furthermore, 67.2% of the AOD sample had
sustained head injuries and 50% of the sample required hospitalization for head injury.
History of head injury was a significant determinant of cognitive impairment, and
associated with greater levels of psychological distress.
Conclusions: There are high rates of inter-related cognitive impairment, head injuries,
and psychological distress among clients in residential AOD treatment. Routine screening
of clients at intake for cognitive impairment by means of a brief screening measure such
as the MoCA, in combination with the assessment of history of head injuries and
comorbid psychological disorders, could inform treatment modifications or adjunct
interventions to increase retention and improve long-term outcomes.
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2.2.

INTRODUCTION
Therapeutic communities (TCs) are a form of residential rehabilitation for

individuals experiencing chronic and severe alcohol and other drug (AOD) problems and
may particularly suit clients with associated comorbidities and other complexities as they
place an emphasis on fostering social support within the community of residents in order
to promote treatment engagement and completion. Dropout from AOD treatment in
general is estimated to be as high as 57% in inpatient settings (Darke, Campbell, &
Popple, 2012; Deane, Wootton, Hsu, & Kelly, 2012; Vergara-Moragues, Gonzalez-Saiz,
Lozano, & Verdejo-García, 2013). Importantly, length of stay in TCs has been shown to
be related to neurocognitive capacity (Fals-Stewart & Lucente, 1994; Fals-Stewart &
Schafer, 1992; Fernández-Serrano, Pérez-García, Perales, & Verdejo-García, 2010). An
extensive systematic review reported that cognitive deficits were one of the most
consistently reported risk factors for dropout from AOD treatment, alongside personality
disorder, low treatment alliance, and younger age (Brorson, Ajo Arnevik, RandHendriksen, & Duckert, 2013).
It is likely that most residential substance misuse programs deliver treatments that
work optimally in those who possess intact cognitive abilities; that cognitive impairment
among residents may hinder treatment success requires further consideration.
Components of residential AOD treatment often rely on capacities such as executive
function (defined broadly as “those capacities that enable a person to engage successfully
in independent, purposive, self-directed, and self-serving behavior”; Lezak, Howieson,
Bigler, & Tranel, 2012, p. 37) and working memory (Fernández-Serrano, Pérez-García,
Río-Valle, & Verdejo-García, 2010; Yücel & Lubman, 2007), as clients are required to
integrate new information, formulate goals, establish new behavioural strategies, and plan
for the future in overcoming addiction.
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However, most misused substances impair attention, learning and memory,
visuospatial abilities, and executive functioning, with perhaps the most robust deficits
across all substances evident in inhibitory control, working memory, and decisionmaking (Fernández-Serrano, Pérez-García, Río-Valle, et al., 2010; Yücel & Lubman,
2007; Yücel, Lubman, Solowij, & Brewer, 2007). Structural and functional brain changes
may occur after substance misuse (Broyd, van Hell, Beale, Yücel, & Solowij, 2016;
Caplan, Epstein, Quinn, Stevens, & Stern, 2007; Ersche & Sahakian, 2007; Gonzalez,
2007; Gruber, Silveri, & Yurgelun-Todd, 2007; Lorenzetti, Solowij, & Yücel, 2016;
Oscar-Berman & Marinković, 2007; Scott et al., 2007). Traumatic brain injury (TBI) is
also highly prevalent in substance misuse populations, leading to significant complexities
in the process of AOD treatment (Sacks et al., 2009; Solomon & Malloy, 1992; Walker,
Cole, Logan, & Corrigan, 2007; West, 2011).
Although cognitive dysfunction is common in AOD samples and increasingly
recognized by staff, there is often insufficient time or resources to implement detailed
neuropsychological assessments. Cognitive assessment may be instrumental in
facilitating the detection of AOD clients with clinically significant cognitive impairment,
irrespective of etiology. Assessing clients' cognitive capacities can inform subsequent
implementation of strategies aimed at improving treatment retention and outcomes.
In the AOD treatment environment a brief but valid and reliable measure is
required. This would provide an indication of potential cognitive dysfunction and alert
staff to the possibility that further neuropsychological assessment and/or treatment
modifications may be indicated. The Montreal Cognitive Assessment (MoCA;
Nasreddine et al., 2005) comprises 12 items that tap five key neuropsychological
domains: executive function, working memory, short-term memory, language, and
visuospatial ability. The MoCA takes 15 minutes to administer, is a free resource
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(Nasreddine, 2015), and can be administered by staff without formal neuropsychological
training. Initial studies have found evidence supporting the use of the MoCA in AOD
treatment settings (Copersino et al., 2009; Copersino et al., 2012).
The current study was exploratory in nature and sought to provide a naturalistic
overview of a sample of Australian TC residents, with the MoCA administered as a brief
screening measure to assess neuropsychological functioning. Performance on the MoCA
was investigated in relation to demographic, substance use, psychological, and other
variables related to impairments in cognition, including TBI.

2.3.

MATERIAL AND METHODS
2.3.1. PARTICIPANTS
The AOD group was recruited from We Help Ourselves (WHOs), a large provider

of residential AOD treatment in Australia that uses the therapeutic community model of
treatment. Participants were recruited across seven WHOs sites in New South Wales
(Sydney, Hunter Valley) and Queensland (Sunshine Coast). The response rate was
approximately 90%. Specific inclusion and exclusion criteria were not applied in order to
capture the heterogeneous and complex presentations of residential AOD treatment
populations and to increase the generalizability of results. Although there was no formal
assessment of substance use disorders using the Diagnostic and Statistical Manual of
Mental Disorders (5th ed.; DSM-5; American Psychiatric Association, 2013) criteria it
was assumed that residents would meet these criteria given their attendance at a highintensity residential program.
A control group was recruited through the University of Wollongong College, a
provider of educational programs to persons who have not completed high school
matriculation, as an alternative pathway to tertiary study. All students were invited to
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participate and the response rate was approximately 60%. Control participants, all native
English speakers, were excluded for any lifetime dependence on or treatment for alcohol
or other drugs, and any psychiatric or neurological diagnoses.

2.3.2. PROCEDURE
After a group information session, interested participants provided written
consent and were individually assessed in a quiet testing room. This was conducted within
the TC facility for the AOD group, and at a University psychology clinic for the control
group. The MoCA was administered in approximately 15 minutes, adhering to the
administration and scoring guidelines (Nasreddine, 2015). Additional information (e.g.,
basic demographics, history of head injury, current and past substance use for controls)
was obtained through a 10-minute semi-structured interview and the Kessler
Psychological Distress Scale (K10; Kessler et al., 2002) was administered, as well as the
Severity of Dependence Scale (SDS; Gossop et al., 1995) for the AOD group. Control
participants received a $20 gift card as reimbursement for their time.

2.3.3. MEASURES
2.3.3.1.

MoCA

The MoCA was used to assess neuropsychological functioning across its
purported five domains (executive function, working memory, short-term memory,
language and visuospatial ability). Executive function is assessed using trail-making,
phonemic fluency, and verbal abstraction tasks. Working memory is assessed using
sustained attention, serial subtraction, and digit span forward/backward tasks. Short-term
memory is assessed through the delayed recall of five nouns. Language is assessed using
naming (low familiarity animals), sentence repetition, and the phonemic fluency task.
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Visuospatial ability is assessed using clock-drawing and cube-copying tasks. The MoCA
has displayed acceptable reliability in clinical groups (Bernstein, Lacritz, Barlow,
Weiner, & DeFina, 2011; Freitas, Simões, Marôco, Alves, & Santana, 2012). Outcome
measures included total MoCA score and domain subscores.

2.3.3.2.

Clinical variables

The SDS (Gossop, Best, Marsden, & Strang, 1997) measured AOD participants'
level of dependence on their primary substance of misuse. The K10 was used to capture
level of psychological distress experienced by all participants. The K10 has been
extensively used in both community and clinical samples as an indicator of a potential
psychological disorder, and has demonstrated acceptable psychometric properties
(George, Kinner, Bruno, Degenhardt, & Dunn, 2010; Hides et al., 2007; Sunderland,
Mahoney, & Andrews, 2012). Relevant demographic and substance use data routinely
collected by WHOs were accessed, following participants and the director of the service
providing written consent.

2.3.4. DATA ANALYSIS
All data were analyzed using IBM Statistical Package for the Social Sciences
(version 19; IBM Corp, 2010). The primary goals of the analysis were to compare the
performance of residents and controls on the MoCA and to explore variation in MoCA
scores and potential predictors (e.g., primary substance of misuse, gender effects) within
the AOD sample.
Shapiro–Wilk statistics and visual inspection of histograms and boxplots
determined that total MoCA score, MoCA domain subscores, age, years of education,
K10 and SDS scores were not normally distributed for both AOD and control groups.
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Consequently, nonparametric techniques were employed for most of the analyses.
Nonparametric analysis of covariance was required for some analyses to enable covarying
demographic characteristics that differed between groups. Quade’s (1967) distributionfree procedure was used as a nonparametric alternative to analysis of covariance (see
Olejnik & Algina, 1985). This involved ranking the dependent variable and all covariates
for all cases, ignoring the grouping variable. Following this, the linear regression of the
ranked dependent variable on the ranked covariate measure was calculated and the
unstandardized residuals saved, again ignoring the grouping factor. To calculate Quade's
F statistic, a one-way analysis of variance using the residuals from the regression as the
dependent variable and the grouping variable as the factor was performed.
Total MoCA score and cognitive domain subscores were the primary dependent
variables for analysis. However, factor analyses of the MoCA have demonstrated that
domains may be grouped differently (e.g., Duro, Simões, Ponciano, & Santana, 2010;
Freitas et al., 2012). Given the multi-process nature of neuropsychological tasks, whereby
any single task may tap into a range of perceptual, cognitive and motor abilities, and the
overlapping nature of the cognitive domains assessed by the MoCA (Freitas et al., 2012),
we created an additional score for analysis of executive function. This was of particular
interest because executive dysfunction is especially common in substance misusing
individuals (e.g., Fernández-Serrano, Pérez-García, Río-Valle, et al., 2010; Gierski et al.,
2013; Hester, Lubman, & Yücel, 2010; Perry et al., 2011). As such, we utilized the
standard measure of executive function from the MoCA as well as an extended measure
that included performance on the visuospatial cube-copying and clock-drawing tasks,
with the rationale that these tasks rely on key component processes of executive function.
All AOD residents were compared to controls in the first instance. Residents were
then compared in terms of gender and primary substance of misuse. Primary substance of
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misuse groupings were formed by choosing the three largest representative groups in
residence at the time of testing (alcohol, heroin and amphetamines). A broader opiates
group was then formed by the addition of clients on methadone maintenance and
buprenorphine users. Cocaine users, minimal in Australian AOD samples (Australian
Institute of Health and Welfare, 2005), were grouped with amphetamine users to form a
stimulants group. This strategy maximized group sizes for comparison, grouping together
substances with similar chemical properties. However, primary users of cannabis,
tranquilisers and benzodiazepines were not grouped or included in these comparisons due
to insufficient sample sizes of these subgroups (see Results). Finally, AOD users
hospitalized after a head injury were compared to those without serious head injuries.

2.4.

RESULTS
2.4.1. PRELIMINARY ANALYSES
MoCA data were available for 128 AOD residents and 37 controls. For some

analyses, the AOD sample was reduced to 95 due to missing data (e.g. primary substance
of misuse, n = 16; SDS and K10 scores, n = 33). Table 1 displays demographic, substance
use, psychological, and cognitive functioning variables for the AOD group. AOD
residents were in their mid-thirties on average and predominantly male. Alcohol was the
primary substance of misuse for almost one-third of the sample, followed by heroin and
amphetamine misuse, with these three substances accounting for approximately 80% of
the entire AOD sample. The mean K10 score indicated very high levels of psychological
distress and the mean SDS score indicated high levels of psychological dependence on
participants' primary substance of misuse, although the range extended to 0 in some cases,
reflecting that some residents had progressed further in their treatment. The prevalence
of head injuries was particularly high in the sample.
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Table 1. Demographic, substance use, psychological, and clinical variables for the AOD group (n =
128).
Age (Mdn, range)

35 (19-56)

Gender (% male)

70.3

Education (Mdn, range)

10 (7-16)

Unemployed (%)

90.5

a

Homeless (%)

7.4

Arrested during last three monthsa (%)

43.2

b

Primary substance of misuse (%)

c

Alcohol

30.4

Heroin

27.7

Amphetamines

20.5

Cannabis

8.9

Tranquilisers

4.5

Methadone

2.7

Buprenorphine

1.8

Cocaine

1.8

Benzodiazepines

1.8

a

SDS score (Mdn, range)

11 (0-15)

History of overdose (%)

60.2

Injected during last three months (%)

52.6

d

a

K10 score (M, SD)

29.2 (7.8)

Hospitalised after head injury (%)

50.0

Lost consciousness/concussion after head injury (%) 67.2
a

n = 95.
n = 112.
c
Severity of Dependence Scale.
d
Kessler Psychological Distress Scale.
b

Of the 67.2% who had either lost consciousness or sustained a concussion after a head
injury, the mean number of times this had occurred was 4.98 (SD = 5.95). Half of the total
sample had been hospitalized after sustaining a head injury.
All control participants were screened to ensure that they had not been dependent
on alcohol or other substances and/or received treatment for substance use disorder in the
past. No control participant currently used any substance (excluding alcohol and tobacco)
on a regular basis (i.e., greater than once a month), with minimal prior experimentation
with drugs, and 76% drank alcohol less than twice per week. The 24% of control
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participants who drank alcohol more than once per week were screened to ensure that
their current drinking was not occurring at a problematic level that caused clinically
significant impairment or distress. Despite attempts to match sample characteristics,
controls were significantly younger (Mdn = 25 years, range 21–61) than the AOD group
(Mdn = 35 years, range 19–56), z = −5.21, p < .001, and had significantly more years of
education (Mdn = 12 years vs. Mdn = 10 years), z = −4.26, p < .001. Gender distribution
did not differ significantly between groups (54% male in controls vs. 70.3% male in
AOD). Age and education were therefore included as covariates for group comparisons.
Psychological distress was low to moderate in controls (K10 mean 17), and was
significantly higher in AOD residents (K10 mean 29), F(1, 130) = 33.33, p < .001.

2.4.2. PRIMARY ANALYSES
2.4.2.1.

Covariates

Despite the group difference in age, age was not significantly correlated with total
MoCA score, p = .16. It was also not correlated with any MoCA subscores, all p > .05, in
the entire sample as well as in the AOD group alone. There were significant correlations
between years of education and total MoCA score, r = .18, p = .02, executive function, r
= .36, p < .001, short-term memory, r = .18, p = .02, working memory, r = .21, p = .006,
and language, r = .26, p = .001. Age and education were both included as covariates in
analyses, but while education was consistently significant in the models, age was not.
Age was subsequently dropped from the analyses and results are reported here with
education alone as the covariate in analyses of MoCA outcomes for the AOD vs. control
group.
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2.4.2.2.

MoCA scores

Comparison of the AOD and control group determined a significant difference in
total MoCA score, F(1, 163) = 5.28, p = .023, the combined executive
function/visuospatial subscore, F(1, 163) = 6.91, p = .009, and the visuospatial domain
alone, z = −2.43, p = .015, with poorer performance in the AOD group (Table 2). None

Table 2. Comparison of MoCA scores between AOD and control groups, for entire AOD sample and
those without head injuries: mean (SD).

Total score

Head injuries included

Head injuries excluded

AOD group (n = 128)

AOD group (n = 64)

Control (n = 37)

25.60 (3.13)*

26.39 (2.56)

26.94 (3.10)

Executive/Visuospatial

5.13 (1.57)**

5.53 (1.47)

6.14 (1.64)

Executive

2.48 (1.05)

2.73 (1.03)

3.08 (0.92)

a

3.63 (1.33)

3.78 (1.23)

3.92 (1.23)

WMb

5.36 (1.06)

5.50 (1.04)

5.43 (0.99)

Visuospatial

2.64 (1.01)*

2.80 (0.98)

3.05 (1.13)

Language

5.01 (0.94)

5.16 (0.88)

5.35 (0.82)

STM

*p < .05 **p < .01
a
Short-term memory.
b
Working memory.

of the other cognitive domain subscores differed between groups: short-term memory,
F(1, 163) = .25, p = .62, working memory, F(1, 163) = .27, p = .60, and language, F(1,
163) = 1.04, p = .31. There was a trend toward poorer executive function in the AOD
group, F(1, 163) = 3.01, p = .08.

2.4.2.3.

Gender effects

There were no significant differences between male and female AOD participants
in age, years of education, or SDS scores (all p > .28). Females tended to have higher K10
scores (M = 31.25, SD = 7.89) than males (M = 28.21, SD = 7.60), t(93) = − 1.82, p = .07.
MoCA outcomes for males vs. females were not significantly different (all p > .10)
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although females tended to score slightly higher than males (Mdn 3 vs. 2) on executive
subscores, z = −1.68, p = .09.

2.4.2.4.

Primary substance of misuse

There were significant differences between primary substance of misuse groups
in age, F(2, 92) = 8.25, p = .001, but not years of education, H(2) = 4.15, p = .13, or SDS
scores, H(2) = 1.59, p = .45; age was therefore included as a covariate in the analysis.
There were no significant differences in total MoCA score, F(2, 92) = .04, p = .96, shortterm memory, F(2, 92) = .09, p = .92, language, F(2, 92) = .15, p = .86, executive function,
F(2, 92) = 1.37, p = .26, visuospatial abilities, F(2, 92) = 1.61, p = .21, or combined
executive function/visuospatial abilities, F(2, 92) = 1.30, p = .28, between primary
substance of misuse groups (Table 3). There was a marginally significant difference for
working memory performance, F(2, 92) = 2.98, p = .056, with the poorest performance
in the stimulants group. K10 scores were significantly different across substance of
misuse groups, F(2, 77) = 5.96, p = .004, being higher in the stimulant group relative to
the opiate group (p = .022) and the alcohol group (p = .07), with no difference between
alcohol and opiate groups (p = .69).

Table 3. Comparison of MoCA scores across primary substance of misuse groups: mean (SD).
Alcohol (n = 34)

Opiates (n = 36)

Stimulants (n = 25)

25.85 (3.49)

25.92 (2.55)

25.88 (3.23)

Executive/Visuospatial

5.09 (1.73)

5.14 (1.51)

5.60 (1.58)

Executive

Total score

2.26 (1.14)

2.64 (1.05)

2.68 (1.11)

a

3.76 (1.18)

3.69 (1.35)

3.64 (1.31)

b

5.53 (1.08)

5.56 (0.69)

5.00 (1.22)

Visuospatial

2.82 (0.94)

2.50 (1.06)

2.92 (0.91)

Language

5.12 (0.95)

4.94 (1.01)

4.96 (0.93)

STM
WM

a
b

Short-term memory.
Working memory; trend toward greater impairment in the stimulants group: p = .056.
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2.4.3. EXPLORATORY ANALYSES
2.4.3.1.

Psychological distress and substance dependence

There were significant negative correlations between K10 scores and total MoCA
scores, r = −.22, p = .012, executive function/visuospatial abilities, r = −.21, p = .015, and
language scores, r = −.20, p = .021, and a trend for working memory, r = −.16, p = .06,
in the overall AOD sample. K10 and SDS scores were positively correlated, r = .20, p =
.049, but SDS scores were not correlated with any MoCA scores (all p > .05), other than
a trend toward a correlation with executive function, r = .18, p = .085. This pattern
indicates that greater psychological distress (but not greater drug dependence) is
associated with greater cognitive impairment.

2.4.3.2.

Head injuries

Given that 50% of the AOD sample had been hospitalized for a head injury, the
impact of head injuries on cognitive function was imperative to investigate further. There
were no significant differences in age, z = −1.24, p = .22, education, z = −.94, p = .35, or
K10 scores, t(93) = −.23, p = .82, between AOD residents who had versus had not been
hospitalized after a head injury, but those who had not been hospitalized for head injury
had higher SDS scores, z = −2.10, p = .035, (Mdn = 11 vs. 10). AOD participants who
had been hospitalized had lower total MoCA scores (Mdn = 25.5 vs. 26), z = −2.59, p =
.01, than those who had not. The hospitalized group also had lower executive/visuospatial
(Mdn = 5 vs. 6, z = −2.97, p = .003), working memory (mean rank = 58.38 vs. 70.62, z =
−2.18, p = .03), and executive (Mdn = 2 vs. 3, z = −2.66, p = .008) subscores, than the
non-hospitalized group, with trends toward lower language, z = −1.67, p = .095, and
visuospatial subscores, z = − 1.71, p = .088, but no difference in short-term memory
subscores, z = −1.17, p = .24. Figure 1 displays standardized (out of 6) MoCA domain
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scores for AOD participants hospitalized for head injuries, non-hospitalized AOD
participants and controls.

6
5
4
3

Hospitalised

2

Non-Hospitalised

1

Controls

0

Figure 1. Standardised (out of 6) MoCA domain scores for the AOD patients who were hospitalised for
head injuries, non-hospitalised for any head injury (includes those who never had a head injury or
may have sustained head injuries not requiring hospitalisation), and control participants.

2.4.3.3.

Analysis of sample without significant head injuries

After exclusion of those who had been hospitalized after a head injury, the primary
analyses were repeated to compare only those AOD residents who had not sustained head
injures requiring hospitalization with controls (Table 2). The AOD group in this reduced
sample (n = 64) were significantly older than controls (Mdn = 34 vs. 25, respectively), z
= −4.82, p < .001, and less educated (Mdn = 10 vs. 12), z = −3.65, p < .001. With age and
education included as covariates, there were no significant differences in total MoCA
score, F(1, 99) = .38, p = .54, or any MoCA subscores (all p > .20) between AOD residents
without significant head injuries and controls. Significant differences remained for K10
scores between these AOD residents (Mdn = 29) and controls (Mdn = 16), F(1, 82) =
33.51, p = < .001. Other than males scoring significantly higher (mean rank = 36.43) in
working memory subscores than females (mean rank = 25.50), z = −2.91, p = .004, no
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other effects of gender or primary substance of misuse were found in this sample without
head injuries.

2.4.3.4.

Clinical significance of impairment

To investigate the clinical significance of impairment, total MoCA scores were
recoded as a dichotomous variable to indicate either the presence or absence of cognitive
impairment according to the cut-off score suggested by Copersino et al. (2009) as ≥ 26
reflecting no evidence of cognitive impairment. Within the overall AOD group, 43.8%
met criteria for cognitive impairment. After removing those hospitalized for head injuries,
37.5% met criteria for impairment and this represented a significantly greater proportion
than the 16.2% of controls meeting criteria for impairment,

2

(1, N = 101) = 5.09, p =

.019. However, after removing a further 27 participants in the AOD sample who had
sustained concussion or lost consciousness after a head injury but had not been
hospitalized, the prevalence of impairment dropped to 29.7% and this did not represent a
statistically significant difference when compared to the 16.2% of impaired controls (p =
.13). Subsequently, it was deemed appropriate to examine the prevalence of impairment
within the AOD group who had been hospitalized after a head injury. Of those who had
been hospitalized (n = 64), only 50% met criteria for cognitive impairment, indicating
that hospitalization for head injuries alone may not predict cognitive impairment. There
was no difference in the total number of head injuries (including those that did not require
hospitalization) sustained by those who met criteria for impairment (Mdn = 3) vs. those
who did not (Mdn = 3), p = .67.
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2.5.

DISCUSSION
This study used a brief screening tool, the MoCA, to provide an overview of

cognitive functioning in residents of a substance misuse TC. The major findings were that
43.8% of the AOD group met criteria for cognitive impairment and head injuries were a
significant determinant of this impairment. Within the AOD group, 50% had been
hospitalized after a head injury and were more cognitively impaired than those who had
not sustained head injuries requiring hospitalization. Greater psychological distress in the
AOD group was also associated with greater cognitive deficits.

2.5.1. NEUROPSYCHOLOGICAL FUNCTIONING
AOD residents overall scored significantly lower on the MoCA and showed
greater deficits in executive function and visuospatial abilities than controls. No other
cognitive domains differed between residents and controls. Within the AOD group, there
were no gender effects other than a trend toward males displaying greater executive
dysfunction than females and females tended to have higher levels of psychological
distress than males. MoCA outcomes did not differ according to primary substance of
misuse, other than stimulant users showing marginally poorer working memory ability
and higher levels of psychological distress. The lack of observed differences in
neuropsychological outcomes between substance of misuse groups may be explained by
the prevalence of polysubstance use in clients undergoing residential AOD treatment;
differences may not be detected between groups in which substance use has reached a
level necessitating residential treatment. Generally, clients in residential AOD treatment
have extensive histories of substance use with considerable variability between
individuals. Another possible explanation is that differences do exist between substance
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of misuse groups in residential treatment but that the current study did not possess group
sizes large enough to detect these differences.

2.5.1.1.

Head injuries

Half of the AOD sample in the current study had been hospitalized after a head
injury and were more cognitively impaired than those who had not, with lower total
MoCA scores, and poorer executive/visuospatial and working memory abilities. When
the hospitalized group were excluded from the analysis, there were no differences in any
neuropsychological outcomes between AOD residents and controls, and no differences
between primary substance of misuse groups, but females in this subset displayed poorer
working memory performance than males.
In general, these findings are congruent with the literature suggesting that
cognitive impairments exist in AOD populations (Caplan et al., 2007; Ersche & Sahakian,
2007; Fernández-Serrano, Pérez-García, Río-Valle, et al., 2010; Gonzalez, 2007; Gruber
et al., 2007; Oscar-Berman & Marinković, 2007; Scott et al., 2007; Yücel & Lubman,
2007; Yücel et al., 2007) and may be detected by a brief cognitive impairment-screening
tool (the MoCA). In assessing a residential AOD sample, arguably we accessed those
most severely affected by their addiction, and also those with a high prevalence of head
injuries requiring hospitalization. The level of cognitive impairment detected in this
sample, as measured by the MoCA, was not severe and was largely associated with TBI,
a factor that has not routinely been considered in previous studies and may account for a
significant portion of the deficits observed in the literature.
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2.5.2. IMPLICATIONS
This study showed that having sustained a TBI requiring hospitalization
accounted for the majority of cognitive impairment detected in the sample. There are two
major implications: first, simply asking clients whether they have ever sustained a head
injury requiring hospitalization may be the most time-efficient way to informally gauge
the possibility of cognitive deficits. Clients may be unable, however, to provide accurate
accounts due to the high rate of TBIs occurring during intoxication that may remain
undetected and receive no medical intervention. While half of the AOD group in the
current study had sustained a head injury requiring hospitalization, 50% of this subgroup
did not meet criteria for impairment based on the MoCA score threshold. As such,
screening for head injuries alone without subsequent cognitive assessment may lead to
inflated estimates of impairment. Furthermore, this type of screening would not capture
approximately one third of the AOD sample that had never sustained head injuries and
yet met criteria for cognitive impairment. Thus, the second implication is that cognitive
deficits may also exist independently of head injuries in AOD samples and hence require
screening in their own right.
These complex findings highlight the importance of brief cognitive screening as
a standardized assessment procedure for all clients entering residential treatment. In this
way, treatment planning may account for the presence of cognitive deficits. Further
neuropsychological assessment may be recommended and modifications to treatment
and/ or targeted interventions may be implemented.
Regardless of the etiology of cognitive impairment, cognitive screening has the
potential to inform interventions aimed at alleviating these deficits. For example, adjunct
interventions to remediate cognitive deficits together with better-tailored specific
treatments may bolster residential services, reducing dropout rates and consequently
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improving treatment outcomes. Evidence suggests that the neuropsychological deficits
associated with TBI can be alleviated through cognitive remediation interventions (Maas
et al., 2013; Manley & Maas, 2013; Tsaousides & Gordon, 2009), and there is emerging
evidence for the use of cognitive remediation programs in substance misuse populations
as a way to improve treatment retention (Bates, Buckman, & Nguyen, 2013; Fals-Stewart
& Lam, 2010; Rupp, Kemmler, Kurz, Hinterhuber, & Fleischhacker, 2012; VerdejoGarcía, 2011; Wexler, 2011). Further research aimed at developing and trialling cognitive
remediation programs for AOD populations is required and providing these interventions
within residential treatment services would be most ideal (e.g., Gonçalves et al., 2014).

2.5.3. LIMITATIONS AND FUTURE DIRECTIONS
There are several limitations of the current study. There were clear differences
between the AOD group and controls (e.g., age, education, inferred socioeconomic
status). While some of these differences were accounted for statistically, future research
would benefit from the inclusion of better-matched control groups. The exploration of
primary substance of misuse groups resulted in small sample sizes with reduced statistical
power for comparison; larger samples in future studies may reveal substance-specific
impairment. Another limitation of the current study is its failure to assess for psychiatric
comorbidities, which are common in AOD populations and add substantial complexity to
the process of treatment. The current study utilized the K10 as a measure of psychological
distress and higher scores were associated with greater cognitive impairment. Future
studies should include formal psychiatric diagnoses in order to examine their interaction
with substance use disorders and head injuries in terms of cognitive outcomes.
Additionally, the current study focused on hospitalization and frequency of head injuries,
but not their nature, severity or age of occurrence, which could be further examined in
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future studies. Also, despite the AOD sample being abstinent from AOD, there was no
assessment of their duration of abstinence or length of stay in residential services prior to
cognitive assessment; this, along with a more detailed substance use history (including
age of onset and number of years of substance use) and objective measures of abstinence
(e.g. urine testing in both AOD and control samples), could have provided further
information regarding the nature and extent of the observed cognitive deficits. Finally,
the potential lack of sensitivity of the MoCA to more specific cognitive deficits in AOD
populations cannot be underestimated; the scores observed in this sample were not
substantially below the cut-off indicative of impairment. Nevertheless, the MoCA can
serve as a cost-effective screening tool that would detect severe deficits in those most
requiring further neurocognitive assessment.

2.6.

CONCLUSION
The current study identified that the MoCA may be usefully applied in the AOD

treatment setting as a brief screening tool. We showed in a naturalistic snapshot of clients
in AOD residential treatment that cognitive impairment is common and may be related to
the effects of head injuries, which are also highly prevalent. Cognitive abilities such as
executive function and working memory are important for AOD residents to engage
meaningfully in treatment and achieve successful outcomes. If these capacities are
compromised, residents may be more likely to drop out from treatment and fail to recover
from their addiction. The first step in rectifying this situation is to improve the assessment
and detection of those who present with cognitive deficits. This will help to inform
modifications to treatment and/or cognitive remediation interventions that may be
beneficial in accommodating and potentially remediating impairments in cognition,
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increasing the likelihood of treatment engagement and retention, and hopefully leading
to long-term recovery from addiction.
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3.1.

ABSTRACT

Background: Executive dysfunction is common in substance use disorder (SUD)
populations and hinders treatment. We previously found that 50% of residents in SUD
therapeutic communities had been hospitalized for head injuries; this was a significant
determinant of cognitive impairment. The current study aimed to establish whether
cognitive remediation improves executive functions (EFs) and self-regulation in an
ecologically valid sample of female residents attending SUD therapeutic community
treatment, including those with past head injuries and psychiatric comorbidities.
Methods: Controlled sequential groups design with residents (N = 33, all female)
receiving treatment as usual (TAU). The intervention group (n = 16) completed four
weeks of cognitive remediation (CR) and the control, TAU only (n = 17). Outcome
measures assessed pre- and post-intervention included both performance- and inventorybased measures of EFs, and self-reported self-regulation and quality of life.
Results: CR relative to TAU significantly improved performance-based assessment of
inhibition (Color-Word Interference Test; F = 4.29, p = 0.047), inventory-based
assessment of EFs (Behavior Rating Inventory of Executive Function - Adult Version:
Global Executive Composite; F = 6.38, p = 0.017), impulsivity (Barratt Impulsiveness
Scale; F = 4.61, p = 0.040), self-control (Brief Self-Control Scale; F = 5.53, p = 0.026)
and quality of life (Quality of Life Enjoyment and Satisfaction Questionnaire - Short
Form; F = 7.68, p = 0.010).
Conclusions: Findings suggest that CR improves EFs in a heterogeneous sample of
female residents in therapeutic community SUD treatment. Future research may explore
the possibility of tailoring CR interventions for various SUD subgroups.
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3.2.

INTRODUCTION
Self-regulation is a protective factor in ameliorating many social and mental

health problems and is understood as the capacity “to make plans, choose from
alternatives, control impulses, inhibit unwanted thoughts and regulate social behavior”
(Heatherton & Wagner, 2011, p. 132). Individuals in residential rehabilitation treatment
for substance use disorders (SUDs) must possess some capacity for self-regulation in
order to meaningfully engage in treatment and ultimately change their behavior. This is
particularly true of therapeutic community treatment (Vanderplasschen et al., 2013),
which entails significant social participation and shared responsibility for activities of
daily life.
Cognitive deficits are one of the four biggest risk factors for dropout from SUD
treatment (Brorson, Ajo Arnevik, Rand-Hendriksen, & Duckert, 2013), and executive
function (EF) impairment is commonly observed in individuals experiencing SUDs
(Fernández-Serrano, Pérez-García, Río-Valle, & Verdejo-García, 2010; Hester, Lubman,
& Yücel, 2010). Diverse definitions of EFs exist (Friedman & Miyake, 2017) but they
are broadly understood as “those capacities that enable a person to engage successfully
in independent, purposive, self-directed, and self-serving behavior” (Lezak, Howieson,
Bigler, & Tranel, 2012, p. 37). An influential threefold model of EFs includes ‘working
memory’, ‘inhibition’, and ‘shifting’ (Miyake et al., 2000). Working memory refers to
the capacity to monitor and alter information held in mind temporarily, inhibition
involves overriding an unwanted distraction to maintain task-focus, and shifting pertains
to flexibly switching attention between tasks or mental sets (Hofmann, Schmeichel, &
Baddeley, 2012). These basic EFs are intricately linked to and may subserve effective
self-regulation (Hofmann et al., 2012).
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Individuals in residential treatment for SUDs often have psychiatric and medical
comorbidities, including history of head injury. For example, we previously found that
67.2% of residents in SUD therapeutic community treatment (70.3% male) had sustained
one or more head injuries, while 50% required hospitalisation following a head injury
(Marceau, Lunn, Berry, Kelly, & Solowij, 2016). History of head injury was a significant
determinant of cognitive impairment and was associated with higher levels of
psychological distress. Psychiatric comorbidities are also frequently observed in SUD
populations and add further complexity to the process of addiction recovery (Baingana,
al'Absi, Becker, & Pringle, 2015). Personality disorders are particularly prevalent (e.g.,
Pennay et al., 2011) and are not only associated with global neurocognitive and specific
EF deficits, (Fertuck, Lenzenweger, Clarkin, Hoermann, & Stanley, 2006; Ruocco &
Carcone, 2016; Unoka & Richman, 2016), but also with dropout from SUD treatment
(Brorson et al., 2013).
Given the high rates of head injury and psychiatric comorbidities in SUD
populations, and the positive relationship of these variables with cognitive impairment,
the application of evidence-based neuropsychological interventions designed for use in
both brain injury (usually referred to as cognitive rehabilitation) and mental health
(usually referred to as cognitive remediation) populations might be expected to result in
reductions of cognitive impairment, and potentially lead to better SUD treatment
outcomes. It has been recommended that these interventions be adapted for use in SUD
treatment populations (Bates, Buckman, & Nguyen, 2013) and there have been a number
of attempts at this to date (e.g., Alfonso, Caracuel, Delgado-Pastor, & Verdejo-García,
2011; Bickel, Yi, Landes, Hill, & Baxter, 2011; Houben, Wiers, & Jansen, 2011; VallsSerrano, Caracuel, & Verdejo-García, 2016).

69

Neuropsychological interventions for SUD populations have tended to adopt
either a drill and practice (e.g., Houben et al., 2011) or strategy-based (e.g., Valls-Serrano,
Caracuel, et al., 2016) approach. To our knowledge, there are no published studies
incorporating a combined approach that utilises both domains. The cognitive remediation
literature within psychiatry has suggested that whilst drill and practice approaches (e.g.,
computerized cognitive training) may lead to greater gains on cognitive test scores,
strategy-based training (e.g., instruction in specific strategy use) leads to greater
functional outcomes for individuals with schizophrenia (Paquin, Wilson, Cellard,
Lecomte, & Potvin, 2014; Wykes, Huddy, Cellard, McGurk, & Czobor, 2011).
Combining approaches in an SUD population may result in greater gains across a range
of measures. This study aimed to determine the effectiveness of a cognitive remediation
intervention that incorporated both drill and practice and strategy-based training for a
treatment seeking SUD population, inclusive of those with psychiatric and head injury
comorbidities.
Assessment of EFs may be performance- (i.e., assessing performance on working
memory, inhibition, and shifting tasks) or inventory-based (i.e., based on self-reports of
executive functioning). Whilst performance-based measures of EFs are sensitive to brain
impairment that implicates the frontal lobes (Jurado & Rosselli, 2007), some may
demonstrate limited ecological validity and may not capture problems with everyday
functioning as well as inventory-based measures (Isquith, Roth, & Gioia, 2013).
Inventory- and performance-based measures of EFs are minimally correlated and may
assess distinct components of EFs that contribute independently to clinical problems
(Toplak, West, & Stanovich, 2013). For example, to determine the relative sensitivities
of performance- and inventory-based EFs measures in an SUD treatment population,
Hagen and colleagues (2016) showed that inventory-based assessment using the Behavior
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Rating Inventory of Executive Function – Adult Version (BRIEF-A; Roth, Isquith, &
Gioia, 2005) better distinguished polysubstance users from controls and was more
strongly associated with real-world social adjustment outcomes compared to
performance-based measures, which included the Iowa Gambling Task (Bechara,
Damasio, Damasio, & Anderson, 1994), the Trail-Making Test (Strauss, Spreen, &
Sherman, 2006), and the Stroop test (Golden, 1978). In light of these findings and to
provide a more comprehensive assessment of EFs, the current study included both
performance- and inventory-based measures.
The current study aimed to examine the effectiveness of cognitive remediation vs.
treatment-as-usual (TAU) in: (1) improving performance- and inventory-based measures
of EFs and (2) improving self-report measures of self-regulation. Quality of life was
included as a secondary clinical outcome measure, as it plays an important role in
sustained remission from SUDs (Laudet, Becker, & White, 2009). We hypothesized that
cognitive remediation would be effective in improving EFs, self-regulation, and quality
of life.

3.3.

METHODS
3.3.1. PARTICIPANTS
Fifty participants were recruited from a women’s residential treatment facility in

Sydney run by We Help Ourselves (WHOs) – a large provider of residential SUD
rehabilitation in Australia, utilising the therapeutic community model of treatment.
Inclusion criteria for the study were: (i) diagnosis of substance abuse/dependence, based
on DSM-IV-TR criteria, assessed using the Mini-International Neuropsychiatric
Interview (MINI-Plus; Sheehan et al., 1998), (ii) a minimum abstinence period of 7 days
(with confirmation of detoxification a prerequisite of entry to treatment), (iii) absence of
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any neurological, infectious, or other disease affecting the central nervous system (e.g.,
epileptic seizures, stroke, brain tumour, meningitis, encephalitis, multiple sclerosis, HIV
positive), and (iv) English as native language. A condition of staying at the residential
facility is that participants remain abstinent from substances of abuse and this is
monitored through routine urinalysis (random resident checks occurring several times per
week) and 24-hour observation from experienced staff and co-residents.

3.3.2. DIAGNOSTIC AND CLINICAL ASSESSMENT
Diagnostic and clinical assessment at baseline included the following: Psychiatric
comorbidities (DSM-IV-TR) were assessed using the MINI-Plus and Standardised
Assessment of Personality – Abbreviated Scale (Moran et al., 2003), as shown to be
appropriate for SUD populations (Gonzalez, 2014; Hesse & Moran, 2010; Hesse,
Rasmussen, & Pedersen, 2008). Questions were adapted from the Addiction Severity
Index – Fifth Edition (ASI; McLellan et al., 1992) to assess lifetime substance use history.
Additionally, a brief semi-structured interview was used to assess history of head injury.
The Test of Premorbid Functioning (TOPF; Pearson Assessment, 2009) was used to
estimate overall level of intellect.

3.3.3. OUTCOME MEASURES
3.3.3.1.

Executive functions – performance-based

Working memory: Working Memory Index (WMI; Wechsler Adult Intelligence Scale,
fourth edition: WAIS-IV; Wechsler, 2008). The WMI of the WAIS-IV assesses
components of working memory and is comprised of 2 subtests, which were administered
according to standard instructions. The digit span subtest requires participants to recall
various sequences of numbers (forward, backward, and in sequence) and the arithmetic
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subtest involves participants solving numerical problems within 30 seconds, after they
have been read aloud by the examiner. The subtest scores were summed to yield a total
score, which was then scaled to provide an index score, as per standardized scoring
instructions.
Inhibition: Color-Word Interference Test (Delis-Kaplan Executive Function System: DKEFS; Delis, Kaplan, & Kramer, 2001). This subtest of the D-KEFS assesses response
inhibition and provides an auxiliary measure of shifting. Participants are instructed to
read the items presented in each of four conditions as quickly and accurately as possible.
Performance is measured in time (seconds). The first condition presents patches of
colours and requires participants to name the colours. The second condition presents the
words “red”, “blue”, and “green” and requires participants to read the words. The third
condition presents words printed in incongruent colours and requires the participant to
ignore the word and say the colour. The fourth condition presents words printed in
incongruent colours and requires the participant to switch between two rules: (a) ignore
the word and say the colour; and (b) ignore the colour and say the word. Outcome
variables were contrast scaled scores of inhibition (condition 3 scaled score minus
condition 1 scaled score) and inhibition/shifting (condition 4 scaled score minus condition
1 scaled score).
Shifting: Trail-Making Test (TMT; Strauss et al., 2006). This test provides a measure of
shifting, with Part A assessing simple psychomotor ability and Part B assessing
psychomotor ability and shifting. In part A, participants connect 25 numbered circles in
ascending order. In part B, 13 numbers and 12 letters have to be alternately connected in
their numerical and alphabetical order. Participants are notified of any errors immediately
and must correct them without assistance. The outcome variable was the difference in
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time (seconds) to complete part B versus part A (time B minus time A), which specifically
reflects shifting.

3.3.3.2.

Executive functions – inventory-based

Behavior Rating Inventory of Executive Function – Adult Version (BRIEF-A; Roth et al.,
2005). The BRIEF-A is a 75-item self-report questionnaire consisting of nine subscales.
Participants are instructed to answer each question by selecting “never”, “sometimes”, or
“often”, in relation to whether they have had problems with any of the listed behaviors in
the past month. Example items include: “I have trouble getting ready for the day”; “I have
trouble coming up with ideas for what to do with my free time”. The Global Executive
Composite (GEC) provides an overall summary score. The Behavioral Regulation Index
(BRI) includes the subscales Inhibit; Shift; Emotional Control; Self-Monitor. The
Metacognition Index (MI) includes subscales Initiate; Working Memory; Plan/Organize;
Task Monitor; Organisation of Materials. Elevated scores indicate executive dysfunction.
Scores on the GEC, BRI, and MI subscales were used as outcome variables in the
analyses.

3.3.3.3.

Self-regulation

Barratt Impulsiveness Scale – Version 11 (BIS-11; Patton, Stanford, & Barratt, 1995).
The BIS-11 is a 30-item self-report questionnaire that assesses trait and behavioral aspects
of the construct of impulsivity. There are six first-order factors: Attention, Cognitive
Instability, Motor, Perseverance, Self-Control, and Cognitive Complexity. These firstorder factor scores were summed to yield a total score, which was used as the outcome
variable.
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Brief Self-Control Scale (BSCS; Tangney, Baumeister, & Boone, 2004). The BSCS is a
13-item self-report questionnaire that assesses individual differences in the construct of
self-control. The outcome variable was total score.
Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004). The DERS is
a 41-item self-report questionnaire that assesses clinically relevant difficulties in emotion
regulation. There are six subscales (Nonacceptance of Emotional Responses, Difficulties
Engaging in Goal-Directed Behavior, Impulse Control Difficulties, Lack of Emotional
Awareness, Limited Access to Emotion Regulation Strategies, and Lack of Emotional
Clarity) contributing to a total score, which was used as the outcome variable.
Penn Alcohol Craving Scale (PACS; Flannery, Volpicelli, & Pettinati, 1999). The PACS
is a 5-item self-report questionnaire that assesses level of cravings for alcohol and other
drugs. Participants were asked to respond to all items in relation to their primary
substance of misuse. The outcome variable was total score.
Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form (Q-LES-Q-SF;
Endicott, Nee, Harrison, & Blumenthal, 1993). The Q-LES-Q-SF is a 16-item self-report
questionnaire that assesses quality of life across areas of daily functioning. Total score
was used as the outcome variable.

3.3.4. DESIGN AND PROCEDURES
The study employed a controlled sequential groups design and was a naturalistic
study, capturing a snapshot of residents in treatment at the time of recruitment. This
design was chosen due to resource constraints and logistic difficulty of having the small
sample of residents in treatment at any one time being allocated to differing treatment
regimes. All residents in the treatment facility were invited to participate in the study and
the response rate was 96%. Those who met inclusion criteria and provided consent took
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part in either: (a) a cognitive remediation (CR; n = 23) group program or (b) treatment as
usual (TAU; n = 27). The CR group were recruited first followed by the TAU group,
allowing sufficient time for a new cohort of residents to become available. Unexpectedly,
the CR group had spent more time in treatment prior to baseline assessment (Mdn = 67
days) than the TAU group (Mdn = 25 days).
Both groups engaged in the usual therapeutic community model of treatment
(Vanderplasschen et al., 2013). In addition to this, the CR group attended a total of 12 x
2-hour group sessions across 4 weeks (3 sessions per week held on Mondays,
Wednesdays, and Fridays). All participants in the CR group attended these sessions at the
same time, with all sessions facilitated by the second author (JB) and co-facilitated by the
first author (EM). The first hour of each session was dedicated to strategy training, which
included traditional instructional pedagogical approaches, modelling, exercises to
demonstrate concepts, and role-plays. The second hour included group computerized
cognitive training using the Lumosity application (Lumosity, 2016) on iPads. Although
Lumosity has not previously been used in SUD populations, it has been utilized across a
broad range of other clinical populations (e.g., multiple sclerosis (Charvet, Shaw, Haider,
Melville, & Krupp, 2015), mild cognitive impairment (Dannhauser et al., 2014), and
childhood cancer-related brain injury (Kesler, Lacayo, & Jo, 2011)) and was chosen for
its web-based platform and ease of access. Participants played specific games during
which they were instructed to use and practice certain strategies that linked to the strategybased learning in the previous hour. They were asked to share other strategies they may
have found useful during the cognitive exercises and this was discussed and sometimes
integrated with the learning material by the facilitators. The amount of time spent training
on each game was held constant, rather than the number of trials of each game. This
allowed participants to progress through the exercises at their own pace. The CR
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intervention was developed with a strong emphasis on the training of EFs and selfregulation in view of the finding that EFs are particularly impaired in an SUD treatment
population. The intervention incorporated elements from well researched CR
interventions designed for an acquired brain injury (ABI) population, including self-alert
training (O’Connell et al., 2008; Robertson, Tegnér, Tham, Lo, & Nimmo-Smith, 1995),
goal management training (Levine et al., 2011), time pressure management (Fasotti,
Kovacs, Eling, & Brouwer, 2000), and multifaceted treatment of executive dysfunction
(Spikman, Boelen, Lamberts, Brouwer, & Fasotti, 2010). Other relevant evidence-based
interventions originally designed for a non-ABI population were also incorporated, such
as mental contrasting and implementation intentions (Duckworth, Grant, Loew,
Oettingen, & Gollwitzer, 2011). Barkley’s (2001, 2012) evolutionary model of EFs was
used to structure a large component of the program. The modules covered the following
topics: levels of brain functioning, attention, learning and memory, executive functions,
self-awareness, inhibition, visual and verbal working memory, emotion regulation,
decision-making and problem-solving. The facilitators followed a manual (available on
request) to ensure treatment consistency.
The CR group completed baseline assessments in the week prior to the
commencement of the intervention and post-intervention assessments in the week
following its completion. Similarly, the TAU group completed baseline assessments
followed by a period of approximately 4 weeks and were reassessed during the
subsequent week. There was a 5-day difference between groups in the interval between
baseline and post-intervention assessments (CR: Mdn = 34 days; TAU: Mdn = 29 days).
The final sample size, accounting for treatment dropout, was 33: n = 16 (CR group) and
n = 17 (TAU group). During the study period, the rates of unplanned discharges from the
residential program did not significantly differ between groups (CR = 30%, TAU = 37%,
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X2 = 0.24, p = 0.62) and are comparable to those observed in SUD therapeutic community
treatment (Darke, Campbell, & Popple, 2012).

3.3.5. STATISTICAL METHODS
All statistical analyses were performed using IBM Statistical Package for the
Social Sciences (SPSS version 21; IBM Corp, 2012). Standardized residuals were
assessed to detect possible outliers (values greater than ± 3). Two outliers were found in
the Inhibition condition of the Color-Word Interference Test and one was found in the
Trail Making Test B-A. With exclusion of these outliers from analyses, the pattern of
results did not change and therefore outliers were retained. One missing value was
detected in the TAU group (PACS) and three were detected in the CR group (BSCS;
DERS; Q-LES-Q-SF).
Socio-demographic characteristics of the CR vs. TAU groups were compared
using Student’s t-test and Mann-Whitney U tests as a nonparametric alternative. Chisquare and Fisher’s exact tests were used to compare percentage variables.
Despite significant differences in treatment duration and days from baseline to
post-intervention between groups, these variables were not included as covariates in
subsequent analyses. This is based on the recommendations of Kraemer (2015) that
covariates should be selected a priori and be as few in number as possible, with a
subsequent option of examining moderators of treatment response separately (see
Discussion). However, any potential influence of these variables was probed in a series
of separate preliminary exploratory analyses using analysis of covariance (ANCOVA) to
compare all outcome variables between groups, including the covariates of baseline score,
treatment duration, and days from baseline to post-intervention.
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ANCOVA (with baseline score as covariate) was the preferred method of primary
analysis for all outcome variables (Egbewale, Lewis, & Sim, 2014; Kraemer, 2015;
Overall & Ashby, 1991), which were analysed separately.
ANCOVA could not be applied to two analyses (Inhibition/Shifting vs. Colour
Naming and Q-LES-Q-SF) due to non-normal distributions, as determined by ShapiroWilk tests of within-group and overall model standardized residuals. Subsequently,
Quade’s (1967) rank ANCOVA was conducted as a nonparametric ANCOVA alternative
(Olejnik & Algina, 1985). In a further two analyses (TMT and DERS), ANCOVA was
deemed to be inappropriate due to violation of statistical assumptions. As a result, two 2
(Time: Pre- vs. Post-intervention) x 2 (Treatment: CR vs. TAU) mixed-design analyses
of variance (ANOVAs) were conducted with a logarithmic data transformation for one
variable (TMT) whereas the other (DERS) was not able to be transformed and is reported
despite violation of the assumption of homogeneity of variances, as assessed by Levene's
test of homogeneity of variance (p < .05).
Finally, a series of Mann-Whitney U tests were performed to examine potential
baseline demographic characteristic differences between those who completed the
intervention (n = 33) vs. those who dropped out of treatment (n = 17). Nonparametric
group comparisons were chosen on account of the small and unbalanced group size.

3.4.

RESULTS
Table 4 presents socio-demographic characteristics and substance use and head

injury history for CR vs. TAU groups. There were no significant differences in age (CR:
Mdn = 32.5 years, range 22–56; TAU: Mdn = 33 years, range 19–53), education (CR:
Mdn = 12 years, range 7–15; TAU: Mdn = 12 years, range 7–20), intelligence,
employment, marital status, or history of losing consciousness/concussion or
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hospitalisation after a head injury. Additionally, primary substance of misuse did not
significantly differ between groups, with significant heterogeneity observed. The
descriptive data regarding substance use history presented in Table 4 suggest that
participants used a variety of substances over many years, with particularly high rates of
polysubstance use. Treatment duration was significantly longer (p = .003) for participants
in the CR group (Mdn = 67 days, range 16–160) compared to the TAU group (Mdn = 25
days, range 2–82). Additionally, there was a 5-day difference between groups in the
interval between baseline and post-intervention assessments (p = .005) (CR: Mdn = 34
days, range 33–36; TAU: Mdn = 29 days, range 26–36).
Psychiatric comorbidity data for the CR vs. TAU groups are displayed in Table 5.
No significant differences between groups were found for the proportions meeting criteria
for current or past Axis I diagnoses (other than SUDs), personality disorders, or the full
range of other psychiatric comorbidities.
The exploratory ANCOVA analyses of all outcome variables including baseline
score, treatment duration, and days from baseline to post-intervention as covariates, found
treatment duration to be significant in only one analysis (BIS-11, p = .045) and the
interval between baseline and post-intervention in only one other (BSCS, p = .036). These
variables conferred only a small effect, with BIS-11 decreasing by .07 units for every
one-day increase in treatment duration, and BSCS increasing by .06 units for every oneday increase in assessment interval.
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Table 4. Baseline socio-demographic, substance use and head injury characteristics of residents of a
female-only substance use therapeutic community.
Characteristic

Cognitive Remediation

Treatment As Usual

(n = 16)
Age (M, SD)a
Education (M, SD)

a

Test of Premorbid Functioning (M, SD)
Unemployed (%)

b

Marital status (% single)

b

p

(n = 17)

33.6 (10.1)

32.9 (7.6)

.85

11.3 (2.4)

11.6 (2.6)

.82

96.0 (11.7)

99.1 (12.9)

.48

81.2

82.4

1.00

75.0

82.4

.69

Primary substance of misuse (%)c

.20

Methamphetamine

50.0

29.4

Alcohol

18.8

35.3

Amphetamines

12.5

0

Heroin

6.2

11.8

Cannabis

0

17.6

Sedatives

12.5

5.9

Alcohol (any use)

12.9 (13.5, 9.0; 12)

9.5 (6.5, 7.0; 16)

Alcohol (to intoxication)

10.0 (8.0, 7.2; 11)

8.0 (5.0, 7.0; 16)

Heroin

16.0 (n = 1)

9.7 (8.0, 8.6; 5)

8.0 (n = 1)

8.3 (8.3, 11.0; 2)

Years of regular use (M, Mdn, SD; n)

Methadone
Other opiates/analgesics

11.5 (12.0, 4.3; 3)

7.2 (6.0, 5.7; 5)

Sedatives/hypnotics/tranquilizers

10.6 (12.0, 4.4; 5)

6.3 (3.5, 6.0; 8)

Cocaine

7.0 (4.0, 7.9; 3)

7.0 (8.5, 4.2; 4)

Amphetamines

7.8 (8.0, 5.6; 14)

9.2 (10.5, 6.1; 12)

11.2 (10.0, 7.7; 13)

10.5 (12.5, 6.6; 13)

5.2 (3.0, 6.1; 5)

8.0 (8.0, 5.7; 2)

9.5 (9.5, 4.9; 12)

10.6 (10.0, 6.7; 15)

Cannabis
Hallucinogens
More than one substance per day
Lost consciousness/concussion after head injury (%)
Hospitalized after head injury (%)
a

b

c
c

c

50.0

58.8

.61

25.0

47.1

.19

Mann-Whitney U test. Fisher’s exact test. Chi-square test.
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Table 5. Psychiatric comorbidities of residents of a female-only substance use therapeutic community.
Psychiatric Comorbiditya

Cognitive Remediation

Current Axis I psychiatric diagnosisb (%)
b

Past Axis I psychiatric diagnosis (%)
Personality disorder screen (met criteria)

b, c

(%)

Treatment As Usual

p

(n = 16)

(n = 17)

56.2

76.5

.22

68.8

64.7

.81

50.0

41.2

.61

Major depressive episodeb

.81

Never (lifetime)

50.0

35.3

Major depressive episode (past 2 weeks)

18.7

11.8

Substance-induced mood disorder (past 2 weeks)

0

5.9

Mood disorder due to medical condition

0

5.9

25.0

35.3

6.2

5.9

(past 2 weeks)
Past major depressive episode
Past mood disorder due to medical condition
Dysthymia

b

.40

Never (lifetime)

56.2

76.5

Dysthymia (past 2 years)

25.0

17.6

Past dysthymia

18.8

5.9

Manic episode

b

.54

Never (lifetime)

87.5

70.6

Current manic episode

0

0

Past manic episode

0

11.8

Past hypomanic episode

6.2

5.9

Past substance-induced hypomanic episode

6.2

5.9

Past hypomanic episode due to medical condition

0

5.9

Panic disorderb

.63

Never (lifetime)
Panic disorder (past month)

62.5

70.6

6.2

0

0

5.9

6.2

5.9

18.8

5.9

6.2

11.8

Substance-induced anxiety disorder with
panic attacks (past month)
Anxiety disorder with panic attacks due to
a medical condition (past month)
Panic disorder (lifetime)
Panic disorder symptoms (lifetime)
Agoraphobia

b

.29

Never (lifetime)

43.8

70.6

Current agoraphobia

31.2

17.6

Agoraphobia (lifetime)

25.0

11.8

Social phobiad (past month)

18.8

17.6

1.0

12.5

0

.23

d

Specific phobia (past month)
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Table 5. Psychiatric comorbidities of residents of a female-only substance use therapeutic community.
(continued)
Psychiatric Comorbiditya

Cognitive Remediation
(n = 16)

Obsessive compulsive disorder (past month)

Treatment As Usual

p

(n = 17)

0

0

Posttraumatic stress disorder (past month)

18.8

11.8

.66

Substance-induced psychotic disorderd (lifetime)

25.0

23.5

1.0

Anorexia nervosa (past 3 months)

0

0

d

0

11.8

.49

25.0

17.6

.16

0

23.5

d

Bulimia nervosa (past 3 months)
Generalized anxiety disorderb (past 6 months)
Substance-induced generalised
anxiety disorder
Generalised anxiety disorder due to
medical condition
d

Antisocial personality disorder (lifetime)
Somatization disorder (lifetime)
d

Hypochondriasis (past 6 months)
Pain disorder (current)

6.2

0

25.0

35.3

0

0

0

5.9

0

0

d

Adult attention deficit/hyperactivity disorder (lifetime)18.8
d

Probable premenstrual dysphoric disorder (past year) 25.0
a

b

.71
1.0

23.5

1.0

11.8

.40

c

Mini-International Neuropsychiatric Interview. Chi-square test. Standardised Assessment of

Personality – Abbreviated Scale. d Fisher’s exact test.

Primary ANCOVA and mixed-design ANOVA results are displayed in Table 6.
With baseline scores included as covariates, post-intervention scores in the CR group
relative to the TAU group were significantly higher for the Color-Word Interference Test
(Condition Three: Inhibition vs. Colour Naming) and significantly lower for GEC and MI
of the BRIEF-A, with a trend also for BRI; a pattern of results indicating that the CR vs.
TAU group displayed improvements in executive functions. The CR group also differed
from the TAU group on the self-regulation measures, with lower BIS-11 and higher BSCS
scores, as well as higher Q-LES-Q-SF scores, and a trend towards lower PACS scores.
These results indicate that the CR group relative to the TAU group displayed reduced
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impulsivity, higher self-control, and higher quality of life, as well as a trend towards
reduced cravings.
ANCOVA results indicated no significant differences between groups for WMI
and Inhibition/Shifting vs. Color Naming, and mixed-design ANOVA results indicated
no significant Time x Treatment interactions for TMT and the DERS.
With regards to baseline demographic differences between the group of
participants who completed the intervention (n = 33) vs. those who dropped out of
treatment (n = 17), completers had significantly higher levels of education (Completers:
Mdn = 12 years, range 7–20; Non-completers: Mdn = 10 years, range 6–13, p = .008) and
Test of Premorbid Functioning scores (Completers: Mdn = 97, range 76–122; Noncompleters: Mdn = 82, range 50–117, p = < .001). Age did not significantly differ (p =
.72) between those who completed the intervention (Mdn = 33 years, range 19–56) vs.
those who dropped out of treatment (Mdn = 30 years, range 19–41).
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Table 6. Post-intervention effects of cognitive remediation vs. treatment as usual on executive functions, self-regulation and quality of life in residents of a female-only
substance use therapeutic community.
Dependent measures

Cognitive Remediation (CR)

Treatment As Usual (TAU)

(n = 16)

(n = 17)

F

p

Partial
η2

Baseline

Post-intervention

Baseline

Post-intervention

M (SD)

Adjusted M (SD)

M (SD)

Adjusted M (SD)

91.88 (10.61)

96.97 (6.08)

93.53 (13.01)

95.85 (6.08)

0.28

0.60

Inhibition vs. Colour Naming

9.44 (3.01)

11.44 (1.73)

10.47 (2.00)

10.18 (1.73)

4.29

0.047* 0.125

Inhibition/Shifting vs. Colour Naminga

9.31 (3.14)

11.44 (2.19)

10.41 (2.27)

10.77 (2.05)

1.41

0.25

0.043

38.47 (17.63)

35.27 (20.79)

31.50 (9.27)

21.13 (7.78)

1.80

0.19

0.058

†Global Executive Composite

59.44 (11.19)

53.07 (6.94)

67.59 (12.47)

59.35 (6.93)

6.38

0.017* 0.175

†Behavioral Regulation Index

60.63 (12.40)

55.28 (7.74)

67.59 (10.24)

60.32 (7.73)

3.34

0.08

†Metacognition Index

57.31 (10.36)

51.46 (6.50)

66.41 (13.78)

57.04 (6.49)

5.69

0.024* 0.160

75.44 (12.15)

70.57 (7.39)

77.76 (14.08)

76.11 (7.39)

4.61

0.04*

2.81 (0.90)

2.90 (0.42)

2.13 (0.87)

2.55 (0.40)

5.53

0.026* 0.160

Executive functions
WMI

†TMT (B-A; time s)

b,c

0.009

BRIEF-A
0.100

Self-regulation
†BIS-11
BSCS

d

†DERS

b,d,e

0.133

94.93 (33.15)

88.60 (31.10)

94.47 (16.37)

92.47 (14.02)

0.44

0.51

0.014

f

9.31 (8.47)

7.84 (5.54)

11.56 (6.01)

11.48 (5.54)

3.41

0.08

0.105

Q-LES-Q-SFa,d

0.62 (0.12)

0.71 (0.06)

0.55 (0.18)

0.61 (0.16)

7.68

0.01** 0.204

†PACS
Quality of life

* p ≤ .05 ** p ≤ .01
ANCOVA analyses: Post-intervention adjusted means determined using baseline values as covariates.
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Partial η2 effect size interpretation guidelines (Cohen, 1988): 0.01 = small; 0.06 = medium; 0.14 = large.
† Lower scores reflect better performance.
a

Quade’s nonparametric rank analysis of covariance: post-intervention unadjusted M (SD), Quade’s F statistic.

b

2 x 2 mixed-design analysis of variance: post-intervention unadjusted M (SD), F-Interaction.

c

Logarithmic data transformation (n = 31 as 2 cases unable to be transformed).

d

CR group n = 15.

e

Data could not be transformed.

f

TAU group n = 16.
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3.5.

DISCUSSION
This study aimed to test the effectiveness of cognitive remediation to improve

executive functions, self-regulation and quality of life in female residents of an SUD
therapeutic community. It was based on a theoretical framework positing that basic EFs
underpin effective self-regulation (i.e., the capacity for effective goal-directed behavior
in everyday life; Hofmann et al., 2012). Results indicated that the group receiving the CR
intervention improved performance on an inhibition task, facets of self-regulation (i.e.,
impulsivity and self-control) and quality of life post-intervention relative to the TAU
group. CR also improved self-reported EFs (i.e., GEC and MI of the BRIEF-A, with a
trend towards BRI) compared to TAU. Additionally, there was a trend towards reduced
cravings in the CR vs. TAU group. These results provide significant new evidence for the
potential utility of neuropsychological interventions in SUD treatment contexts.
Importantly, the current study suggests that CR may be a viable intervention in SUD
treatment settings where high rates of comorbidities such as past head injuries and
psychiatric diagnoses are common.
Inhibition is one of the EFs recognized as making a significant contribution to the
development and maintenance of SUD (Jentsch & Pennington, 2014). The core inhibitory
deficits contributing to SUD are increased tendencies to approach substances and/or the
inability to suppress this approach-behavior, which manifest at different levels of analysis
and have been assessed via behavioral task-specific and trait self-report methods (Gullo,
Loxton, & Dawe, 2014). There is ongoing debate over the use of self-report vs. behavioral
laboratory task assessment methodology, with strengths and weakness of each method
noted (Cyders & Coskunpinar, 2011). The current study utilized task-specific assessment
of inhibition and inventory-based measurement of impulsivity (i.e., BIS-11), with
improvements in task-performance and reduced levels of trait impulsivity reported in the
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CR group. Although these findings may seem to converge, it has been noted that selfreport measures vs. behavioral laboratory tasks may assess divergent components of the
construct (Cyders & Coskunpinar, 2011).
Self-control is inversely related to trait impulsivity and refers to the capacity to
overcome unwanted urges to achieve goal-directed behavior (Hofmann et al., 2012). Selfcontrol plays an important role in SUD (Volkow, Wang, Tomasi, & Baler, 2013) and
interacts dynamically with cravings in contributing to problematic substance use
(Grasman, Grasman, & van der Maas, 2016). Decreased self-control is associated with
cumulative stress and this relationship is moderated by self-reported, but not behavioral,
impulsivity (Hamilton, Sinha, & Potenza, 2014). The CR group in the current study
reported increased self-control, which may have played a role in the marginal decrease
also reported for cravings. Interventions that bolster self-control in SUD populations,
such as CR, may help to shield against the deleterious effects of cravings (Fatseas et al.,
2015) and stress (Sinha, Shaham, & Heilig, 2011) in relapse to substance use.
Unlike previous cognitive remediation interventions that focused on one
component of cognition (e.g., working memory training in Houben et al., 2011), the
current study incorporated training exercises that involved a range of cognitive skills
(e.g., working memory, selective attention, divided attention, planning, inhibition, and
flexibility). As such, the reduced total training time on some components may partly
explain the absence of effects on some EF domains. It is possible that the domains that
showed gains had more time dedicated to them during the strategy and drill practice
components of the program.
The CR group also demonstrated improvements in EFs as measured by the
BRIEF-A. Specifically, these improvements were observed in the overall summary score
(GEC) and one of the index scores (MI), with a trend towards improvement in the other
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index score (BRI). Given the minimal correlation between inventory- and performancebased measures of EFs and likelihood that such methods of assessment may be capturing
distinct components of EFs (Toplak et al., 2013), the improvements observed across both
types of measures in the current study may indicate a robust change in EF. Further
research, however, is needed to tease apart the complex relationship between various
components of EFs and self-regulation. This endeavour could involve diverse
methodologies and several levels of analysis (e.g., self-report, laboratory tasks,
neuropsychological assessment, neuroimaging techniques, clinical outcomes).
Quality of life spans broad areas of psychological wellbeing, physical health, level
of independence, and social connectedness, and has been defined as “an individual's
perception of their position in life in the context of the culture and value systems in which
they live and in relation to their goals, expectations, standards and concerns” (Feelemyer,
Des Jarlais, Arasteh, Phillips, & Hagan, 2014, p. 251). Findings from the current study
showed that CR impacted positively upon quality of life. This is a promising preliminary
finding as quality of life is an important predictor of sustained remission from SUD
(Laudet et al., 2009).
A recent study found that cognitive training improved EFs (i.e., working memory
and reflection-impulsivity/decision-making) in polysubstance users in therapeutic
community treatment (Valls-Serrano, Caracuel, et al., 2016). Importantly, that study was
the first to also demonstrate improved self-regulation performance in an ecologically
valid task of goal-directed behavior, the Multiple Errands Test − contextualized version
(Shallice & Burgess, 1991; Valls-Serrano, Verdejo-García, & Caracuel, 2016). The study
excluded participants with psychiatric comorbidities and those with a history of head
injury to capture efficacy of cognitive training. In a previous study we demonstrated that
50% of residents in residential treatment for SUD had been hospitalized after sustaining
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a head injury and this was a significant determinant of cognitive impairment (Marceau et
al., 2016). Psychiatric comorbidities are common (Baingana et al., 2015), with Borderline
Personality Disorder diagnosed in up to 65% of individuals with SUDs (Pennay et al.,
2011). Similarly, the current study found that over 50% of the overall sample met criteria
for a current Axis I diagnosis, while over 40% had a positive screen for personality
disorder. Over 50% of the sample had lost consciousness or been concussed after a head
injury and over 30% had been hospitalized after a head injury. The current study extends
the findings of Valls-Serrano and colleagues (2016) to a research context high in
ecological validity by including participants with psychiatric or head injury
comorbidities. In the present study, there were improvements on conventional
neuropsychological tests (e.g., inhibition task), whereas that was not the case in the VallsSerrano (2016) study. This may be due to the inclusion of computerized cognitive training
and/or because the present sample were more impaired by virtue of greater comorbidities.
These preliminary results suggest that cognitive remediation may be a viable option to
improve EFs and self-regulation for SUD populations, including those with psychiatric
and/or head injury comorbidities.
A strength of the current study is that it shows significant promise for the use of
CR interventions as adjunct treatments for SUD. To the best of our knowledge, this is the
first study to inclusively demonstrate feasibility and effectiveness of neuropsychological
intervention for female residents that engage in SUD therapeutic communities, without
exclusion of those with psychiatric and head injury comorbidities. Certain limitations,
however, must be noted. The sample size of the current study was small and it used a
controlled sequential groups design. Related to the constraints of this design, the
significant difference in length of treatment and assessment interval between groups was
not ideal. This is particularly relevant to the observed improvements in impulsivity and
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self-control, as these improvements were, to some degree, respectively related to variance
in treatment length and assessment interval observed between groups. Future studies
should investigate the benefit of CR in groups matched on interval between assessments
and treatment duration, accounting for the heterogeneity of treatment length occurring
across SUD populations in residential facilities. Specifically, studies should further
examine the role of treatment and/or abstinence length in relation to the neurocognitive
and self-regulation improvements that may occur as a result of cognitive training. It is
also important to note that while statistical tests revealed no significant differences in
socio-demographic, psychiatric, head injury, and primary substance of misuse
characteristics between CR vs. TAU groups, there were apparent differences in history of
substance use (i.e., years of regular use across substances) which were not compared
statistically due to insufficient subgroup sample sizes. Taken together, and particularly in
light of the small sample size of this study, these limitations raise the possibility of
significant between-group variability due to the range of potential confounding factors
(e.g., treatment duration and hence abstinence length, assessment interval, primary
substance of misuse, and substance use history). Also of note were the observed baseline
demographic differences between participants who completed the intervention vs. those
who dropped out of treatment. While these groups did not differ in age, those who
completed the intervention had more years of education and higher levels of premorbid
functioning. This finding is congruent with literature suggesting that cognitive deficits
are one of the most consistently reported risk factors for dropout from SUD treatment
(Brorson et al., 2013). At the same time, it points toward the need for further studies to
investigate characteristics that may predict response to cognitive training (e.g., premorbid
cognition). For these reasons, it is imperative that future studies aim to replicate the
current findings in larger, multi-site, randomized controlled trials, with the inclusion of a
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well-matched, active control group. It is hoped that this study prompts much-needed
further research that may aim to replicate these findings and more thoroughly investigate
the effectiveness of cognitive training in SUD populations with comorbid conditions such
as psychiatric diagnoses and history of head injury.
Rates of cognitive recovery across the first year of SUD treatment have been
investigated at group and individual levels, with qualitatively different trajectories of
change observed between individuals (Bates, Buckman, Voelbel, Eddie, & Freeman,
2013). This has implications for the development and implementation of
neuropsychological interventions in SUD treatment contexts. As this area of research
grows, studies could begin to explore the effectiveness of interventions for SUD across
varying subgroups, in order to ascertain the influence of individual differences that are
present in the often heterogeneous makeup of SUD populations, and tailor interventions
accordingly. Studies that also track clinical outcomes related to sustained remission from
SUDs (e.g., quality of life, length of stay in treatment, program completion, dropout,
relapse to substance use) will be beneficial in further informing neuropsychological
interventions as a strategy to reduce the individual and collective harms associated with
SUDs. Nevertheless, the preliminary evidence from the current study suggests that CR
may improve EFs, self-regulation, and quality of life, and with further examination may
be a promising intervention for use within residential SUD treatment settings.
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CHAPTER 4: LONGITUDINAL FOLLOW-UP OF OUTCOMES FROM A
COGNITIVE REMEDIATION INTERVENTION

Marceau, E. M., Berry, J., Lunn, J., Kelly, P. J., & Solowij, N. (in preparation). A
three-month follow-up of cognitive remediation for substance use disorder:
Executive functions, self-regulation and treatment outcomes.
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4.1.

ABSTRACT

Introduction: Cognitive training is currently being investigated as a viable intervention to
address the highly prevalent cognitive deficits associated with substance use disorder
(SUD). Few studies have included longitudinal follow-up of clinically meaningful
outcomes. The current study presents three-month follow-up outcomes of a cognitive
remediation (CR) intervention designed to improve executive functions (EFs) in a sample
of female residents attending therapeutic community treatment for SUD.
Methods: A controlled sequential groups design was utilised. All residents (N = 50, all
female) attended a residential therapeutic community (i.e. treatment as usual, TAU) and
completed baseline assessments. Of the completers in this trial, the first group (n = 16)
completed four weeks of CR and the second group attended TAU only (n = 17). Outcomes
assessed post-intervention (Marceau, Berry, Lunn, Kelly, & Solowij, 2017) and at threemonth follow-up (reported here: CR n = 12; TAU n = 12) included the Behavior Rating
Inventory of Executive Function – Adult Version (BRIEF-A), self-regulation, and quality
of life measures. A snapshot of participants’ treatment status at three-month follow-up
was also obtained.
Results: The CR group improved on BRIEF-A outcomes at post-intervention and
improvements were sustained at three-month follow-up (Global Executive Composite; F
= 15.25, p < .001). Mixed-effects models found no significant differences in selfregulation or quality of life between the CR and TAU groups (all p > .34). Rates of
treatment completion were significantly higher for the CR vs. TAU group (37.5% vs.
5.9%, respectively; p = .039), but may have been confounded by unexpected differences
in baseline treatment duration observed between groups. Other treatment outcomes did
not differ between groups (all p > .20).
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Conclusions: Although self-regulation and quality of life did not differ between groups
at three-month follow-up, the CR group demonstrated improvements in EFs that were
maintained over time. Future studies may seek to replicate these findings and explore
longitudinal clinically meaningful outcomes for a range of cognitive training
interventions for SUD.
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4.2.

INTRODUCTION
Enhancing cognition is a desirable treatment strategy for multiple psychiatric

disorders and has led to the application of behavioural interventions to achieve this aim.
These interventions are selectively known as cognitive training, cognitive remediation,
and cognitive rehabilitation, with the terms often used interchangeably and inconsistently
(Keshavan, Vinogradov, Rumsey, Sherrill, & Wagner, 2014). This may be partly related
to the interdisciplinary nature of this research field, with multiple disciplines making
significant contributions (e.g., clinical neuropsychology, cognitive psychology, and
neuroscience). For the purposes of this article, the term cognitive training has been
adopted to describe the broad spectrum of interventions that utilise “specifically designed
and behaviorally constrained cognitive or socio-affective learning events, delivered in a
scalable and reproducible manner, to potentially improve neural system operations”
(Keshavan et al., 2014, p. 510). The ultimate goal of cognitive training is the translation
of changes at neural and cognitive levels into clinically meaningful improvements in
everyday functioning.
In a review of evidence for the efficacy of cognitive training in substance use
disorder (SUD) populations, Verdejo-García (2016) proposed a framework to locate the
variety of interventions recently trialled in the literature. They were classified into two
broad classes based on proposed neuroscientific mechanisms: (1) retraining neural
systems related to impulsivity to reduce approach and avoidance biases (i.e., cognitive
bias modification and response inhibition) and (2) strengthening executive functions
(EFs) to enhance goal-directed behaviour (i.e., working memory training and goaldirected approaches). In the context of this framework, a selection of evidence pertaining
to four intervention modalities was reviewed: cognitive bias modification (CBM),
response inhibition, working memory training, and goal-directed approaches. Findings
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indicated that these interventions generally demonstrated efficacy in improving the
targeted cognitive outcomes, but the extent to which these improvements translate into
clinically meaningful outcomes is inconclusive across studies. This issue is a source of
ongoing debate in the wider cognitive training sphere, particularly regarding the benefit
of working memory training (Melby-Lervåg, Redick, & Hulme, 2016; Owen et al., 2010).
In addition to the paucity of clinically meaningful outcomes included in cognitive
training SUD research, there is a lack of studies that track the durability of outcomes over
time. The few studies that have included longitudinal outcomes have conducted followups ranging from one-month to one-year post-intervention (Eberl et al., 2013; Houben,
Wiers, & Jansen, 2011; Wiers, Eberl, Rinck, Becker, & Lindenmeyer, 2011).
In a study of alcohol users in inpatient treatment, Wiers and colleagues (2011)
used a brief CBM intervention targeting approach bias for alcohol. Control conditions
included no training and sham training. Post-intervention outcomes indicated that
participants in the experimental group, but not controls, developed an avoidance bias
towards alcohol, which generalised to novel stimuli. The study included relapse to alcohol
use as a clinical outcome at one-year follow-up and there was a marginally significant
difference between groups, with 46% of the experimental group relapsing, compared to
59% of controls. In replication of this study, and to explore possible mediators and
moderators, CBM was applied to a larger sample of alcohol users in inpatient treatment,
with a treatment as usual control condition (Eberl et al., 2013). A one-year follow-up of
relapse outcomes indicated that the training group had significantly lower rates of relapse,
with 54.9% successfully remaining abstinent, compared to 45.1% of controls, and this
was mediated by change in alcohol-approach tendencies.
A study investigating working memory training for a community sample of
identified problem drinkers included both neuropsychological and clinical outcomes
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assessed post-intervention and at one-month follow-up (Houben et al., 2011). Participants
in the control condition also received working memory training but task-difficulty
increased only in the experimental group. Findings indicated improvements in the
experimental group’s working memory capacity and also fewer alcoholic drinks
consumed per week at post-intervention, relative to controls. Furthermore, these
improvements were retained at one-month follow-up.
As described above, only three studies – two of CBM and one of working memory
training – have included longitudinal follow-up of neuropsychological and/or clinical
outcomes in the emerging research area of cognitive training for SUD. To the best of our
knowledge, longitudinal outcomes of response inhibition and goal-directed cognitive
training interventions for SUD have not yet been explored in the literature.
Our team recently conducted a study investigating the effectiveness of cognitive
remediation for females attending residential therapeutic community treatment for SUD
(Marceau et al., 2017). This study included residents with psychiatric diagnoses and
history of head injury, as these factors are associated with cognitive dysfunction
(Marceau, Lunn, Berry, Kelly, & Solowij, 2016), but have been excluded from previous
similar studies in order to establish the efficacy of cognitive training interventions for
unconfounded SUD (e.g., Valls-Serrano, Caracuel, & Verdejo-García, 2016). In the
context of the neuroscientific framework established by Verdejo-García (2016), our
intervention is most appropriately located within the second class of proposed underlying
mechanisms, which focuses on enhancing goal-directed behaviour through strengthening
EFs. A unique aspect of this intervention was the inclusion of and synergy between both
computerised and strategy-based goal-directed training approaches. Findings indicated
that at post-intervention the cognitive remediation group demonstrated improvements in
EFs, self-regulation, and quality of life, relative to the control group, who attended
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treatment as usual only. With the aim of contributing to the existing literature of
longitudinal outcomes investigating the benefit of cognitive training for SUD, the current
paper presents the three-month follow-up outcomes of this study, which were collected
for a subset of measures, including EFs and self-regulation. Clinically meaningful
outcomes, treatment retention data and quality of life, were also captured at a snapshot
point in time.

4.3.

METHODS
4.3.1. PARTICIPANTS
Participants (N = 50) were recruited from a women’s residential treatment facility

in Sydney run by We Help Ourselves (WHOs) – a large provider of residential SUD
rehabilitation in Australia.
Inclusion criteria were: (1) Diagnosis of substance abuse/dependence, based on
DSM-IV-TR criteria, confirmed using the Mini-International Neuropsychiatric Interview
(MINI-Plus; Sheehan et al., 1998); (2) Minimum abstinence period of 7 days; (3) Absence
of any neurological, infectious, or other disease affecting the central nervous system (e.g.,
epileptic seizures, stroke, brain tumour, meningitis, encephalitis, multiple sclerosis, HIV
positive); (4) English as native language.

4.3.2. DIAGNOSTIC AND CLINICAL ASSESSMENT
Psychiatric comorbidities were assessed using the MINI-Plus and Standardised
Assessment of Personality – Abbreviated Scale (Moran et al., 2003), shown to be an
appropriate cost-effective and time-efficient personality disorder screening measure in
SUD populations (Gonzalez, 2014; Hesse & Moran, 2010; Hesse, Rasmussen, &
Pedersen, 2008). Questions were adapted from the Addiction Severity Index – Fifth
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Edition (ASI; McLellan et al., 1992) to assess lifetime substance use history. A brief semistructured interview was used to assess history of head injury and the Test of Premorbid
Functioning (TOPF; Pearson Assessment, 2009) was used to estimate overall level of
premorbid intellect.

4.3.3. DESIGN AND PROCEDURES
A non-randomised controlled sequential groups design was used and the study
provided a naturalistic snapshot of residents in treatment at the time of recruitment. All
residents were invited to participate in the study, with a response rate of 96%. Those who
met inclusion criteria and provided consent took part in either: (a) a cognitive remediation
(CR; n = 23) group program or (b) treatment as usual (TAU; n = 27). The CR group were
recruited first, followed by the TAU group, allowing sufficient time for a new cohort of
residents to become available. Unexpectedly, the CR group had spent more time in
treatment prior to baseline assessment (Mdn = 62 days) than the TAU group (Mdn = 23
days).
Both groups engaged in the usual therapeutic community model of treatment
(Vanderplasschen et al., 2013), and the CR group participated in 12 x 2-hour group
sessions across 4 weeks (3 sessions/week held on alternating weekdays), facilitated by
the second author (JB) and co-facilitated by the first author (EM). The CR intervention
was developed with a primary focus on training EFs and self-regulation, given that EFs
are particularly impaired in SUD treatment populations (e.g., Fernández-Serrano, PérezGarcía, Perales, & Verdejo-García, 2010). Further details of the intervention have been
reported elsewhere (Marceau et al., 2017). The facilitators followed a manual (available
on request) to ensure treatment consistency.
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The CR group completed baseline assessments in the week prior to the
commencement of the intervention and post-intervention assessments in the week
following its completion. Similarly, the TAU group completed baseline assessments
followed by a period of approximately 4 weeks and were reassessed during the
subsequent week. The post-intervention sample size was 33 completers: n = 16 (CR
group) and n = 17 (TAU group). The rates of dropout from the intervention study were
30% and 37% respectively, did not significantly differ between groups (X2 = 0.241, p =
0.623) and are comparable to those observed in SUD therapeutic community treatment
(Darke, Campbell, & Popple, 2012).
Approximately three months after post-intervention assessments, contact with all
participants who completed post-intervention assessments (n = 33) was attempted via
phone to collect three-month follow-up data, with success rates of 75% (CR group; n =
12) and 71% (TAU group; n = 12). Measures administered over the phone were the Brief
Self-Control Scale (Tangney, Baumeister, & Boone, 2004), Penn Alcohol Craving Scale
(Flannery, Volpicelli, & Pettinati, 1999), Drug-Taking Confidence Questionnaire: eightitem version (Sklar & Turner, 1999), and EUROHIS-QOL 8-item index (Skevington,
Lotfy, & O' Connell, 2004; WHOQOL Group, 1998), as well as relapse to substance use
in the past month. At the end of each approximately 20-minute call, participants were
given the option of receiving a final questionnaire, the Behavior Rating Inventory of
Executive Function – Adult version (BRIEF-A; Roth, Isquith, & Gioia, 2005), via post
with a reply paid envelope included and asked whether they would be willing to complete
and return this questionnaire. All participants agreed and were subsequently mailed
BRIEF-A questionnaires. After allowing sufficient time for participants to receive,
complete, and return BRIEF-A questionnaires, 92% (n = 11) and 33% (n = 4), from the
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CR and TAU groups respectively, were returned. Additionally, with consent of
participants and service manager, treatment retention data were accessed.

4.3.4. THREE-MONTH OUTCOME MEASURES
4.3.4.1.

Executive functions and self-regulation

Behavior Rating Inventory of Executive Function – Adult Version (BRIEF-A; Roth et al.,
2005). The BRIEF-A is a self-report questionnaire consisting of 75 items and nine
subscales. Participants are instructed to answer each question by selecting “never”,
“sometimes”, or “often”, in relation to whether they have had problems with any of the
listed behaviours in the past month. Example items include: “I am bothered by having to
deal with changes”; “I say things without thinking”. The Global Executive Composite
(GEC) provides an overall summary score. The Behavioral Regulation Index (BRI)
includes the subscales Inhibit; Shift; Emotional Control; Self-Monitor. The
Metacognition Index (MI) includes subscales Initiate; Working Memory; Plan/Organise;
Task Monitor; Organisation of Materials. Elevated scores indicate executive dysfunction.
The outcome variable used was GEC.
Brief Self-Control Scale (BSCS; Tangney et al., 2004). The BSCS is a 13-item self-report
questionnaire assessing individual differences in the construct of self-control and
outcome variable was total score, with greater scores indicating higher levels of selfcontrol.
Penn Alcohol Craving Scale (PACS; Flannery et al., 1999). The PACS is a 5-item selfreport questionnaire that assesses level of cravings for alcohol and other drugs, with
greater scores indicating stronger cravings. Participants were asked to respond to all items
in relation to their primary substance of misuse and outcome variable was total score.
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Drug-Taking Confidence Questionnaire – Eight-Item Version (DTCQ-8; Sklar & Turner,
1999). The DTCQ-8 is an 8-item self-report questionnaire that measures coping selfefficacy by gauging the likelihood of abstinence from alcohol and other drugs across a
number of hypothetical high-risk scenarios. The outcome variable was derived by
dividing total scores by number of items (i.e., total score divided by 8), with higher scores
indicating a greater likelihood of abstinence.

4.3.4.2.

Clinically meaningful outcomes

Treatment retention data. Treatment retention outcome variables included rates of
treatment completion (i.e., residents who were deemed to have finished the program,
based on the assessment of all staff), dropout, and residents currently in treatment. Length
of time in treatment (days) since post-intervention assessments was also included. Selfreported relapse to substance use in the past month was included and coded as a
dichotomous response.
EUROHIS-QOL 8-Item Index (EUROHIS-QOL-8; Skevington et al., 2004; WHOQOL
Group, 1998). The EUROHIS-QOL-8 is an 8-item self-report questionnaire used to
assess quality of life across four domains of functioning, including physical health,
psychological wellbeing, social relationships, and environment. Total score was used as
the outcome variable, with higher scores indicating greater quality of life.

4.3.5. STATISTICAL METHODS
Statistical analyses were performed using IBM Statistical Package for the Social
Sciences (SPSS version 21; IBM Corp, 2012). Screening of baseline data indicated six
missing BSCS values (CR = 1; TAU = 5). Post-intervention and three-month follow-up
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data each contained one missing value in the TAU group (PACS and DTCQ,
respectively).
Socio-demographic characteristics and substance use data of the CR vs. TAU
groups were compared using Student’s t-test and Mann-Whitney U tests as a
nonparametric alternative. Chi-square and Fisher’s exact tests were used to compare
percentage variables, including psychiatric and head injury characteristics, as well as
treatment retention data.
The three-month follow-up outcomes of CR vs. TAU groups were examined via
a series of linear mixed-effects models. Intention-to-treat analyses were used, with all
participants who completed at least baseline assessments included (N = 50). The models
included fixed effects for group, time and the group x time interaction, and random effects
for participants. Both random intercept and random intercept/random slope models were
considered. Due to the low return of questionnaires from the TAU group, BRIEF-A GEC
outcomes were examined only for the CR group, also via a series of linear mixed-effects
models.
For each of the five outcome variables, a variety of mixed-effects models were
fitted. Standard goodness-of-fit criteria (Honghu, Yan, & Jie, 2008) were used to guide
model selection. The final models chosen included fixed effects for group, time and the
group x time interaction, and a random intercept term for participants, and the model
pertaining to GEC outcomes included fixed effects for time and a random intercept term
for participants. An autoregressive error structure was utilised (Wolfinger, 1993). Based
on the recommendation that covariates be selected a priori and be as few in number as
possible (Kraemer, 2015), only treatment duration was included as a covariate. Treatment
duration was found to improve model fit for only one analysis (DTCQ-8) and, therefore,
this covariate was omitted for all other analyses.
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4.4.

RESULTS
Baseline socio-demographic characteristics and substance use, psychiatric, and

head injury history for CR vs. TAU groups are presented in Table 7. No significant
differences in age, education, current or past Axis I diagnoses, personality disorder
screening, history of losing consciousness/concussion or hospitalisation after a head
injury, primary substance of misuse, or years of regular substance use were found
between groups. Treatment duration was significantly longer (p = .001) for participants
in the CR group (n = 23, Mdn = 62 days, range 16–160) compared to the TAU group (n
= 27, Mdn = 23 days, range 2–82). Additionally, there was a 5-day difference between
groups in the interval between baseline and post-intervention assessments (p = .005) (CR:
n = 16, Mdn = 34 days, range 33–36; TAU: n = 17, Mdn = 29 days, range 26–36). The
interval between post-intervention assessments and three-month follow-up did not
significantly differ between groups (p = .67) (CR: n = 12, Mdn = 106.5 days, range 93–
183; TAU: n = 12, Mdn = 102 days, range 94–147).
Linear mixed-effects models results are displayed in Table 8. No significant
differences were found between the CR group and TAU group at three-month follow-up,
for all four dependent measures (BSCS, PACS, DTCQ-8, EUROHIS-QOL-8).
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Table 7. Socio-demographic, substance use, psychiatric and head injury characteristics of residents of
a female-only substance use therapeutic community at baseline.
Characteristic
Age (Mdn, range)a
Education (Mdn, range)

a

Test of Premorbid Functioning (M, SD)
Unemployed (%)

b

Marital status (% single)

b

Cognitive Remediation

Treatment as Usual

(n = 23)

(n = 27)

p

32 (22-56)

33 (19-53)

.79

10 (6-15)

11 (7-20)

.21

91.0 (14.3)

94.2 (14.2)

.44

73.9

81.5

.52

69.6

77.8

.51

Primary substance of misuse (%)c

.13

Methamphetamine

43.5

44.4

Alcohol

21.7

33.3

Amphetamines

17.4

0

Heroin

8.7

Cannabis

0

Sedatives

8.7

7.4
11.1
3.7

Years of regular use (M, Mdn, SD; n)
Alcohol (any use) a

13.7 (16, 8.7; 17)

9.5 (7.0, 7.7; 26)

.12

11.6 (13.5, 7.8; 16)

8.4 (5.5, 7.4; 26)

.23

13.0 (16.0, 8.9; 3)

8.4 (6.5, 8.3; 6)

.47

6.7 (7.0, 1.5; 3)

8.3 (8.3, 11.0; 2)

1.0

Other opiates/analgesics

11.1 (11.0, 3.6; 4)

5.3 (2.0, 5.7; 7)

.10

Sedatives/hypnotics/tranquilisersa

10.4 (10.0, 3.6; 7)

7.5 (3.5, 7.7; 10)

.24

4.7 (1.5, 6.4; 5)

8.1 (8.5, 4.7; 6)

.27

7.7 (8, 4.9; 20)

8.6 (9.0, 6.1; 22)

.61

11.6 (11.0, 6.6; 20)

10.6 (10.0, 7.5; 23)

.67

4.8 (3.0, 5.6; 6)

6.3 (4.0, 4.9; 3)

.36

9.2 (9.0, 4.9; 17)

10.4 (10.0, 7.0; 24)

.56

Alcohol (to intoxication)

a

Heroin
Methadone

Cocaine

a

Amphetamines

a

Cannabis
Hallucinogens

a

More than one substance per day
Psychiatric diagnostic assessmentand screening (%)

b

Current Axis I psychiatric diagnosis

56.5

70.4

.31

Past Axis I psychiatric diagnosis

65.2

63.0

.87

52.2

29.6

.11

47.8

55.6

.59

30.4

44.4

.31

Personality disorder screen (met criteria)
Lost consciousness/concussion after head injury (%)
b

Hospitalised after head injury (%)
a

b

Mann-Whitney U test. b Chi-square test. c Fisher’s exact test.
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Table 8. Three-month follow-up of cognitive remediation (CR) vs. treatment as usual (TAU) on self-regulation and quality of life outcomes in residents of a female-only
substance use therapeutic community (N = 50).
Analysisa

Time point
Baseline

Month 1

Month 4

M (SE)

M (SE)

M (SE)

Dependent measures

Treatment

Brief Self-Control Scale

CR

2.73 (0.17)

3.12 (0.18)

3.63 (0.20)

TAU

2.19 (0.17)

2.34 (0.18)

2.97 (0.20)

CR

8.48 (1.63)

6.52 (1.82)

5.97 (1.95)

TAU

11.59 (1.50)

12.32 (1.76)

9.66 (1.90)

CR

62.05 (5.99)

72.51 (6.86)

72.97 (7.92)

TAU

61.08 (5.59)

61.56 (6.57)

74.37 (7.76)

CR

28.91 (1.18)

32.23 (1.27)

32.51 (1.42)

TAU

24.96 (1.08)

28.06 (1.21)

30.55 (1.41)

Penn Alcohol Craving Scale
Drug Taking Confidence Questionnaireb
EUROHIS-QOL 8-Item Index
a
b

Results of linear mixed-effects models group x time interactions. Means are predicted from linear mixed-effect intention-to-treat models.
Days in treatment prior to baseline included as a covariate.

F

df

p

1.02

2, 56

.37

0.77

2, 47

.47

0.93

2, 64

.40

0.67

2, 51

.52
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Treatment outcomes are displayed in Table 9. Significantly higher rates of overall
TC treatment completion were observed for participants in the CR group relative to the
TAU group. Approximately 30% of participants in the CR group left treatment early
compared to slightly over 50% of participants in the TAU group, yet this difference did
not reach statistical significance. On average, the CR group remained in treatment longer
(93.8 days) than the TAU group (76.1), but this difference was also not statistically
significant. There was no difference in self-reported rates of relapse in the past month,
with only one participant from each group reporting relapse to substance use.

Table 9. Treatment retention data for female residents attending therapeutic community treatment for
substance use at three-month follow-up after cognitive remediation (CR) vs. treatment as usual (TAU).
Dependent measures

CR (n = 16)

Completed treatment (%)a
Left treatment early (%)

b

Currently in treatment (%)

b

Days in treatment post-intervention (M, SD)
Relapsed to substance use (% past month)
a

a,d

c

TAU (n = 17)

p

37.5

5.9

.039

31.2

52.9

.21

31.3

41.2

.55

93.8 (54.9)

76.1 (33.4)

.27

8.3

8.3

1.00

Fisher’s exact test. b Chi-square test. c Independent t-test. d CR: n = 12; TAU: n = 12.

Figure 2a displays GEC outcomes for the CR group (N = 50), which changed
significantly over time, F(2, 33) = 23.32, p < .001. GEC scores significantly reduced from
baseline (M = 61.76, SE = 1.85) to post-intervention (M = 54.53, SE = 1.97; p < .001) and
from baseline to three-month follow-up (M = 53.47, SE = 2.25; p < .001), and did not
significantly differ from post-intervention to three-month follow-up (p = .54). Figure 2b
is for visualisation purposes only and displays changes in GEC outcomes for the CR vs.
TAU groups; the insufficient sample size for the TAU group at three-month follow-up (n
= 4) precluded reporting of valid linear mixed-effects model results (Hox, 2010).
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65

a

60
BRIEF-A GEC
55

50
Baseline

Post-intervention

3-month follow-up

70

b
65
60
CR

55

TAU
50
45
40
Baseline

Post-intervention

3-month follow-up

Figure 2. Changes in Behavior Rating Inventory of Executive Function (BRIEF-A) Global Executive
Composite (GEC) outcomes for residents of a female-only substance use therapeutic community after
cognitive remediation (CR): a) CR group only; b) CR vs. treatment as usual (TAU) groups, for
visualisation purposes only due to insufficient sample size of TAU group at 3-month follow-up (n = 4).
Means are predicted from linear mixed-effect intention-to-treat models.

4.5.

DISCUSSION
The current study aimed to investigate the longer-term effectiveness of a cognitive

remediation intervention in a female-only residential substance use disorder therapeutic
community treatment context. A three-month follow-up, including assessment of
executive functions and self-regulation, as well as treatment retention and outcome data,
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relative to treatment as usual, was conducted. In brief, it was found that the CR group
demonstrated significant improvements in inventory-based assessment of EFs (i.e.,
BRIEF-A GEC) at post-intervention and these improvements were sustained three
months later. Self-regulation and quality of life outcomes, however, did not significantly
differ between the CR and TAU groups at three-month follow-up. A significantly greater
proportion of the CR group (37.5%) were recorded as completing treatment relative to
the TAU group (5.9%), at the particular snapshot in time that treatment retention data
were accessed. While this occurred three months following the intervention for both CR
and TAU groups, it is problematic to infer that these data are associated with completion
of the CR intervention, due to the unexpected baseline imbalance in duration of treatment.
There was no difference between groups for other treatment outcome measures, including
rates of dropout from SUD treatment, number of days spent in treatment following the
intervention, and relapse to substance use.
These results significantly contribute to the emerging body of literature
investigating the effectiveness of cognitive training for SUD (Verdejo-García, 2016). Of
note, few studies have included longitudinal outcomes and the current study, to the best
of our knowledge, is the first to investigate this with regard to a CR intervention applied
within a residential female-only SUD treatment context.
In our original study investigating the effectiveness of CR for SUD immediately
post-intervention (Marceau et al., 2017), the CR group relative to the TAU group
demonstrated improvements in inventory-based assessment of EFs, as measured by the
BRIEF-A. The current study attempted to conduct a three-month follow-up of these
BRIEF-A outcomes. While 92% of the CR group returned these questionnaires via mail,
only 33% of questionnaires sent to the TAU group were returned. This did not permit
meaningful comparison, due to insufficient sample size of the TAU group (Hox, 2010).
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We did find that within the CR group the post-intervention improvements in EFs were
sustained three months later. Furthermore, a purely visual comparison of BRIEF-A
outcomes between the CR and TAU group (Figure 2b) showed potentially promising
benefits of the cognitive remediation intervention leading to improved EFs outcomes in
comparison to TAU. It must be acknowledged, however, that this graph shows potential
baseline differences in BRIEF-A scores between groups, with the TAU group
demonstrating greater levels of executive dysfunction at baseline (which were
nevertheless accounted for in the analysis of post-intervention data, showing a significant
difference between CR and TAU (Marceau et al., 2017; Chapter 3)).
EFs have been proposed as the neurocognitive basis of self-regulation capacity
and subsequently training of EFs has been hypothesised to increase self-regulation
capacity (Hofmann, Schmeichel, & Baddeley, 2012). The current study, however, found
no corresponding improvements in self-regulation capacity, as assessed by self-reported
measures including the BSCS, PACS, and DTCQ-8. These findings indicate that while
CR may potentially produce lasting improvements on EFs, these improvements may not
generalise to increased self-regulation capacity. Indeed, the debate regarding whether
improvements in cognition following cognitive training generalise to untrained tasks and
functional improvement is inconclusive (Melby-Lervåg et al., 2016; Owen et al., 2010;
Verdejo-García, 2016). An alternate explanation is that the measures of self-regulation
used in this study did not appropriately capture all relevant components of this broad
concept.
There was also generally no difference between the CR and TAU groups at threemonth follow-up in terms of treatment outcomes and quality of life, an important clinical
outcome related to sustained remission from substance use (Laudet, Becker, & White,
2009). Of note, 37.5% of the CR group completed treatment compared to only 5.9% of
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the TAU group. While this difference was statistically significant, it may be an artefact
of the significantly longer duration of treatment observed in the CR group (67 days)
relative to the TAU group (25 days) at baseline. Although not statistically significant, it
was also observed that 31.2% of the CR group left treatment early, compared to 52.9%
of the TAU group. Similarly, the CR group completed, on average, 17 more days of
treatment compared to the TAU group (93.8 vs. 76.1 days, respectively), as assessed from
completion of the intervention to three-month follow-up. These findings may indicate
some beneficial effects of the CR intervention on treatment retention but it is also crucial
to acknowledge that these results may be related to the unanticipated differences in
duration of treatment observed between groups at baseline, but also significant variability
in duration of treatment at baseline for both CR (range 16–160 days) and TAU (range 2–
82 days) groups. It is also important to acknowledge that expected length of treatment in
SUD therapeutic communities may significantly vary between individuals, further
affecting interpretation of the treatment retention data presented in this study.
It is also important to consider the ways in which the current study differs from
those previously reported in the literature. First, the intervention utilised a goal-directed
approach that incorporated both computerised and strategy-based training. Such
approaches tend to be utilised individually, rather than simultaneously, and each approach
assumes a differential underlying mechanism of action. Strategy-based approaches
operate on the premise that teaching participants problem-solving techniques and
strategies is what ultimately leads to improvements, whereas computerised training most
often utilises drill-practice, which presumably leads to gains via restoring dysfunctional
neuronal circuitry (Paquin, Wilson, Cellard, Lecomte, & Potvin, 2014). A second point
of departure concerns the role of gender in cognitive training for SUD. In contrast to the
longitudinal studies reported in the literature (Eberl et al., 2013; Houben et al., 2011;
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Wiers et al., 2011), the sample of the current study consisted solely of females. The study
investigating working memory training (Houben et al., 2011) incorporated an
approximately equal male vs. female ratio. The original CBM study (Wiers et al., 2011)
was only 20% and 28% female in the training and control groups, respectively, whereas
the replication of this study (Eberl et al., 2013) did not specify the gender ratio of the
sample. Finally, participants in the current study were not excluded on the basis of
psychiatric diagnoses or history of head injury. Psychiatric diagnoses (Grant et al., 2015;
Grant et al., 2016) and history of head injury (Marceau et al., 2016) are commonly
observed in SUD populations, and this study contributes to the longitudinal literature on
SUD cognitive training through inclusion of participants with these comorbidities.
As there is a paucity of research including longitudinal follow-up of clinically
meaningful outcomes for the range of cognitive training interventions for SUD, future
studies are required to clarify the extent of long-term benefits and functional
improvement. Limitations of the current study include the small sample size, minimal
follow-up data, non-randomised design, and lack of an active control group (as opposed
to TAU). In the future, larger multi-site randomised controlled trials, including
thoughtfully planned active control conditions in addition to treatment as usual, are
required. It is also recommended that future studies investigate the role of length of
treatment more thoroughly, to determine the benefit of cognitive training in light of the
diversity in treatment length commonly observed in residential treatment settings. This
may be best achieved by ensuring that treatment and control groups are matched on length
of treatment, perhaps through enrolment into intervention studies at entry to treatment. In
this way, it would be possible to ascertain whether cognitive training is related to
improved treatment outcomes. Despite best intentions, and in light of the constraints of
real-world applied research in SUD treatment populations, the current study was
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unfortunately unable to extract meaningful treatment completion outcomes, primarily due
to the unanticipated baseline imbalance in duration of treatment between the CR and TAU
groups. Future studies may also seek to examine potential differences in baseline EFs
measures and other sample characteristics (e.g., age, education, premorbid functioning,
substance use history variables, length of abstinence) and how these may influence the
effectiveness of cognitive training interventions for SUD.
As per the recommendations of Verdejo-García (2016), future studies should
investigate a range of cognitive training interventions with clearly articulated
mechanisms, and well-matched control groups to elucidate mechanisms of action.
Moreover, diverse measures of EFs and self-regulation, including inventory- and
performance-based assessments, as well as relevant neuroimaging measures should be
utilised, in order to shed light on not only the potential benefits of cognitive training for
SUD, but also the underlying mechanisms of these benefits. The current study, in spite of
certain limitations, provides preliminary longitudinal data for the effectiveness of a
combined CR intervention in a sample of females in residential SUD therapeutic
community treatment, with improvements in EFs as assessed by the BRIEF-A sustained
for the CR group at three-month follow-up, potentially indicating durability of these
changes.
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5.1.

ABSTRACT

Background: Difficulties in emotion regulation influence the development of substance
use disorder (SUD), its severity and course, treatment outcomes, and relapse. Impaired
executive functions (EFs) are common in SUD populations and may relate to emotion
dysregulation. The current study tested whether performance on three basic EF tasks
(‘working memory’, ‘inhibition’, and ‘task-switching’) and/or inventory-based
assessment of EF predicted difficulties in emotion regulation in females attending
residential SUD therapeutic community treatment.
Methods: Cross-sectional design with participants (N = 50, all female) completing a
questionnaire battery including the Difficulties in Emotion Regulation Scale (DERS) and
Behavior Rating Inventory of Executive Function – Adult Version (BRIEF-A).
Participants also completed neuropsychological assessment of EF including the Working
Memory Index (WMI; Wechsler Adult Intelligence Scale), and measures of inhibition
and task-switching (Color-Word Interference Test; Delis-Kaplan Executive Function
System).
Results: Executive dysfunction, as assessed by the Global Executive Composite (GEC;
BRIEF-A), and personality disorder indicators (Standardised Assessment of Personality
– Abbreviated Scale; SAPAS) were positively correlated with DERS scores, whilst taskswitching was negatively correlated. Sequential hierarchical regression indicated that
task-switching, GEC, and SAPAS scores uniquely predicted DERS scores. Neither
working memory nor inhibition predicted DERS scores. Mediation analysis indicated that
there was a significant indirect effect of GEC scores and task-switching performance on
DERS scores, through SAPAS scores.
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Conclusions: Impairment of EF, particularly task-switching, contributes to difficulties in
emotion regulation in a female sample attending residential SUD treatment. Cognitive
training interventions that improve task-switching performance may be beneficial in
promoting effective emotion regulation and improved SUD treatment outcomes.

126

5.2.

INTRODUCTION
When an emotion arises, a complex interplay between subjective experience,

cognition, physiological changes, and behavioral components takes place, with neural
bases such as the lateral prefrontal and parietal cortices and the ventral anterior cingulate
and ventromedial prefrontal cortices implicated (Etkin, Büchel, & Gross, 2015). The
pursuit of desired emotional states in everyday life is ubiquitous and “emotion regulation”
denotes this process; that of modifying the intensity or duration of existing emotions in
order to maintain goal-directed behavior (Tamir, 2016).
Emotion dysregulation is implicated in various forms of psychopathology (Aldao,
Nolen-Hoeksema, & Schweizer, 2010), including substance use disorder (SUD;
Cheetham, Allen, Yücel, & Lubman, 2010), in which it has a significant effect on the
initiation, severity, and prognosis of the disorder (Wilcox, Pommy, & Adinoff, 2016).
For example, the capacity for effective emotion regulation is under development during
adolescence and may, in combination with other risk factors, increase the likelihood of
early initiation of substance use, disruption of neuromaturational processes, and
subsequent poor prognosis (Gladwin, Figner, Crone, & Wiers, 2011; Lubman, Yücel, &
Hall, 2007; Smith & Cyders, 2016; Wills, Simons, Sussman, & Knight, 2016).
Individuals with affective disorders (e.g., anxiety and mood disorders) commonly
experience comorbid SUD and, conversely, SUDs also contribute to the development of
affective disorders (Cheetham et al., 2010). Additionally, SUD populations experience
greater difficulties with emotion regulation relative to controls (Wilcox & Adinoff, 2015)
and substance use may develop as a mechanism to relieve negative affect (Blevins,
Abrantes, & Stephens, 2016). Emotion dysregulation increases the severity of SUD (Tull,
Bardeen, DiLillo, Messman-Moore, & Gratz, 2015) and predicts relapse to substance use
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(Witkiewitz & Wu, 2010), while reductions in negative affect predict reduced SUD
severity following treatment completion (Mo & Deane, 2016).
Akin to the role of emotion dysregulation in SUD, cognitive deficits are
commonly observed and also impede the treatment process. Cognitive impairment is one
of the four most common risk factors for dropout from SUD treatment (Brorson, Ajo
Arnevik, Rand-Hendriksen, & Duckert, 2013) and the specific impairment of executive
function (EF) is well documented in SUD populations (Fernández-Serrano, Pérez-García,
Perales, & Verdejo-García, 2010; Hester, Lubman, & Yücel, 2010).
Along with the challenges to effective SUD treatment associated with emotion
dysregulation and cognitive deficits, comorbid personality disorder is a significant risk
factor for early dropout (Brorson et al., 2013) and is highly prevalent in SUD populations
(Grant et al., 2015; Grant et al., 2016). Further to this, personality disorder is
independently associated with cognitive deficits, with the most commonly observed
deficits in memory, decision-making, and EFs (Unoka & Richman, 2016).
While several conceptualisations of EF exist, Miyake et al. (2000) proposed the
unity/diversity framework of EF, which posits three separable, basic EFs: ‘working
memory’, ‘inhibition’, and ‘task-switching’ (Friedman & Miyake, 2017; Miyake &
Friedman, 2012). Working memory refers to the capacity to monitor and alter the contents
of working memory, inhibition is the ability to override an unwanted distraction to
maintain task-focus, and task-switching involves flexibly switching attention between
tasks or mental sets (Hofmann, Schmeichel, & Baddeley, 2012).
It has been proposed that these basic EFs (i.e., working memory, inhibition, and
task-switching) may subserve effective emotion regulation (Hofmann et al., 2012;
Schmeichel & Tang, 2015). The contributions of working memory, inhibition, and taskswitching to emotion regulation have been explored in a number of studies,
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predominantly drawing from nonclinical populations. For example, a series of studies
explored the role of working memory (assessed using the operation span task) in emotion
regulation within a university student sample (Schmeichel & Demaree, 2010;
Schmeichel, Volokhov, & Dernaree, 2008). Participants with a higher working memory
capacity were better able to appraise emotional stimuli and, consequently, more
effectively experience and express emotion (Schmeichel et al., 2008); these abilities were
not confounded with higher working memory capacity leading to participants being better
able to follow instructions (Schmeichel & Demaree, 2010). Another study in a
community sample found that effective reappraisal of emotions was predicted by higher
working memory capacity in a modified operation span task (McRae, Jacobs, Ray, John,
& Gross, 2012). The specific role of updating the contents of working memory in emotion
regulation was explored in university students using the emotional 2-back task (Pe et al.,
2015). Participants with better updating abilities displayed higher levels of emotional
reactivity, but were more quickly and effectively able to regulate their emotions and
return to a baseline level of arousal.
Several studies have demonstrated links between inhibition and emotion
regulation. Inhibition performance, as measured by the Stroop task, was found to predict
effective restraint of socially inappropriate behaviors in university students (von Hippel
& Gonsalkorale, 2005). Similarly, university students who demonstrated poorer
inhibition performance in the stop-signal task experienced larger increases in negative
emotions following an emotion induction paradigm, relative to those with better
inhibition performance (Tang & Schmeichel, 2014). In a sample of 5- to 7-year-old
children, inhibition performance assessed by a go/no-go task predicted effort exerted in
regulating emotions (Hudson & Jacques, 2014), with similar findings demonstrated in
preschool-aged children (Carlson & Wang, 2007). In a clinical sample of patients with
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frontal lobe damage, inhibition performance via a go/no-go task mediated the relationship
between prefrontal lobe damage and maladaptive emotion regulation strategies (Falquez
et al., 2015).
There is a paucity of studies investigating the role of task-switching in emotion
regulation (Schmeichel & Tang, 2015). The previously mentioned study of working
memory by McRae and colleagues (2012), also included a measure of task-switching (i.e.,
set-shifting costs based on a standardized global/local task), and found that as well as
working memory capacity, task-switching also predicted effective reappraisal of
emotions.
While a range of studies have investigated the role of working memory, inhibition,
and, to a lesser extent, task-switching, these studies have primarily involved nonclinical
populations and to the best of our knowledge, the role of these basic EFs in emotion
regulation have not been explored in an SUD population.
While these basic performance-based EF tasks are sensitive to impairment of the
frontal lobes (Jurado & Rosselli, 2007), some tasks may arguably have limited ecological
validity and may not capture impaired functioning as effectively as inventory-based (i.e.,
self-report) assessment of EFs (Isquith, Roth, & Gioia, 2013). Furthermore, performanceand inventory-based measures of EFs are minimally correlated and may assess distinct
components of EFs (Toplak, West, & Stanovich, 2013). For example, inventory-based
assessment of EFs, using the Behavior Rating Inventory of Executive Function – Adult
Version (BRIEF-A; Roth, Isquith, & Gioia, 2005), more effectively distinguished
polysubstance users from controls and was more strongly associated with social
adjustment outcomes, compared to performance-based measures (Hagen et al., 2016). In
light of these considerations, the current study included both performance- and inventorybased assessment of EFs.
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Given the importance of emotion regulation in SUD treatment and the potential
connection between EFs and effective emotion regulation, the current study sought to
ascertain whether inventory-based assessment of EFs, and/or performance-based
assessment of working memory, inhibition, and task-switching performance were related
to difficulties in emotion regulation in an all-female residential SUD population. A further
aim of the current study was to explore the role of personality disorder in the relationship
between EFs and emotion dysregulation, given its high prevalence in SUD populations,
deleterious effect on SUD treatment, and independent association with cognitive deficits.

5.3.

MATERIAL AND METHODS
5.3.1. PARTICIPANTS
Participants (N = 50) were recruited from We Help Ourselves (WHOs), a large

provider of residential SUD treatment in Australia, which utilises the Therapeutic
Community model of treatment (De Leon, 1989). Participants from this study were drawn
from baseline assessments of a subsequent study that investigated the effects of cognitive
remediation in residents of an SUD therapeutic community (Marceau, Berry, Lunn, Kelly,
& Solowij, 2017). Inclusion criteria for the study were: (i) diagnosis of substance
abuse/dependence, based on DSM-IV-TR criteria, assessed using the Mini-International
Neuropsychiatric Interview (MINI-Plus; Sheehan et al., 1998), (ii) a minimum abstinence
period of 7 days (with confirmation of detoxification a prerequisite of entry to treatment),
(iii) absence of any neurological, infectious, or other disease affecting the central nervous
system (e.g., epileptic seizures, stroke, brain tumour, meningitis, encephalitis, multiple
sclerosis, HIV positive), and (iv) English as native language. Limited leave from the
residential facility, close observation by staff and other residents, and random urine tests
assured abstinence during the course of participation in this study.

131

5.3.2. PROCEDURE
All residents in the treatment facility were invited to participate in the study and
the recruitment rate was 96%. Participants were female, aged between 19 and 56 years
(M = 32.5, SD = 8.1), and had completed an average of 10.8 years of education (SD = 2.5,
range 6-20). Participants had been in treatment for an average of 46.9 days (SD = 38.9,
range 2-160).

5.3.3. SCREENING, DIAGNOSTIC AND CLINICAL ASSESSMENT
Diagnostic and clinical assessment at baseline included the following: Diagnoses
of substance abuse/dependence and other current and past Axis I diagnoses were assessed
using the MINI-Plus. Screening for personality disorder diagnoses was conducted using
the Standardised Assessment of Personality – Abbreviated Scale (SAPAS; Moran et al.,
2003), as shown to be an appropriate time-efficient and cost-effective assessment for
SUD populations (Gonzalez, 2014; Hesse & Moran, 2010; Hesse, Rasmussen, &
Pedersen, 2008). The SAPAS is an 8-item scale including questions such as, “In general,
do you have difficulty making and keeping friends?” and “In general, do you trust other
people?”. Participants were instructed that the questions were about “how you behave
and the way you think and feel things usually – in other words they are about your
behavior and your way of being in general” and were asked to answer with a yes/no
response. In the case of answering “yes” to a question, participants were then asked if
their response applied “most of the time and in most situations” to which they also
responded yes or no. SAPAS responses were scored as per the standardized instructions
(i.e., one point assigned when participants endorsed both initial and follow-up questions).
Scores ≥ 4 are considered to be an indicator of personality disorder, as this threshold
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demonstrated correct classification of 73.6% of an inpatient SUD sample, with a
sensitivity of 81.8% and a specificity of 67.7% (Gonzalez, 2014). The SAPAS
demonstrated concurrent validity in an SUD sample, as it correlated with other
personality disorder measures after controlling for psychiatric symptoms and recent
substance use (Hesse & Moran, 2010). Additionally, the SAPAS demonstrated modest
internal consistency and test-retest correlation, and was shown to correlate with clinicianreport of externalising and global assessment of functioning (Hesse et al., 2008). The
current study utilised SAPAS scores as a dimensional indicator of personality disorder,
in light of research suggesting that personality disorder may be more accurately
characterised as a dimensional, rather than categorical, construct (Karukivi, Vahlberg,
Horjamo, Nevalainen, & Korkeila, 2017). Higher scores indicated greater likelihood and
severity of personality disorder.

5.3.4. MEASURES
5.3.4.1.

Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer,

2004)
The DERS is a 41-item self-report questionnaire that assesses clinically relevant
difficulties in emotion regulation. Example items include: “When I’m upset, I become
angry with myself for feeling that way”; “I experience my emotions as overwhelming and
out of control”. There are six subscales contributing to a total score, which was used as
the outcome variable: Nonacceptance of Emotional Responses, Difficulties Engaging in
Goal-Directed Behavior, Impulse Control Difficulties, Lack of Emotional Awareness,
Limited Access to Emotion Regulation Strategies, and Lack of Emotional Clarity. Higher
scores denoted greater difficulties in emotion regulation.
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5.3.4.2.

Behavior Rating Inventory of Executive Function – Adult Version

(BRIEF-A; Roth et al., 2005)
The BRIEF-A is a 75-item self-report questionnaire consisting of nine subscales
(Inhibit; Shift; Emotional Control; Self-Monitor; Initiate; Working Memory;
Plan/Organize; Task Monitor; Organisation of Materials). Participants are instructed to
answer each question by selecting “never”, “sometimes”, or “often”, in relation to
whether they have had problems with any of the listed behaviors in the past month.
Example items include: “I don’t plan ahead for tasks”; “I forget what I am doing in the
middle of things”. The outcome variable was the Global Executive Composite (GEC),
which provides an overall summary score, with elevated scores indicating executive
dysfunction.

5.3.4.3.

Working memory: Working Memory Index (WMI; Wechsler Adult

Intelligence Scale, fourth edition: WAIS-IV; Wechsler, 2008)
The WMI of the WAIS-IV assesses components of working memory and is
comprised of 2 subtests, which were administered as per the standardized instructions.
The digit span subtest requires participants to recall various sequences of numbers
(forward, backward, and in sequence) and the arithmetic subtest involves participants
solving numerical problems within 30 seconds, after they have been read aloud by the
examiner. The outcome variable was computed by following the standard scoring
instructions and was the sum of the 2 subtests, which yielded a scaled index score, with
higher scores corresponding to better performance.
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5.3.4.4.

Inhibition and task-switching: Color-Word Interference Test

(Delis-Kaplan Executive Function System: D-KEFS; Delis, Kaplan, & Kramer,
2001)
These subtests of the D-KEFS assess response inhibition and task-switching.
Participants are instructed to read the items presented in each of four conditions as quickly
and accurately as possible. Performance is measured in time (seconds). The first condition
presents patches of colors and requires participants to name the colors. The second
condition presents the words “red”, “blue”, and “green” and requires participants to read
the words. The third condition presents words printed in incongruent colors and requires
the participant to ignore the word and say the color. The fourth condition presents words
printed in incongruent colors and requires the participant to switch between two rules: (a)
ignore the word and say the color; and (b) ignore the color and say the word. Outcome
variables were scaled scores of inhibition (condition 3 scaled score) and task-switching
(condition 4 scaled score minus condition 3 scaled score). Higher scores reflect better
performance.

5.3.5. STATISTICAL METHODS
All statistical analyses were performed using IBM Statistical Package for the
Social Sciences (SPSS version 21; IBM Corp, 2012). Three missing values were
identified, one within each of the DERS, inhibition, and task-switching variables.
The data analysis strategy involved three stages. Initially, intercorrelations
amongst study variables were calculated. Spearman’s rank-order correlations were
performed as Shapiro-Wilk statistics indicated non-normal distributions for some
variables. Subsequently, a sequential hierarchical regression was employed with DERS
scores as the dependent variable, with the goal of ascertaining the role of unique EFs and
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other variables of interest in predicting emotion dysregulation. All statistical assumptions
were tested and satisfied (i.e., independence of observations; linear relationships between
variables; homoscedasticity of residuals; multicollinearity; outliers, high leverage points,
highly influential points; normal distribution of residuals). In the final stage, four
mediation models based on the outcomes of the regression analysis were tested in order
to explore the influence of comorbid personality disorders on the relationship between
EFs and emotion regulation. The mediation models were tested using the PROCESS
macro (release 2.16.2; Hayes, 2013), recommended as an alternative to the causal step
approach (Hayes, 2009; Hayes & Rockwood, 2016), and indirect effect was calculated
using a bias-corrected and accelerated (BCa) bootstrapped confidence interval (CI)
method, based on 5000 samples.

5.4.

RESULTS
Socio-demographic, substance use, and psychiatric comorbidity characteristics of

the sample are displayed in Table 10, along with emotion regulation and EF measures.
Participants were, on average, in their early thirties (Mdn = 32.5 years, range 19–56) and
had completed approximately 11 years of education (Mdn = 10.5 years, range 6–20). The
majority of participants (44%) reported methamphetamine as their primary substance of
misuse, followed by approximately 30% who reported alcohol, with smaller numbers of
amphetamines, heroin, cannabis, and sedatives users. However, high rates of
polysubstance use history were evident, with participants reporting using multiple
substances over a number of years.
Table 11 displays Spearman’s rank-order correlations between all continuous
study variables. DERS scores were significantly positively correlated with SAPAS and
GEC scores, and significantly negatively correlated with task-switching performance. No
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significant correlations were found between DERS scores and age, education, treatment
length, WMI scores, or inhibition performance. Education was, however, significantly
correlated with GEC scores, WMI scores, and inhibition performance, and was, therefore,
included as a predictor variable. Similarly, although WMI and inhibition performance
were not significantly correlated with DERS scores, they were also included as predictor
variables in light of the study aim of ascertaining the unique role of EFs in predicting
difficulties in emotion regulation, based on the theoretical framework of Hofmann and
colleagues (2012).
Predictor variables for the sequential hierarchical regression were entered in the
following order: years of education (Step 1); current Axis I diagnosis (excluding SUD;
Step 2); global self-report measure of EFs: GEC scores (Step 3); three specific EF
components: performance in WMI, inhibition, and task-switching tasks (Step 4); and
personality disorder indicators, SAPAS (Step 5). At step 1, the model was nonsignificant, F(1, 46) = 0.16, p = .690, with education accounting for only 0.03% of the
variance in DERS, R = .059, R2 = .003. At step 2, presence of a current Axis I diagnosis
(other than SUD) significantly improved prediction, explaining an additional 27.1% of
the variance, R = .524, R2 = .274, F change (1, 45) = 16.78, p < .001. At step 3, the
addition of GEC scores significantly improved prediction and explained an additional
11.7% of the variance, R = .625, R2 = .291, F change (1, 44) = 8.44, p = .006. At step 4,
the addition of WMI, inhibition, and task-switching performance significantly improved
prediction and explained an additional 16.3% of the variance, R = .745, R2 = .554, F
change (3, 41) = 5.01, p = .005. At the final step, the addition of SAPAS scores
significantly improved prediction and explained a further 4.4% of the variance, R = .774,
R2 = .599, F change (1, 40) = 4.44, p = .042. Table 12 displays unstandardized regression
coefficients (B), standardized regression coefficients (ß), t scores, and R2 change for all
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variables at each step, capturing the proportion of the variance in DERS scores uniquely
explained by each variable at respective points of entry. In the final model task-switching
performance, GEC scores, and SAPAS scores contributed to DERS scores in descending
order of statistical significance.
In light of these regression results highlighting the contribution of EFs in general,
and the task-switching component of EFs in particular in the prediction of DERS scores,
a series of mediation analyses were employed to examine the relationship between EFs
and difficulties in emotion regulation. Specifically, the role of personality disorder, as
indexed by SAPAS scores, was considered as a mediator. As shown in Figure 3, there
was a significant indirect effect of GEC scores and task-switching performance on DERS
scores, through SAPAS scores. The ratio of the indirect effect to the total effect was
calculated to provide a measure of effect size: PM = ab ÷ c (Wen & Fan, 2015); GEC PM
= 0.22; task-switching PM = 0.27. Further mediation models indicated that neither WMI
nor inhibition performance predicted DERS scores (see Figures 3b and 3c, respectively),
although WMI performance predicted SAPAS scores (b = 0.06, p = .002), and there was
a trend toward inhibition performance predicting SAPAS scores (b = 0.15, p = .077).
Additionally, SAPAS scores predicted DERS scores in both WMI (b = 7.06, p < .001)
and inhibition (b = 6.92, p < .001) mediation models.
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Table 10. Socio-demographic, substance use, and psychiatric comorbidity characteristics, and emotion
regulation and executive functions measures of residents of a female-only substance use therapeutic
community.
Characteristic
N = 50
Age (M, SD)
32.5 (8.1)
Education (M, SD)

10.8 (2.5)

Unemployed (%)

78.0

Marital status (% single)

74.0

Treatment length (M, SD)

46.9 (38.9)

Primary substance of misuse (%)
Methamphetamine

44.0

Alcohol

28.0

Amphetamines

8.0

Heroin

8.0

Cannabis

6.0

Sedatives

6.0

Years of regular use (M, Mdn, SD; n)
Alcohol (any use)

11.2 (10.0, 8.3; 43)

Alcohol (to intoxication)

9.6 (6.5, 7.6; 42)

Heroin

9.9 (8.0, 8.3; 9)

Methadone

7.3 (7.0, 5.7; 5)

Other opiates/analgesics

7.4 (7.0, 5.7; 11)

Sedatives/hypnotics/tranquilisers

8.7 (10.0, 6.3; 17)

Cocaine

6.6 (6.0, 5.6; 11)

Amphetamines

8.2 (8.0, 5.5; 42)

Cannabis

11.1 (10.0, 7.0; 43)

Hallucinogens

5.3 (3.0, 5.1; 9)

More than one substance per day

9.9 (10.0, 6.2; 41)

b

Current Axis I psychiatric diagnosis (%)

64.0

b

Past Axis I psychiatric diagnosis (%)
Personality disorder screen (% met criteria)

64.0
c

40.0

SAPAS (M, SD)

3.0 (1.9)

DERS (M, SD)

91.9 (25.2)

GEC (M, SD)

61.8 (13.5)

WMI (M, SD)

88.7 (12.5)

a

Inhibition (M, SD)
a

Task-switching (M, SD)

9.7 (3.3)
10.2 (2.8)

DERS Difficulties in Emotion Regulation Scale, SAPAS Standardised Assessment of Personality –
Abbreviated Scale, GEC Global Executive Composite: Behavior Rating Inventory of Executive Function
– Adult version (BRIEF-A), WMI Working Memory Index: Wechsler Adult Intelligence Scale, fourth
edition (WAIS-IV), Inhibition Condition 3 scaled score; Color-Word Interference Test: Delis-Kaplan
Executive Function System (D-KEFS), Task-switching Condition 4 – Condition 3 contrast scaled score;
Color-Word Interference Test: Delis-Kaplan Executive Function System (D-KEFS) a N = 49. b MiniInternational Neuropsychiatric Interview. c Standardised Assessment of Personality – Abbreviated Scale.
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Table 11. Spearman’s correlations amongst study variables.
DERS

Age

Education

Treatment length SAPAS

GEC

WMI

Inhibition

DERS

1

Age

.14

1

Education

.02

.17

1

Treatment length -.07

.06

-.04

1

SAPAS

.57***

.07

.22

-.02

1

GEC

.60***

.19

.30*

-.41**

.36*

1

WMI

.21

.15

.63***

.06

.38**

.22

1

Inhibition

.18

.27

.35*

-.40**

.29*

.25

.53***

1

Task-switching

-.37*

-.19

-.15

.14

-.28

-.22

-.28

-.49***

Task-switching

1

DERS Difficulties in Emotion Regulation Scale, SAPAS Standardised Assessment of Personality – Abbreviated Scale, GEC Global Executive Composite: Behavior Rating
Inventory of Executive Function – Adult version (BRIEF-A), WMI Working Memory Index: Wechsler Adult Intelligence Scale, fourth edition (WAIS-IV), Inhibition
Condition 3 scaled score; Color-Word Interference Test: Delis-Kaplan Executive Function System (D-KEFS), Task-switching Condition 4 – Condition 3 contrast scaled score;
Color-Word Interference Test: Delis-Kaplan Executive Function System (D-KEFS)
* p ≤ .05; ** p ≤ .01; *** p ≤ .001
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Table 12. Regression coefficients of education, executive functions, and psychiatric comorbidities in
predicting Difficulties in Emotion Regulation Scale (DERS) scores.
Variable

B

ß

t

R2 change

Step 1

Education

0.60

.06

0.40

.003

Step 2

Education

-1.01

-.10

-0.74

.271

Axis I diagnosis

28.26

.54

4.10***

Education

-1.23

-.12

-0.98

Axis I diagnosis

15.51

.30

2.00

GEC

0.79

.43

2.90**

Education

-2.50

-.25

-1.83

Axis I diagnosis

13.39

-.26

1.91

GEC

0.73

.39

2.96**

WMI

0.54

.27

1.84

Inhibition

-2.20

-.29

-2.03*

Task-switching

-3.99

-.45

-3.48***

Education

-2.28

-.22

-1.74

Axis I diagnosis

10.01

.19

1.45

GEC

0.67

.36

2.83**

WMI

0.34

.17

1.16

Inhibition

-2.02

-.26

-1.92

Task-switching

-3.53

-.40

-3.14**

SAPAS

3.46

.26

2.11*

Step 3

Step 4

Step 5

.117

.163

.044

B unstandardized regression coefficients, ß standardized regression coefficients, GEC Global Executive
Composite: Behavior Rating Inventory of Executive Function – Adult version (BRIEF-A), WMI Working
Memory Index: Wechsler Adult Intelligence Scale, fourth edition (WAIS-IV), Inhibition Condition 3
scaled score; Color-Word Interference Test: Delis-Kaplan Executive Function System (D-KEFS), Taskswitching Condition 4 – Condition 3 contrast scaled score; Color-Word Interference Test: Delis-Kaplan
Executive Function System (D-KEFS), SAPAS Standardised Assessment of Personality – Abbreviated
Scale
* p ≤ .05; ** p ≤ .01; *** p ≤ .001
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SAPAS
b = -0.20, p = .044

b = 5.82, p = .001

Task-switching

DERS

Direct effect, b = -3.10, p = .009
Indirect effect, b = -1.17, 95% CI [-3.18, -0.06]
Total effect, b = -4.27, p = .001
Figure 3a. Model of task-switching performance as a predictor of DERS scores, mediated by SAPAS scores (N = 48).

SAPAS
b = 0.06, p = .002

b = 7.06, p < .001

WMI

DERS

Direct effect, b = 0.00, p = .990
Indirect effect, b = 0.46, 95% CI [0.14, 0.96]
Total effect, b = 0.46, p = .114
Figure 3b. Model of WMI performance as a predictor of DERS scores, mediated by SAPAS scores (N = 49).

SAPAS
b = 0.15, p = .077

b = 6.92, p < .001

Inhibition

DERS

Direct effect, b = 0.51, p = .631
Indirect effect, b = 1.07, 95% CI [-0.14, 3.11]
Total effect, b = 1.58, p = .183
Figure 3c. Model of inhibition performance as a predictor of DERS scores, mediated by SAPAS scores (N = 48).

SAPAS
b = 0.05, p = .019

GEC

b = 5.05, p = .002

DERS

Direct effect, b = 0.83, p < .001
Indirect effect, b = 0.23, 95% CI [0.04, 0.59]
Total effect, b = 1.06, p < .0001
Figure 3d. Model of Global Executive Composite (GEC) scores as a predictor of DERS scores, mediated by SAPAS
scores (N = 49).

Figure 3. Models of EFs measures as predictors of Difficulties in Emotion Regulation Scale (DERS)
scores, mediated by Standardised Assessment of Personality – Abbreviated Scale (SAPAS) scores.
Confidence intervals (CIs) for the indirect effects are bias-corrected and accelerated (BCa)
bootstrapped CIs based on 5000 samples.
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5.5.

DISCUSSION
This study sought to determine the role of working memory, inhibition, and task-

switching performance, as well as inventory-based assessment of EFs in predicting
difficulties in emotion regulation in an all-female residential SUD sample attending
therapeutic community treatment. This aim was based upon the theoretical framework
proposing that the capacity for effective emotion regulation may be subserved by
performance in basic EF tasks (Hofmann et al., 2012; Schmeichel & Tang, 2015). Results
indicated that inventory-based executive dysfunction and personality disorder indicator
scores were positively correlated with difficulties in emotion regulation. Additionally,
task-switching performance was negatively correlated with emotion regulation
difficulties. In the final hierarchical regression model, task-switching, executive
dysfunction, and personality disorder indicator scores were the strongest predictors of
difficulties in emotion regulation. Subsequent to this, four mediation models were
employed to examine the relationship between inventory- and performed-based EFs, and
difficulties in emotion regulation. There was a significant indirect effect of inventorybased EFs and task-switching performance, respectively, on difficulties in emotion
regulation, through personality disorder indicator scores. This suggests that the
relationship between both inventory-based assessment of executive dysfunction and
deficits in task-switching performance, respectively, and difficulties in emotion
regulation may be partly explained by the role of personality disorder.
Emotion regulation plays a crucial role in the development, severity, treatment
outcomes, and prognosis of SUD (Wilcox et al., 2016), and increased understanding of
corresponding neurocognitive impairments and related neurobiological substrates (e.g.,
Okita et al., 2016) may serve to advance assessment strategies and the development of
interventions that target emotion dysregulation in SUD treatment. Findings from the
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current study indicate that, compared to other basic performance-based EFs (i.e., working
memory and inhibition), task-switching plays a unique role in predicting difficulties in
emotion regulation. Additionally, this relationship was partly explained by personality
disorder. This finding can be understood in the context of evidence indicating that a range
of cognitive deficits have been demonstrated in personality disorder populations; most
notably EF deficits (Garcia-Villamisar, Dattilo, & Garcia-Martinez, 2017). Along with
cognitive deficits, personality disorder diagnosis has been identified as one of the top four
risk factors for dropout from SUD treatment (Brorson et al., 2013). There is a pressing
need for adjunct interventions and modifications to treatment that bolster individuals with
co-occurring SUD, personality disorder, and/or cognitive deficits and increase the
likelihood of treatment engagement and completion.
Along with the unique role of task-switching as a performance-based EF that was
predictive of difficulties in emotion regulation, inventory-based assessment of executive
dysfunction also uniquely predicted difficulties in emotion regulation, with this
relationship also partly explained by personality disorder. This finding is congruent with
research suggesting that inventory- and performance-based measures of EFs may assess
distinct components of EFs (Hagen et al., 2016; Toplak et al., 2013).
Recently, a number of studies have explored the potential for cognitive screening
(e.g., Marceau, Lunn, Berry, Kelly, & Solowij, 2016) and training/remediation
interventions to respectively facilitate the detection of cognitive dysfunction, and improve
cognition, functional outcomes, and treatment retention in SUD populations (Manning,
Verdejo-García, & Lubman, 2017; Marceau et al., 2017; Verdejo-García, 2016). Four
main classes of interventions have been trialled based on two major proposed
neuroscientific mechanisms: (i) reorienting biases towards impulsive action (i.e., bottomup approach) and (ii) strengthening EFs (i.e., top-down approach), with cognitive bias
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modification and response inhibition training located within the former category, and
working memory training and goal-directed interventions in the latter (Verdejo-García,
2016). Identifying the neurobiological mechanisms of these interventions is an area
currently under investigation, but it is proposed that all interventions share the common
underlying elements of normalising dysfunctional activity related to reward circuitry and
also the strengthening of the inhibitory control network (Zilverstand, Parvaz, Moeller, &
Goldstein, 2016).
A range of cognitive domains have been targeted through cognitive training
interventions for SUD, including working memory, inhibition, attention, sustained
attention, logical reasoning, decision-making, and broad EFs (Marceau et al., 2017;
Verdejo-García, 2016). Gaining a more in-depth understanding of the specific active
ingredients of these interventions and how they relate to improvements in neurocognitive
performance as well as meaningful clinical outcomes is an important area for further
exploration. Given that findings from the current study suggest that task-switching
predicts emotion regulation, future studies may wish to investigate this further, by
assessing whether cognitive training interventions that specifically target improvement in
task-switching performance are efficacious within SUD treatment and whether they also
lead to improved emotion regulation capacity.
As per the recommendations of Hofmann and colleagues (2012), future research
may seek to further examine the relationships between basic EFs and measures of selfregulation more broadly, using a number of proposed theoretical models. Specific to the
addiction field, this line of research may provide significant evidence that could serve to
inform the development of targeted cognitive training interventions. For example, future
studies could examine the relationships between basic EFs (i.e., working memory,
inhibition, task-switching) and a range of other self-regulation outcomes (e.g., self-
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control, responding to cravings in the context of substance-cues, etc.), to explore potential
nuances involving mediating or moderating factors. This endeavour may be enhanced by
employing measures that capture data from multiple levels of analysis (e.g., self-report,
neurocognitive, neuroimaging; for a recent example investigating self-control in a
nonclinical population, refer to Paschke et al., 2016). Furthermore, the inclusion of
functional outcomes pertaining to SUD treatment and recovery in studies exploring the
relationships between basic EFs and self-regulation may enhance this line of research and
lead to fruitful, clinically relevant findings.
Performance on EFs tasks is partly shaped by individual differences (Miyake &
Friedman, 2012). Additionally, individual factors also shape the trajectory of cognitive
recovery in SUD (Bates, Buckman, Voelbel, Eddie, & Freeman, 2013). There are a
variety of pathways leading to the onset of drug and alcohol addiction based on preexisting individual differences in brain functioning; namely susceptibility to increased or
decreased sensitivity in a range of executive systems in the brain (George & Koob, 2010).
In relation to this, future studies may wish to examine the relationship between EFs, selfregulation, and the transition to addiction, while ensuring sufficient power to explore
mediating and moderating factors based on the characteristics of particular subgroups that
reflect these individual differences in the often-heterogeneous SUD populations.
The limitations of the current study must be noted. First, the small sample utilised
exclusively consisted of females in residential SUD treatment. Future research may wish
to explore the relationship between basic EFs and emotion regulation in male or mixed
samples to ascertain whether similar or contrasting relationships exist. Additionally, the
current study utilised a screening measure of personality disorder and, although evidence
suggests that this is an appropriate brief and cost-effective measure for SUD populations
(Gonzalez, 2014; Hesse & Moran, 2010; Hesse et al., 2008), future studies may wish to
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examine the relationship between basic EFs and emotion regulation using full diagnostic
assessments and/or other dimensional measures (Karukivi et al., 2017) of personality
disorder. A further limitation relates to the use of mediation analyses within a crosssectional design. This approach may produce bias (Maxwell, Cole, & Mitchell, 2011) and
future studies may wish to examine mediators of the relationship between EFs and
emotion regulation utilising longitudinal designs.
In conclusion, the current study demonstrated that task-switching performance in
contrast to other basic EFs, working memory and inhibition, uniquely predicted
difficulties in emotion regulation in an all-female sample of residents attending residential
SUD treatment. This relationship was partly explained by personality disorder indicators.
These findings have implications for the design and development of cognitive training
interventions to address the neurocognitive dysfunction present in SUD populations.
There is a pressing need for further research that seeks to explore the neurocognitive bases
of self-regulation to support the development of cognitive training interventions that
include efficacious and specific active ingredients. The development of new interventions
that translate to improvements in clinically meaningful outcomes that support treatment
retention in SUD, such as emotion regulation, may benefit those individuals seeking longterm recovery from drug and alcohol addiction.

147

REFERENCES
Aldao, A., Nolen-Hoeksema, S., & Schweizer, S. (2010). Emotion-regulation strategies
across psychopathology: A meta-analytic review. Clinical Psychology Review,
30(2), 217-237. doi:10.1016/j.cpr.2009.11.004
Bates, M. E., Buckman, J. F., Voelbel, G. T., Eddie, D., & Freeman, J. (2013). The
mean and the individual: Integrating variable-centered and person-centered
analyses of cognitive recovery in patients with substance use disorders.
Frontiers in Psychiatry, 4, Article 177. doi:10.3389/fpsyt.2013.00177
Blevins, C. E., Abrantes, A. M., & Stephens, R. S. (2016). Motivational pathways from
antecedents of alcohol use to consequences: A structural model of using alcohol
to cope with negative affect. American Journal of Drug and Alcohol Abuse,
42(4), 395-403. doi:10.3109/00952990.2016.1141915
Brorson, H. H., Ajo Arnevik, E., Rand-Hendriksen, K., & Duckert, F. (2013). Drop-out
from addiction treatment: A systematic review of risk factors. Clinical
Psychology Review, 33(8), 1010-1024. doi:10.1016/j.cpr.2013.07.007
Carlson, S. M., & Wang, T. S. (2007). Inhibitory control and emotion regulation in
preschool children. Cognitive Development, 22(4), 489-510.
doi:10.1016/j.cogdev.2007.08.002
Cheetham, A., Allen, N. B., Yücel, M., & Lubman, D. I. (2010). The role of affective
dysregulation in drug addiction. Clinical Psychology Review, 30(6), 621-634.
doi:10.1016/j.cpr.2010.04.005
De Leon, G. (1989). Therapeutic communities for substance abuse: Overview of
approach and effectiveness. Psychology of Addictive Behaviors, 3(3), 140-147.
doi:10.1037/h0080571
Delis, D. C., Kaplan, E., & Kramer, J. H. (2001). Delis-Kaplan Executive Function
System: D-KEFS. San Antonio; Texas: The Psychological Corporation.
Etkin, A., Büchel, C., & Gross, J. J. (2015). The neural bases of emotion regulation.
Nature Reviews Neuroscience, 16(11), 693-700. doi:10.1038/nrn4044
Falquez, R., Dinu-Biringer, R., Stopsack, M., Arens, E. A., Wick, W., & Barnow, S.
(2015). Examining cognitive emotion regulation in frontal lobe patients: The
mediating role of response inhibition. NeuroRehabilitation, 37(1), 89-98.
doi:10.3233/NRE-151242
Fernández-Serrano, M. J., Pérez-García, M., Perales, J. C., & Verdejo-García, A.
(2010). Prevalence of executive dysfunction in cocaine, heroin and alcohol users
enrolled in therapeutic communities. European Journal of Pharmacology,
626(1), 104-112. doi:10.1016/j.ejphar.2009.10.019
Friedman, N. P., & Miyake, A. (2017). Unity and diversity of executive functions:
Individual differences as a window on cognitive structure. Cortex, 86, 186-204.
doi:10.1016/j.cortex.2016.04.023
Garcia-Villamisar, D., Dattilo, J., & Garcia-Martinez, M. (2017). Executive functioning
in people with personality disorders. Current Opinion in Psychiatry, 30(1), 3644. doi:10.1097/YCO.0000000000000299
George, O., & Koob, G. F. (2010). Individual differences in prefrontal cortex function
and the transition from drug use to drug dependence. Neuroscience and
Biobehavioral Reviews, 35(2), 232-247. doi:10.1016/j.neubiorev.2010.05.002
Gladwin, T. E., Figner, B., Crone, E. A., & Wiers, R. W. (2011). Addiction,
adolescence, and the integration of control and motivation. Developmental
Cognitive Neuroscience, 1(4), 364-376. doi:10.1016/j.dcn.2011.06.008

148

Gonzalez, C. (2014). Screening for personality disorder in drug and alcohol
dependence. Psychiatry Research, 217(1-2), 121-123.
doi:10.1016/j.psychres.2014.03.007
Gratz, K. L., & Roemer, L. (2004). Multidimensional assessment of emotion regulation
and dysregulation: Development, factor structure, and initial validation of the
Difficulties in Emotion Regulation Scale. Journal of Psychopathology and
Behavioral Assessment, 26(1), 41-54. doi:10.1023/b:joba.0000007455.08539.94
Hagen, E., Erga, A. H., Hagen, K. P., Nesvåg, S. M., McKay, J. R., Lundervold, A. J.,
& Walderhaug, E. (2016). Assessment of executive function in patients with
substance use disorder: A comparison of inventory- and performance-based
assessment. Journal of Substance Abuse Treatment, 66, 1-8.
doi:10.1016/j.jsat.2016.02.010
Hayes, A. F. (2009). Beyond Baron and Kenny: Statistical mediation analysis in the
new millennium. Communication Monographs, 76(4), 408-420.
doi:10.1080/03637750903310360
Hayes, A. F. (2013). Introduction to Mediation, Moderation, and Conditional Process
Analysis: A Regression-Based Approach. New York: The Guilford Press.
Hayes, A. F., & Rockwood, N. J. (2016). Regression-based statistical mediation and
moderation analysis in clinical research: Observations, recommendations, and
implementation. Behaviour Research and Therapy, 1-19.
doi:10.1016/j.brat.2016.11.001
Hesse, M., & Moran, P. (2010). Screening for personality disorder with the
Standardised Assessment of Personality: Abbreviated Scale (SAPAS): Further
evidence of concurrent validity. BMC Psychiatry, 10(1), 10. doi:10.1186/1471244x-10-10
Hesse, M., Rasmussen, J., & Pedersen, M. K. (2008). Standardised assessment of
personality - A study of validity and reliability in substance abusers. BMC
Psychiatry, 8(1), 7. doi:10.1186/1471-244x-8-7
Hester, R., Lubman, D. I., & Yücel, M. (2010). The role of executive control in human
drug addiction. Current Topics in Behavioral Neurosciences, 3, 301-318.
doi:10.1007/7854_2009_28
Hofmann, W., Schmeichel, B. J., & Baddeley, A. D. (2012). Executive functions and
self-regulation. Trends in Cognitive Sciences, 16(3), 174-180.
doi:10.1016/j.tics.2012.01.006
Hudson, A., & Jacques, S. (2014). Put on a happy face! Inhibitory control and
socioemotional knowledge predict emotion regulation in 5- to 7-year-olds.
Journal of Experimental Child Psychology, 123, 36-52.
doi:10.1016/j.jecp.2014.01.012
IBM Corp. (2012). IBM SPSS Statistics for Windows, version 21.0. Armonk; New
York: IBM Corp.
Isquith, P. K., Roth, R. M., & Gioia, G. (2013). Contribution of rating scales to the
assessment of executive functions. Applied Neuropsychology: Child, 2(2), 125132. doi:10.1080/21622965.2013.748389
Jurado, M. B., & Rosselli, M. (2007). The elusive nature of executive functions: A
review of our current understanding. Neuropsychology Review, 17(3), 213-233.
doi:10.1007/s11065-007-9040-z
Karukivi, M., Vahlberg, T., Horjamo, K., Nevalainen, M., & Korkeila, J. (2017).
Clinical importance of personality difficulties: Diagnostically sub-threshold
personality disorders. BMC Psychiatry, 17, 1-9. doi:10.1186/s12888-017-1200-y

149

Lubman, D. I., Yücel, M., & Hall, W. D. (2007). Substance use and the adolescent
brain: A toxic combination? Journal of Psychopharmacology, 21(8), 792-794.
doi:10.1177/0269881107078309
Manning, V., Verdejo-García, A., & Lubman, D. I. (2017). Neurocognitive impairment
in addiction and opportunities for intervention. Current Opinion in Behavioral
Sciences, 13, 40-45. doi:10.1016/j.cobeha.2016.10.003
Marceau, E. M., Berry, J., Lunn, J., Kelly, P. J., & Solowij, N. (2017). Cognitive
remediation improves executive functions, self-regulation and quality of life in
residents of a substance use disorder therapeutic community. Drug and Alcohol
Dependence, 178, 150-158. doi:10.1016/j.drugalcdep.2017.04.023
Marceau, E. M., Lunn, J., Berry, J., Kelly, P. J., & Solowij, N. (2016). The Montreal
Cognitive Assessment (MoCA) is sensitive to head injury and cognitive
impairment in a residential alcohol and other drug therapeutic community.
Journal of Substance Abuse Treatment, 66, 30-36.
doi:10.1016/j.jsat.2016.03.002
Maxwell, S. E., Cole, D. A., & Mitchell, M. A. (2011). Bias in cross-sectional analyses
of longitudinal mediation: Partial and complete mediation under an
autoregressive model. Multivariate Behavioral Research, 46(5), 816-841.
doi:10.1080/00273171.2011.606716
McRae, K., Jacobs, S. E., Ray, R. D., John, O. P., & Gross, J. J. (2012). Individual
differences in reappraisal ability: Links to reappraisal frequency, well-being, and
cognitive control. Journal of Research in Personality, 46(1), 2-7.
doi:10.1016/j.jrp.2011.10.003
Miyake, A., & Friedman, N. P. (2012). The nature and organization of individual
differences in executive functions: Four general conclusions. Current Directions
in Psychological Science, 21(1), 8-14. doi:10.1177/0963721411429458
Miyake, A., Friedman, N. P., Emerson, M. J., Witzki, A. H., Howerter, A., & Wager, T.
D. (2000). The unity and diversity of executive functions and their contributions
to complex “frontal lobe” tasks: A latent variable analysis. Cognitive
Psychology, 41(1), 49-100. doi:10.1006/cogp.1999.0734
Mo, C., & Deane, F. (2016). Reductions in craving and negative affect predict 3-month
post-discharge alcohol use following residential treatment. International Journal
of Mental Health and Addiction, 14(5), 761-774. doi:10.1007/s11469-015-96262
Moran, P., Leese, M., Lee, T., Walters, P., Thornicroft, G., & Mann, A. (2003).
Standardised Assessment of Personality - Abbreviated Scale (SAPAS):
Preliminary validation of a brief screen for personality disorder. British Journal
of Psychiatry, 183, 228-232. doi:10.1192/bjp.183.3.228
Okita, K., Ghahremani, D. G., Payer, D. E., Robertson, C. L., Dean, A. C., Mandelkern,
M. A., & London, E. D. (2016). Emotion dysregulation and amygdala dopamine
D2-type receptor availability in methamphetamine users. Drug and Alcohol
Dependence, 161, 163-170. doi:10.1016/j.drugalcdep.2016.01.029
Paschke, L. M., Dorfel, D., Steimke, R., Trempler, I., Magrabi, A., Ludwig, V. U., . . .
Walter, H. (2016). Individual differences in self-reported self-control predict
successful emotion regulation. Social Cognitive and Affective Neuroscience,
11(8), 1193-1204. doi:10.1093/scan/nsw036
Pe, M. L., Koval, P., Houben, M., Erbas, Y., Champagne, D., & Kuppens, P. (2015).
Updating in working memory predicts greater emotion reactivity to and
facilitated recovery from negative emotion-eliciting stimuli. Frontiers In
Psychology, 6, Article 372. doi:10.3389/fpsyg.2015.00372

150

Roth, R. M., Isquith, P. K., & Gioia, G. (2005). Behavioral Rating Inventory of
Executive Function - Adult Version. Lutz; Florida: Psychological Assessment
Resources Inc.
Schmeichel, B. J., & Demaree, H. A. (2010). Working memory capacity and
spontaneous emotion regulation: High capacity predicts self-enhancement in
response to negative feedback. Emotion, 10(5), 739-744. doi:10.1037/a0019355
Schmeichel, B. J., & Tang, D. (2015). Individual differences in executive functioning
and their relationship to emotional processes and responses. Current Directions
in Psychological Science, 24(2), 93-98. doi:10.1177/0963721414555178
Schmeichel, B. J., Volokhov, R. N., & Dernaree, H. A. (2008). Working memory
capacity and the self-regulation of emotional expression and experience. Journal
of Personality and Social Psychology, 95(6), 1526-1540. doi:10.1037/a0013345
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., . . .
Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview
(M.I.N.I): The development and validation of a structured diagnostic psychiatric
interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry,
59(Suppl. 20), 22-33. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/9881538
Smith, G. T., & Cyders, M. A. (2016). Integrating affect and impulsivity: The role of
positive and negative urgency in substance use risk. Drug and Alcohol
Dependence, 163(Suppl 1), S3-S12. doi:10.1016/j.drugalcdep.2015.08.038
Tamir, M. (2016). Why do people regulate their emotions? A taxonomy of motives in
emotion regulation. Personality and Social Psychology Review, 20(3), 199-222.
doi:10.1177/1088868315586325
Tang, D., & Schmeichel, B. J. (2014). Stopping anger and anxiety: Evidence that
inhibitory ability predicts negative emotional responding. Cognition and
Emotion, 28(1), 132-142. doi:10.1080/02699931.2013.799459
Toplak, M. E., West, R. F., & Stanovich, K. E. (2013). Practitioner review: Do
performance-based measures and ratings of executive function assess the same
construct? Journal of Child Psychology and Psychiatry, 54(2), 131-143.
doi:10.1111/jcpp.12001
Tull, M. T., Bardeen, J. R., DiLillo, D., Messman-Moore, T., & Gratz, K. L. (2015). A
prospective investigation of emotion dysregulation as a moderator of the relation
between posttraumatic stress symptoms and substance use severity. Journal of
Anxiety Disorders, 29, 52-60. doi:10.1016/j.janxdis.2014.11.003
Verdejo-García, A. (2016). Cognitive training for substance use disorders:
Neuroscientific mechanisms. Neuroscience and Biobehavioral Reviews, 68, 270281. doi:10.1016/j.neubiorev.2016.05.018
von Hippel, W., & Gonsalkorale, K. (2005). 'That is bloody revolting!': Inhibitory
control of thoughts better left unsaid. Psychological Science, 16(7), 497-500.
Retrieved from http://www.jstor.org.ezproxy.uow.edu.au/stable/40064257
Wechsler, D. (2008). Wechsler Adult Intelligence Scale (4th ed.). Sydney; Australia:
Pearson.
Wen, Z., & Fan, X. (2015). Monotonicity of effect sizes: Questioning kappa-squared as
mediation effect size measure. Psychological Methods, 20(2), 193-203.
doi:10.1037/met0000040
Wilcox, C. E., & Adinoff, B. (2015). Using neuroimaging to improve emotion
regulation treatments for substance use disorders. In S. W. Feldstein Ewing, K.
Witkiewitz, & F. M. Filbey (Eds.), Neuroimaging and Psychosocial Addiction
Treatment (pp. 158-177). London, UK: Palgrave Macmillan.

151

Wilcox, C. E., Pommy, J. M., & Adinoff, B. (2016). Neural circuitry of impaired
emotion regulation in substance use disorders. American Journal of Psychiatry,
173(4), 344-361. doi:10.1176/appi.ajp.2015.15060710
Wills, T. A., Simons, J. S., Sussman, S., & Knight, R. (2016). Emotional self-control
and dysregulation: A dual-process analysis of pathways to
externalizing/internalizing symptomatology and positive well-being in younger
adolescents. Drug and Alcohol Dependence, 163(Suppl 1), S37-S45.
doi:10.1016/j.drugalcdep.2015.08.039
Witkiewitz, K., & Wu, J. (2010). Emotions and relapse in substance use: Evidence for a
complex interaction among psychological, social, and biological processes. In J.
D. Kassel (Eds.), Substance Abuse and Emotion (pp. 171-187). Washington,
DC: American Psychological Association.
Zilverstand, A., Parvaz, M. A., Moeller, S. J., & Goldstein, R. Z. (2016). Cognitive
interventions for addiction medicine: Understanding the underlying
neurobiological mechanisms. In E. Hamed & P. P. Martin (Eds.), Progress in
Brain Research (pp. 285-304): Elsevier. Retrieved from
http://www.sciencedirect.com/science/article/pii/S0079612315001259

CHAPTER 6: SUMMARY, SYNTHESIS, AND CONCLUSIONS
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The purpose of this concluding chapter is to integrate the findings of the preceding
chapters and explore the clinical implications and future research directions in the field
of cognitive training for substance use disorder (SUD) populations. An understanding of
the impairment of cognitive functioning in addiction, together with the specific
dysfunction of executive processes, and subsequent design and implementation of an
intervention to address these deficits, forms the core of this thesis. Interpretations and
further hypothesising are underpinned by a neuroscience framework. The implications of
these findings in relation to refining understanding of the mechanisms of action and
potential benefit of cognitive training interventions designed to improve cognition in
SUD will be discussed, as well as the limitations of this body of work.

6.1.

SUMMARY AND SYNTHESIS
This thesis is comprised of three major studies, forming four publications included

as chapters. The findings of study one are detailed in Chapter 2 and provide an initial
exploration of cognitive functioning in an Australian SUD sample in residential
treatment. Study two involved the design and evaluation of a cognitive remediation
intervention to improve executive functions (EFs) in an SUD sample in residential
treatment (Chapter 3) with three-month follow-up outcomes (Chapter 4). In study three,
the relationships between EFs and emotion regulation were examined at baseline for the
largest available sample (Chapter 5).

6.1.1. STUDY ONE
Study one was informed by previous theoretical and empirical studies
demonstrating that cognitive deficits are commonly found in SUD populations and
interfere with the process of treatment (Brorson, Ajo Arnevik, Rand-Hendriksen, &
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Duckert, 2013; Domínguez-Salas, Díaz-Batanero, Lozano-Rojas, & Verdejo-García,
2016). This study was an important starting point to inform the development of a
cognitive remediation intervention for an Australian SUD sample in residential
therapeutic community (TC) treatment, as it investigated cognitive functioning and its
relationship to other characteristics within the target population accessed naturalistically
as a snapshot of all clients in residence at the time. A key outcome of study one was the
identification of the high rates of cognitive impairment amongst people attending
residential treatment for SUDs. Nearly half (43.8%) of the SUD group were identified as
cognitively impaired, compared to 16.2% of healthy controls. This impairment was
demonstrated by lower total MoCA scores and lower EFs subscores observed in the SUD
group, relative to controls. A further significant finding was that 67.2% of the SUD group
had a history of head injury, with 50% requiring subsequent hospitalisation. History of
head injury was identified as a significant determinant of the cognitive impairment
observed in the sample. Cognitive impairment was also associated with greater levels of
psychological distress.
These findings provided empirical evidence for cognitive impairment in an
Australian SUD sample in residential TC treatment, and are congruent with previous
findings demonstrating the specific impairment of EFs in SUD populations (FernándezSerrano, Pérez-García, Perales, & Verdejo-García, 2010; Fernández-Serrano, PérezGarcía, Río-Valle, & Verdejo-García, 2010). The findings also highlighted that head
injuries and high levels of psychological distress are also highly prevalent in SUD TCs
and cannot be ignored in attempts to improve treatment nor in consideration of the
cognitive deficits in residents.
With the need for an intervention that could improve EFs in this population
established, study two sought to address this. The findings in study one pertaining to the
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high prevalence of past head injuries and psychological distress, and their relationship to
the observed cognitive impairment, significantly shaped the development of the cognitive
remediation intervention. It was developed with the aim of specifically targeting
improvements in EFs within a sample inclusive of those with comorbid psychiatric
disorders and a history of head injury.
Not only were the findings of study one used to inform the development of the
cognitive remediation intervention, they also carry important clinical implications. Due
to the common time- and resource-constraints within residential SUD treatment facilities,
the inclusion of a brief, cost-effective screening measure within study one was
strategically chosen in order to maximise the potential for clinical translation of this
research. Therefore, an important objective of this study was to provide staff employed
in residential SUD treatment facilities clear, practical guidance around identifying and
responding to cognitive impairment in residents. The arising clinical recommendations
outlined: (a) that brief cognitive screening may be beneficial as a routine intake
procedure; (b) if brief cognitive screening is not feasible in the treatment environment,
simply inquiring whether residents have previously sustained a head injury requiring
hospitalisation may be the most time- and resource-efficient way to screen for the
possibility of cognitive impairment; (c) those residents identified as displaying cognitive
deficits may benefit from further neuropsychological assessment; (d) modifications to
treatment and/or adjunct interventions may be useful in increasing the likelihood of
residents effectively engaging in treatment.
In summary, study one demonstrated the prevalence of cognitive impairment, and
particularly executive dysfunction, in an Australian SUD TC sample through the use of a
brief cognitive screening measure. Major implications include the necessity of cognitive
screening as a part of the standardised assessment protocol for all clients entering
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treatment. Furthermore, this study highlighted the potential benefit of trialling adjunct
interventions in residential SUD treatment settings to improve cognitive functioning, as
has recently been explored in the literature (Manning, Verdejo-García, & Lubman, 2017).

6.1.2. STUDY TWO
A number of cognitive training interventions have been trialled in SUD
populations (Verdejo-García, 2016). With the completion of study one, an intervention
designed to specifically address executive dysfunction in this population was developed.
Study two consisted of the evaluation of this intervention and its longer-term outcomes,
comprising of Chapters 3 and 4. Chapter 3 was focussed on the evaluation of this
intervention immediately post-treatment, whereas Chapter 4 examined longitudinal
outcomes in the form of a three-month follow-up for a subset of measures.
A recent framework characterising the existing cognitive training interventions
for SUD populations with respect to the proposed neuroscientific mechanisms classified
these interventions into two broad classes (Verdejo-García, 2016): (1) Reorienting
impulsive biases with a focus on retraining those brain regions (e.g., amygdala and medial
prefrontal cortex) involved in impulsive responding (i.e., a bottom-up approach: cognitive
bias modification and response inhibition training); (2) Strengthening EFs (i.e., a topdown approach: working memory training and goal-directed approaches). With regard to
this framework, the cognitive remediation intervention evaluated in study two would be
best classified as a top-down approach aimed at strengthening EFs. A novel aspect of this
intervention was the inclusion of and synergy between both drill and practice and
strategy-based approaches. The intervention was particularly targeted towards improving
EFs and this was achieved through the use of a format that included an initial strategybased session followed by a drill and practice session in which participants completed
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computer-based tasks that were specifically chosen to provide practice and reinforcement
of the prior strategy-based learning. A further novel aspect of study two was the inclusion
of participants meeting criteria for psychiatric diagnoses and with a history of head injury.
Previous studies of cognitive remediation in SUD have tended to exclude participants
with comorbidities such as this, in order to establish efficacy rather than effectiveness of
cognitive training interventions (e.g., Valls-Serrano, Caracuel, & Verdejo-García, 2016).
With regard to evaluation of the cognitive remediation intervention examined in
study two, Chapter 3 presents the post-intervention outcomes for the intervention group
compared to a treatment as usual control group. Findings indicated that the intervention
group (vs. controls) improved on measures of EFs (inventory-based assessment and
performance on an inhibition task), self-regulation, and quality of life. These findings
provide important preliminary evidence for the potential effectiveness of cognitive
remediation in an SUD population in residential treatment, including those with comorbid
psychiatric disorders and history of head injury.
The improvements in EFs, self-regulation, and quality of life associated with the
cognitive remediation intervention may be understood in the context of a neuroscience
framework. While it was not feasible within the scope of this thesis to implement methods
to explore potential neurobiological changes that may underlie these observed
improvements, a potential explanation for the beneficial effects on EFs, self-regulation,
and quality of life, is that underlying neurobiological changes may have occurred as a
result of the intervention: This is further discussed in section 6.1.4. below.
While initial studies investigating cognitive training for SUD populations have
demonstrated some evidence for the potential benefit of these interventions (Manning et
al., 2017), there is a need for further research that investigates whether improvements are
durable over time. Although EFs, quality of life, and psychological distress improve with
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abstinence over a one-year period (Hagen et al., 2017), relatively few studies have
included longitudinal follow-up of cognitive training for SUD. These considerations
formed the basis of Chapter 4, which presents a three-month follow-up of a subset of
measures to assess the durability of the cognitive remediation intervention outcomes.
The longitudinal intervention outcomes presented in Chapter 4 indicated that there
were generally no differences between the intervention and control group on measures of
self-control, cravings for primary substance of abuse, and likelihood of relapse. While
approximately 50% of controls left the treatment program early, compared to 30% of the
intervention group, this difference was not statistically significant. Additionally, there
were no differences between groups with regards to duration of treatment (days since
post-intervention) or relapse to substance use. Within the intervention group, 37.5% of
residents were identified as completing treatment, compared to only 5.9% of the TAU
controls. While this difference was statistically significant, it may be confounded with
the significant difference in duration of treatment unexpectedly observed between groups
at baseline, with the intervention group having been in treatment longer than controls.
Though there were insufficient numbers of inventory-based EFs data within the control
group to enable comparison with the intervention group, participants in the intervention
group demonstrated improved EFs immediately post-intervention, and these
improvements were maintained at three-month follow-up.
Though the majority of these results did not provide conclusive support for the
long-term benefit of this cognitive remediation intervention, it is important to note the
small sample sizes for each group obtained at follow-up. Additional longitudinal studies
with larger sample sizes may be beneficial in providing further evidence regarding the
long-term benefit of cognitive training interventions for SUD populations. Another area
of concern was the baseline difference in treatment duration between groups in relation
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to the observed rates of treatment completion. Furthermore, while the result indicating
that improvements in EFs for the intervention group were maintained over time is
promising, there is a significant need for further research evaluating the long-term effects
of cognitive training for SUD. The extent to which interventions that target both topdown and bottom-up components produce durable improvements in cognition and
functioning is an important area for future research in this field (Manning et al., 2017;
Verdejo-García, 2016). A potential mechanism of longer-term improvements may be that
through improving cognition, cognitive training interventions subsequently increase the
likelihood of individuals with SUD engaging with and benefitting from traditional
treatment approaches (Domínguez-Salas et al., 2016).

6.1.3. STUDY THREE
Chapter 5 presents the final study of this thesis – an investigation of the
relationship between basic EFs and emotion regulation. These relationships were
explored in a cross-sectional design that utilised all baseline data from the same sample
who commenced participation in the intervention study. This was based on the theoretical
framework proposed by Hofmann and colleagues (2012) postulating that basic EFs (i.e.,
working memory, inhibition, and task-switching) may serve as the neurocognitive bases
of a range of self-regulation capacities. Emotion regulation was selected as an important
self-regulatory capacity in the context of SUD populations, due to the significant role it
plays in the onset, maintenance, and prognosis of SUD (Wilcox, Pommy, & Adinoff,
2016).
The major findings of this study indicated that poorer performance on a measure
of task-switching predicted greater difficulties with emotion regulation, suggesting that
task-switching may be one potential cognitive capacity that subserves effective emotion
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regulation. No relationships between emotion regulation and either working memory or
inhibition were observed. Additionally, mediation analyses indicated that the relationship
between task-switching and difficulties in emotion regulation was partly explained by
personality disorder indicators, as assessed by a screening measure.
These findings contribute to the literature by providing further data that may
inform the development and refinement of novel cognitive training interventions for SUD
populations, by identifying potential mechanistic drivers. For example, future research
may explore whether targeted training of task-switching promotes effective emotion
regulation. At a neural level, task-switching is believed to be subserved by a distributed
frontoparietal network of brain regions (Kim, Cilles, Johnson, & Gold, 2012).
Improvements in task-switching associated with cognitive training may have beneficial
effects on emotion regulation through strengthening of these brain networks. This may
be dependent, however, on the type of task-switching involved. Three distinct types of
task-switching, perceptual, response, and context, have been documented, with dorsal
premotor cortex activation implicated in perceptual task-switching and frontopolar cortex
activation associated with context task-switching (Kim et al., 2012).

6.1.4. FINDINGS

INTERPRETED

WITHIN

A

NEUROSCIENCE

FRAMEWORK
Collectively, the three studies completed in the course of this thesis
comprehensively investigate the rationale, utility, and future directions of cognitive
training as a treatment for SUD populations. The benefit of targeted cognitive training
interventions for SUD can be understood particularly in terms of recent neuroscientific
frameworks of addiction. Neuroimaging methods have identified brain regions
underlying the development and maintenance of addiction, along with associated
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neurocircuitry (Koob & Volkow, 2016). It is believed that cognitive training interventions
have the potential to enhance and/or attenuate activity in the salient regions involved and
it is through this process that neurocognitive and, subsequently, self-regulation capacities
and functional outcomes improve (Kelley, Wagner, & Heatherton, 2015; Verdejo-García,
2016).
Neuroimaging studies may further assist in elucidating the mechanisms of action
underlying improvements in cognition and functional outcomes associated with cognitive
training. The neural correlates of cognitive training for other clinical populations, most
notably schizophrenia (Isaac & Januel, 2016; Penadés et al., 2017; Ramsay & MacDonald
III, 2015), but also mood disorders (Meusel, Hall, Fougere, McKinnon, & MacQueen,
2013), have been documented; increased activity in prefrontal brain regions is
consistently observed across studies. At present, however, only a limited number of
studies have examined the neural correlates of cognitive training for SUD (VerdejoGarcía, 2016).
A series of studies used functional magnetic resonance imaging (fMRI) to
examine the neural changes occurring after cognitive bias modification (CBM) for SUD
(Wiers, Ludwig, et al., 2015; Wiers, Stelzel, et al., 2015). Prior to training, participants
demonstrated increased medial prefrontal cortex activity, which was related to alcohol
approach bias. CBM resulted in greater reductions in approach bias-related medial
prefrontal cortex activation, in comparison to placebo training, but had no effect on
nucleus accumbens activation, contrary to study hypotheses (Wiers, Ludwig, et al., 2015).
Additionally, the role of mesolimbic brain areas in approach bias triggered by alcohol
cues was explored and CBM, compared to sham training, resulted in greater reductions
in cue-evoked activation of the amygdala (Wiers, Stelzel, et al., 2015).
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There are no studies investigating potential neural correlates of response
inhibition

training

in

SUD,

but

a

single

study

examined

changes

in

electroencephalographic (EEG) recordings within a community sample of hazardous
drinkers (Bowley et al., 2013). Inhibition training, compared to sham training and
treatment as usual, resulted in non-significant increases in lateral prefrontal cortex
activity associated with approach motivation, as hypothesised.
Of note, there are no neuroimaging studies of working memory training or goaldirected approaches in SUD populations. These specific cognitive training interventions
for SUD are proposed to work through strengthening of EFs (Verdejo-García, 2016).
Exploration of the neural mechanisms of these interventions is crucial in furthering the
development and effective implementation of goal-directed cognitive training
interventions, but also for SUD cognitive training more widely, given the relative lack of
neuroimaging studies investigating neural correlates.
While there are no neuroimaging studies of goal-directed cognitive training
interventions for SUD, such as cognitive remediation, the neural correlates of cognitive
remediation for schizophrenia populations have been explored (Isaac & Januel, 2016;
Ramsay & MacDonald III, 2015). Cognitive remediation is associated with increased
activation in frontal regions, particularly prefrontal areas, but also anterior cingulate and
occipital regions (Isaac & Januel, 2016). Increased activation of the lateral and medial
prefrontal cortex, parietal cortex, the caudate and thalamus, as well as the insula have
been observed (Ramsay & MacDonald III, 2015). Structural changes in grey and white
matter also suggest neuroprotective effects of cognitive remediation for schizophrenia
populations (Penadés et al., 2017).
Based on neuroscience theories of addiction implicating two key brain systems in
the development and maintenance of SUD, an impulsive amygdala-striatum system and
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reflective prefrontal cortex system (Noël, Brevers, & Bechara, 2013), it is hypothesised
that cognitive remediation for SUD, as a top-down approach utilising broad strategybased learning, may result in improved functioning of brain areas and networks related to
the prefrontal cortex system, congruent with findings investigating the neural correlates
of cognitive remediation for schizophrenia populations. In this way, cognitive
remediation may serve to alleviate hypofunction of the ventromedial prefrontal cortex,
which is associated with chronic substance use (Volkow & Morales, 2015). Conversely,
the neurobiological underpinnings of successful abstinence implicate improved structure
and function of prefrontal brain regions (Garavan, Brennan, Hester, & Whelan, 2013),
indicating one potential treatment target for cognitive training interventions.

6.2.

LIMITATIONS AND FUTURE RESEARCH DIRECTIONS
While the findings of this thesis provide evidence for the use of cognitive training

interventions within residential SUD treatment, certain limitations of the thesis as a whole
must be acknowledged. Future research directions that may overcome these limitations
and expand the existing evidence base in the field, along with clinical implications of
findings, will also be discussed.
Study one incorporated a mixed-gender sample while studies two and three were
conducted in a female-only residential service. For this reason, the findings associated
with studies two and three may only apply to females in residential SUD treatment. Future
research incorporating males is necessary to empirically evaluate whether the findings of
this thesis also extend to male populations in residential SUD treatment. This is important
given the significant role of sex differences in SUD. Distinct pathways leading to the
onset and maintenance of addiction for males vs. females are associated with
neurobiological sex differences (Becker, Perry, & Westenbroek, 2012; Bobzean,
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DeNobrega, & Perrotti, 2014), changes in brain functioning related to substance use are
influenced by sex differences (Becker, McClellan, & Reed, 2017), and gender differences
arise within a sociocultural context potentially influencing how men and women
differentially respond to SUD treatment (Becker, McClellan, & Reed, 2016). For these
reasons, treatment response and effectiveness of cognitive training interventions for
males may differ considerably in comparison to females, and is an important area for
future research to investigate.
Another limitation of this thesis concerns the evaluation of the intervention
presented in Chapters 3 and 4. The differences between intervention and control groups
regarding length of time in treatment at baseline prior to commencement of the
intervention, as well as the period of time between baseline and post-intervention
assessments, were problematic. Future studies would benefit from standardised
recruitment times (e.g. enrolment at intake to the service) to ensure treatment groups are
matched on duration of treatment. A matched interval between assessments is also
important in terms of refining interpretations of the empirical findings for cognitive
training in SUD populations. Furthermore, the inclusion of active control groups, as
opposed to TAU, would provide further data that may be beneficial in clarifying the
mechanisms of action driving any potential improvements in cognition and functioning
following cognitive training interventions for SUD. With respect to this consideration, it
may be argued that the control group from study two of this thesis could be considered as
“active”. This is based on the notion of SUD TC treatment requiring a high level of
engagement: residents actively participate in treatment, which emphasises their roles and
responsibilities in not only the various components of treatment (e.g., multiple therapeutic
groups) but also in coordinating activities of daily life (e.g., cleaning, cooking, organising
leisure activities). These tasks require certain degrees of planning, monitoring, and
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problem-solving, and may be underpinned by specific EFs. If this is the case, it serves to
support the validity of the findings of the intervention study, given that controls were
routinely and actively involved in other tasks that may serve to strengthen EFs. It is
important to acknowledge, however, that an ideal active control condition would also
include participants attending a specific group intervention matched on important
variables such as session length and frequency, social interaction, and facilitator
involvement.
A broader issue within this thesis concerns the use of self-report measures
generally, and particularly with regard to reliable reporting of behavioural problems
related to executive dysfunction and emotion dysregulation. While there is some evidence
suggesting that the Behavior Rating Inventory of Executive Function (BRIEF-A) is an
appropriate and sensitive measure of EFs in SUD populations (e.g., Hagen et al., 2016),
further studies should investigate the reliability and validity of the BRIEF-A in SUD
populations. Similarly, there are no large-scale validation studies that have investigated
the reliability and validity of the Difficulties in Emotion Regulation Scale (DERS) in
SUD populations. Given the prevalence of executive dysfunction in SUD populations,
and the associated difficulties with insight, awareness, and self-monitoring, the question
of whether self-report ratings of emotion regulation and behavioural problems are
appropriate requires further empirical investigation.
As the trajectory of cognitive improvement observed in SUD shows variance at
the individual-level, further studies identifying subgroups and potential predictors of
cognitive recovery may inform the development and clinical translation of cognitive
training interventions (Bates, Buckman, Voelbel, Eddie, & Freeman, 2013). Related to
this, future studies assessing the effects of cognitive remediation for SUD would benefit
from the inclusion of larger sample sizes in order to explore variation between subgroups
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(e.g., those with vs. without history of head injury; psychiatric diagnostic groups; primary
substance of abuse groups) and to examine mediating and moderating factors related to
improvement. For example, a recent study utilised neuroimaging to investigate whether
variability in brain structure predicted response to cognitive training in a healthy
population (Verghese, Garner, Mattingley, & Dux, 2016). Response to training was
predicted by volume of the rostral part of the left dorsolateral prefrontal cortex. This
approach aligns well with recent research attempting to identify biomarkers with the
capacity for clinical translation to enhance the process of treatment selection based on
individual characteristics (Perlis, 2011). Relating to this, it will be important for future
studies to delineate characteristics that may predict response to cognitive training. For
example, premorbid cognitive impairment could influence the degree to which
individuals with SUD benefit from cognitive training. In the future, research discoveries
in this area may enable personalised cognitive training interventions for individuals with
SUD (e.g., individually tailored modules based on an assessment of specific
neurobiological and neuropsychological factors).
Another potentially fruitful line of future research concerns the use of assessment
techniques from multiple disciplines that have the potential to provide data from different
levels of analysis (e.g., self-report, neuropsychological, neuroimaging). This approach
may provide a more comprehensive understanding of the mechanisms of action and
potential benefits of cognitive training for SUD. As different assessment techniques may
measure distinct aspects of the construct under investigation (e.g., Cyders & Coskunpinar,
2011; self-report vs. behavioural laboratory task assessment of impulsivity), multimethod
research studies may provide a more comprehensive understanding of the changes in
cognitive processes and self-regulatory capacities observed following cognitive training
interventions. The significance of multimethod research relates to an important area of
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future investigation concerning not only whether cognitive training for SUD may produce
improvements in cognition, presumably through enhancing neural functioning, but also
whether these improvements increase self-regulation capacity. Studies that include
relevant self-regulation measures (e.g., emotion regulation) and clinical outcomes (e.g.,
response to SUD treatment, relapse, quality of life) are essential in answering these
questions.
Utilising neuroimaging methods in assessing the outcomes of cognitive training
interventions may provide significant data to further elucidate mechanisms of action and
establish neurobiologically based treatment targets for cognitive training (Cabrera et al.,
2016). As there are only a very small number of studies utilising neuroimaging methods
to investigate cognitive training for SUD, there is still much to discover regarding
neurobiological changes over the course of training and mechanisms of action. There are
a variety of cognitive training interventions for SUD (Verdejo-García, 2016) and
significant variability in the content and methods employed in strategy-based cognitive
remediation interventions, in particular (Bryce, Lee, Ponsford, & Rossell, 2016). It is
hypothesised that cognitive training for SUD may achieve its effects through two broad
mechanisms: decreasing impulsive responding through reduced substance cue-related
activation of the medial prefrontal cortex and amygdala, and increasing goal-related
activation of the dorsolateral and ventrolateral prefrontal cortex (Verdejo-García, 2016).
Neuroimaging methods could elucidate the mechanisms of action associated with
particular cognitive training interventions. Furthermore, neuroimaging research utilising
a functional connectome approach may be appropriate to investigate complex interactions
of several brain regions, and any temporal changes that may occur with cognitive training
for SUD (Taya, Sun, Babiloni, Thakor, & Bezerianos, 2015). Research of this kind may
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inform the development of targeted SUD cognitive training interventions with clear
mechanisms of action based on the neurobiology of addiction.

6.3.

CONCLUSIONS
In summary, this thesis aimed to investigate the potential for neuropsychological

assessment and cognitive training interventions to improve SUD treatment outcomes.
Findings from study one provided empirical evidence supporting the prevalence of
cognitive deficits and, in particular, executive dysfunction in an SUD sample in
residential treatment. In light of these findings, study two implemented a cognitive
remediation intervention that targeted executive dysfunction, aiming to facilitate
improvement in EFs as well as translation to clinically meaningful outcomes, with
promising findings indicating improvement in EFs and self-regulation measures. The
longitudinal outcomes of this intervention were investigated at three-month follow-up,
although the long-term benefit of cognitive remediation was found to be inconclusive in
the small sample available. Finally, the relationships between emotion regulation and
basic EFs were investigated, with task-switching significantly predicting emotion
regulation capacity. Taken together, the results of these studies provide further
preliminary support for the use of cognitive remediation interventions in SUD
populations and inform the replication and extension of research in the area of cognitive
training for SUD.

169

REFERENCES
Bates, M. E., Buckman, J. F., Voelbel, G. T., Eddie, D., & Freeman, J. (2013). The
mean and the individual: Integrating variable-centered and person-centered
analyses of cognitive recovery in patients with substance use disorders.
Frontiers in Psychiatry, 4, Article 177. doi:10.3389/fpsyt.2013.00177
Becker, J. B., McClellan, M., & Reed, B. G. (2016). Sociocultural context for sex
differences in addiction. Addiction Biology, 21(5), 1052-1059.
doi:10.1111/adb.12383
Becker, J. B., McClellan, M. L., & Reed, B. G. (2017). Sex differences, gender and
addiction. Journal of Neuroscience Research, 95(1-2), 136-147.
doi:10.1002/jnr.23963
Becker, J. B., Perry, A. N., & Westenbroek, C. (2012). Sex differences in the neural
mechanisms mediating addiction: A new synthesis and hypothesis. Biolology of
Sex Differences, 3(1), 14-48. doi:10.1186/2042-6410-3-14
Bobzean, S. A., DeNobrega, A. K., & Perrotti, L. I. (2014). Sex differences in the
neurobiology of drug addiction. Experimental Neurolology, 259, 64-74.
doi:10.1016/j.expneurol.2014.01.022
Bowley, C., Faricy, C., Hegarty, B., Johnstone, S. J., Smith, J. L., Kelly, P. J., &
Rushby, J. A. (2013). The effects of inhibitory control training on alcohol
consumption, implicit alcohol-related cognitions and brain electrical activity.
International Journal of Psychophysiology, 89(3), 342-348.
doi:10.1016/j.ijpsycho.2013.04.011
Brorson, H. H., Ajo Arnevik, E., Rand-Hendriksen, K., & Duckert, F. (2013). Drop-out
from addiction treatment: A systematic review of risk factors. Clinical
Psychology Review, 33(8), 1010-1024. doi:10.1016/j.cpr.2013.07.007
Bryce, S. D., Lee, S. J., Ponsford, J. L., & Rossell, S. L. (2016). Desire for greater
clarity when defining ‘cognitive remediation’ in reviews of treatment efficacy
for schizophrenia. Australian and New Zealand Journal of Psychiatry, 50(5),
497-497. doi:10.1177/0004867415617838
Cabrera, E. A., Wiers, C. E., Lindgren, E., Miller, G., Volkow, N. D., & Wang, G. J.
(2016). Neuroimaging the effectiveness of substance use disorder treatments.
Journal of Neuroimmune Pharmacology, 11(3), 408-433. doi:10.1007/s11481016-9680-y
Cyders, M. A., & Coskunpinar, A. (2011). Measurement of constructs using self-report
and behavioral lab tasks: Is there overlap in nomothetic span and construct
representation for impulsivity? Clinical Psychology Review, 31(6), 965-982.
doi:10.1016/j.cpr.2011.06.001
Domínguez-Salas, S., Díaz-Batanero, C., Lozano-Rojas, O. M., & Verdejo-García, A.
(2016). Impact of general cognition and executive function deficits on addiction
treatment outcomes: Systematic review and discussion of neurocognitive
pathways. Neuroscience and Biobehavioral Reviews, 71, 772-801.
doi:10.1016/j.neubiorev.2016.09.030
Fernández-Serrano, M. J., Pérez-García, M., Perales, J. C., & Verdejo-García, A.
(2010). Prevalence of executive dysfunction in cocaine, heroin and alcohol users
enrolled in therapeutic communities. European Journal of Pharmacology,
626(1), 104-112. doi:10.1016/j.ejphar.2009.10.019
Fernández-Serrano, M. J., Pérez-García, M., Río-Valle, J. S., & Verdejo-García, A.
(2010). Neuropsychological consequences of alcohol and drug abuse on

170

different components of executive functions. Journal of Psychopharmacology,
24(9), 1317-1332. doi:10.1177/0269881109349841
Garavan, H., Brennan, K. L., Hester, R., & Whelan, R. (2013). The neurobiology of
successful abstinence. Current Opinion in Neurobiology, 23(4), 668-674.
doi:10.1016/j.conb.2013.01.029
Hagen, E., Erga, A. H., Hagen, K. P., Nesvåg, S. M., McKay, J. R., Lundervold, A. J.,
& Walderhaug, E. (2016). Assessment of executive function in patients with
substance use disorder: A comparison of inventory- and performance-based
assessment. Journal of Substance Abuse Treatment, 66, 1-8.
doi:10.1016/j.jsat.2016.02.010
Hagen, E., Erga, A. H., Hagen, K. P., Nesvåg, S. M., McKay, J. R., Lundervold, A. J.,
& Walderhaug, E. (2017). One-year sobriety improves satisfaction with life,
executive functions and psychological distress among patients with
polysubstance use disorder. Journal of Substance Abuse Treatment, 76, 81-87.
doi:10.1016/j.jsat.2017.01.016
Hofmann, W., Schmeichel, B. J., & Baddeley, A. D. (2012). Executive functions and
self-regulation. Trends in Cognitive Sciences, 16(3), 174-180.
doi:10.1016/j.tics.2012.01.006
Isaac, C., & Januel, D. (2016). Neural correlates of cognitive improvements following
cognitive remediation in schizophrenia: A systematic review of randomized
trials. Socioaffective Neuroscience and Psychology, 6(1), 1-18.
doi:10.3402/snp.v6.30054
Kelley, W. M., Wagner, D. D., & Heatherton, T. F. (2015). In search of a human selfregulation system. Annual Review Of Neuroscience, 38, 389-411.
doi:10.1146/annurev-neuro-071013-014243
Kim, C., Cilles, S. E., Johnson, N. F., & Gold, B. T. (2012). Domain general and
domain preferential brain regions associated with different types of task
switching: A meta-analysis. Human Brain Mapping, 33(1), 130-142.
doi:10.1002/hbm.21199
Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: A neurocircuitry
analysis. Lancet Psychiatry, 3(8), 760-773. doi:10.1016/S2215-0366(16)001048
Manning, V., Verdejo-García, A., & Lubman, D. I. (2017). Neurocognitive impairment
in addiction and opportunities for intervention. Current Opinion in Behavioral
Sciences, 13, 40-45. doi:10.1016/j.cobeha.2016.10.003
Meusel, L. A., Hall, G. B., Fougere, P., McKinnon, M. C., & MacQueen, G. M. (2013).
Neural correlates of cognitive remediation in patients with mood disorders.
Psychiatry Research: Neuroimaging, 214(2), 142-152.
doi:10.1016/j.pscychresns.2013.06.007
Noël, X., Brevers, D., & Bechara, A. (2013). A neurocognitive approach to
understanding the neurobiology of addiction. Current Opinion in Neurobiology,
23(4), 632-638. doi:10.1016/j.conb.2013.01.018
Penadés, R., González-Rodríguez, A., Catalán, R., Segura, B., Bernardo, M., & Junqué,
C. (2017). Neuroimaging studies of cognitive remediation in schizophrenia: A
systematic and critical review. World Journal of Psychiatry, 7(1), 34-43.
doi:10.5498/wjp.v7.i1.34
Perlis, R. H. (2011). Translating biomarkers to clinical practice. Molecular Psychiatry,
16(11), 1076-1087. doi:10.1038/mp.2011.63
Ramsay, I. S., & MacDonald III, A. W. (2015). Brain correlates of cognitive
remediation in schizophrenia: Activation likelihood analysis shows preliminary

171

evidence of neural target engagement. Schizophrenia bulletin, 41(6), 1276-1284.
doi:10.1093/schbul/sbv025
Taya, F., Sun, Y., Babiloni, F., Thakor, N., & Bezerianos, A. (2015). Brain
enhancement through cognitive training: A new insight from brain connectome.
Frontiers in Systems Neuroscience, 9, 44. doi:10.3389/fnsys.2015.00044
Valls-Serrano, C., Caracuel, A., & Verdejo-García, A. (2016). Goal Management
Training and Mindfulness Meditation improve executive functions and transfer
to ecological tasks of daily life in polysubstance users enrolled in therapeutic
community treatment. Drug and Alcohol Dependence, 165, 9-14.
doi:10.1016/j.drugalcdep.2016.04.040
Verdejo-García, A. (2016). Cognitive training for substance use disorders:
Neuroscientific mechanisms. Neuroscience and Biobehavioral Reviews, 68, 270281. doi:10.1016/j.neubiorev.2016.05.018
Verghese, A., Garner, K. G., Mattingley, J. B., & Dux, P. E. (2016). Prefrontal cortex
structure predicts training-induced improvements in multitasking performance.
The Journal of Neuroscience, 36(9), 2638-2645.
doi:10.1523/JNEUROSCI.3410-15.2016
Volkow, Nora D., & Morales, M. (2015). The brain on drugs: From reward to addiction.
Cell, 162(4), 712-725. doi:10.1016/j.cell.2015.07.046
Wiers, C. E., Ludwig, V. U., Gladwin, T. E., Park, S. Q., Heinz, A., Wiers, R. W., . . .
Bermpohl, F. (2015). Effects of cognitive bias modification training on neural
signatures of alcohol approach tendencies in male alcohol-dependent patients.
Addiction Biology, 20(5), 990-999. doi:10.1111/adb.12221
Wiers, C. E., Stelzel, C., Gladwin, T. E., Park, S. Q., Pawelczack, S., Gawron, C. K., . .
. Bermpohl, F. (2015). Effects of cognitive bias modification training on neural
alcohol cue reactivity in alcohol dependence. American Journal of Psychiatry,
172(4), 335-343. doi:10.1176/appi.ajp.2014.13111495
Wilcox, C. E., Pommy, J. M., & Adinoff, B. (2016). Neural circuitry of impaired
emotion regulation in substance use disorders. American Journal of Psychiatry,
173(4), 344-361. doi:10.1176/appi.ajp.2015.15060710

172

Appendix A: Statement of Contributions of Others
These statements identify the nature and extent of the intellectual input of the
candidate and co-authors for all chapters based on journal articles:
Chapter 2
Author EMM designed the study, collected all data, and drafted the manuscript. Authors
JL, JB, and PJK contributed to the design of study and interpretation of data. Author NS
provided intellectual input to the overall design and conduct of the study, data analysis
and interpretation of results, and critically revised the manuscript. All authors contributed
to and approved the final manuscript.
Chapter 3
EMM, JB, JL, PJK, and NS designed the study. JB created and facilitated the intervention.
EMM co-facilitated the intervention, performed clinical and neuropsychological
assessments, conducted data analysis, and wrote the first draft of the manuscript. All
authors contributed to the final version of the manuscript.
Chapter 4
EMM, JB, JL, PJK, and NS designed the study. JB created and facilitated the intervention.
EMM co-facilitated the intervention, performed clinical and neuropsychological
assessments, conducted data analysis, and wrote the first draft of the manuscript. All
authors contributed to the final version of the manuscript.
Chapter 5
EMM designed the study, performed clinical and neuropsychological assessments,
conducted data analysis, and drafted the manuscript. Authors NS and PJK contributed to
the design of study and interpretation of results. All authors contributed to the final
version of the manuscript.

173

174

Appendix B: Published Papers

175

176

177

178

179

180

181

182

183

Accepted Manuscript
Title: The relationship between executive functions and
emotion regulation in females attending therapeutic
community treatment for substance use disorder
Authors: Ely M. Marceau, Peter J. Kelly, Nadia Solowij
PII:
DOI:
Reference:

S0376-8716(17)30537-9
https://doi.org/10.1016/j.drugalcdep.2017.10.008
DAD 6708

To appear in:

Drug and Alcohol Dependence

Received date:
Revised date:
Accepted date:

5-5-2017
8-10-2017
11-10-2017

Please cite this article as: Marceau, Ely M., Kelly, Peter J., Solowij, Nadia, The
relationship between executive functions and emotion regulation in females attending
therapeutic community treatment for substance use disorder.Drug and Alcohol
Dependence https://doi.org/10.1016/j.drugalcdep.2017.10.008
This is a PDF ﬁle of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its ﬁnal form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.

184

Journal of Substance Abuse Treatment 66 (2016) 30–36

Contents lists available at ScienceDirect

Journal of Substance Abuse Treatment

The Montreal Cognitive Assessment (MoCA) is Sensitive to Head Injury
and Cognitive Impairment in a Residential Alcohol and Other Drug
Therapeutic Community
Ely M. Marceau, B.Psych. (Hons.) a, Jo Lunn, B.A. b, Jamie Berry, M.Clin.Neuro., D.Psych. (Clin. Neuro.) c,
Peter J. Kelly, Ph.D. a, Nadia Solowij, Ph.D. a,⁎
a
b
c

School of Psychology, Centre for Health Initiatives, and Illawarra Health and Medical Research Institute, University of Wollongong, Northﬁelds Avenue, Wollongong, NSW 2522, Australia
We Help Ourselves (WHOs), Building 128, Church Street, Lilyﬁeld, NSW 2040, Australia
Advanced Neuropsychological Treatment Services, PO Box 4070 Strathﬁeld South, NSW 2136, Australia

a r t i c l e

i n f o

Article history:
Received 20 December 2015
Received in revised form 22 February 2016
Accepted 18 March 2016
Keywords:
Substance misuse
Cognitive impairment
Therapeutic community
Residential treatment
Cognitive screening
Head injury

a b s t r a c t
Introduction: Retaining clients in residential alcohol and other drug (AOD) treatment is difﬁcult and cognitive impairment has been identiﬁed as a signiﬁcant predictor of treatment dropout. The application of extensive screening for cognitive impairment is cost-prohibitive for most AOD treatment services. The current study aimed to
explore cognitive functioning and impairment-associated factors in a typical sample of residential AOD clients
using a free brief screening tool that could be utilised by front-line AOD services.
Methods: Residents of an AOD therapeutic community (n = 128) and a non-substance using control group (n = 37)
were administered a brief cognitive screening measure, the Montreal Cognitive Assessment (MoCA). MoCA total and
domain scores were compared between these groups and within the AOD group examined in association with primary substance of misuse, severity of dependence, gender, psychological distress, and history of head injury.
Results: Almost half (43.8%) of the AOD sample were identiﬁed as cognitively impaired, compared to 16.2% of the
control group. Furthermore, 67.2% of the AOD sample had sustained head injuries and 50% of the sample required
hospitalization for head injury. History of head injury was a signiﬁcant determinant of cognitive impairment, and
associated with greater levels of psychological distress.
Conclusions: There are high rates of inter-related cognitive impairment, head injuries, and psychological distress
among clients in residential AOD treatment. Routine screening of clients at intake for cognitive impairment by
means of a brief screening measure such as the MoCA, in combination with the assessment of history of head injuries
and comorbid psychological disorders, could inform treatment modiﬁcations or adjunct interventions to increase retention and improve long-term outcomes.
© 2016 Elsevier Inc. All rights reserved.

1. Introduction
Therapeutic communities (TCs) are a form of residential rehabilitation
for individuals experiencing chronic and severe alcohol and other drug
(AOD) problems and may particularly suit clients with associated comorbidities and other complexities as they place an emphasis on fostering social support within the community of residents in order to promote
treatment engagement and completion. Dropout from AOD treatment in
general is estimated to be as high as 57% in inpatient settings (Darke,
Campbell, & Popple, 2012; Deane, Wootton, Hsu, & Kelly, 2012; VergaraMoragues, Gonzalez-Saiz, Lozano, & Verdejo Garcia, 2013). Importantly,
length of stay in TCs has been shown to be related to neurocognitive capacity (Fals-Stewart & Lucente, 1994; Fals-Stewart & Schafer, 1992;
⁎ Corresponding author at: School of Psychology, University of Wollongong, Northﬁelds
Ave Wollongong NSW 2522 Australia. Tel.: +61 242213732; fax: +61 242214163.
E-mail address: nadia@uow.edu.au (N. Solowij).
http://dx.doi.org/10.1016/j.jsat.2016.03.002
0740-5472/© 2016 Elsevier Inc. All rights reserved.

Fernández-Serrano, Pérez-García, Perales, & Verdejo-García, 2010). An extensive systematic review reported that cognitive deﬁcits were one of the
most consistently reported risk factors for dropout from AOD treatment,
alongside personality disorder, low treatment alliance, and younger age
(Brorson, Ajo Arnevik, Rand-Hendriksen, & Duckert, 2013).
It is likely that most residential substance misuse programs deliver
treatments that work optimally in those who possess intact cognitive
abilities; that cognitive impairment among residents may hinder treatment success requires further consideration. Components of residential
AOD treatment often rely on capacities such as executive function (deﬁned broadly as “those capacities that enable a person to engage successfully in independent, purposive, self-directed, and self-serving
behavior”; Lezak, Howieson, Bigler, & Tranel, 2012, p. 37) and working
memory (Fernández-Serrano, Pérez-García, Río-Valle, & VerdejoGarcía, 2010; Yϋcel & Lubman, 2007), as clients are required to integrate
new information, formulate goals, establish new behavioural strategies,
and plan for the future in overcoming addiction.
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However, most misused substances impair attention, learning and
memory, visuospatial abilities, and executive functioning, with perhaps
the most robust deﬁcits across all substances evident in inhibitory control,
working memory, and decision-making (Fernández-Serrano, PérezGarcía, Río-Valle, et al., 2010; Yücel, Lubman, Solowij, & Brewer, 2007;
Yϋcel & Lubman, 2007). Structural and functional brain changes may
occur after substance misuse (Broyd, van Hell, Yücel, & Solowij, 2016;
Caplan, Epstein, Quinn, Stevens, & Stern, 2007; Ersche & Sahakian, 2007;
Gonzalez, 2007; Gruber, Silveri, & Yurgelun-Todd, 2007; Lorenzetti,
Solowij, & Yücel, 2016; Oscar-Berman & Marinković, 2007; Scott et al.,
2007). Traumatic brain injury (TBI) is also highly prevalent in substance
misuse populations, leading to signiﬁcant complexities in the process of
AOD treatment (Sacks et al., 2009; Solomon & Malloy, 1992; Walker,
Cole, Logan, & Corrigan, 2007; West, 2011).
Although cognitive dysfunction is common in AOD samples and increasingly recognized by staff, there is often insufﬁcient time or resources to implement detailed neuropsychological assessments.
Cognitive assessment may be instrumental in facilitating the detection
of AOD clients with clinically signiﬁcant cognitive impairment, irrespective of etiology. Assessing clients' cognitive capacities can inform subsequent implementation of strategies aimed at improving treatment
retention and outcomes.
In the AOD treatment environment a brief but valid and reliable
measure is required. This would provide an indication of potential cognitive dysfunction and alert staff to the possibility that further neuropsychological assessment and/or treatment modiﬁcations may be
indicated. The Montreal Cognitive Assessment (MoCA; Nasreddine
et al., 2005) comprises 12 items that tap ﬁve key neuropsychological domains: executive function, working memory, short-term memory, language, and visuospatial ability. The MoCA takes 15 minutes to
administer, is a free resource (Nasreddine, 2015), and can be administered by staff without formal neuropsychological training. Initial studies
have found evidence supporting the use of the MoCA in AOD treatment
settings (Copersino et al., 2009; Copersino et al., 2012).
The current study was exploratory in nature and sought to provide a
naturalistic overview of a sample of Australian TC residents, with the
MoCA administered as a brief screening measure to assess neuropsychological functioning. Performance on the MoCA was investigated in
relation to demographic, substance use, psychological, and other variables related to impairments in cognition, including TBI.

2. Material and methods
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2.2. Procedure
After a group information session, interested participants provided
written consent and were individually assessed in a quiet testing
room. This was conducted within the TC facility for the AOD group,
and at a University psychology clinic for the control group. The MoCA
was administered in approximately 15 minutes, adhering to the administration and scoring guidelines (Nasreddine, 2015). Additional information (e.g., basic demographics, history of head injury, current and
past substance use for controls) was obtained through a 10-minute
semi-structured interview and the Kessler Psychological Distress Scale
(K10; Kessler et al., 2002) was administered, as well as the Severity of
Dependence Scale (SDS; Gossop et al., 1995) for the AOD group. Control
participants received a $20 gift card as reimbursement for their time.
2.3. Measures
2.3.1. MoCA
The MoCA was used to assess neuropsychological functioning across
its purported ﬁve domains (executive function, working memory,
short-term memory, language and visuospatial ability). Executive function is assessed using trail-making, phonemic ﬂuency, and verbal abstraction tasks. Working memory is assessed using sustained
attention, serial subtraction, and digit span forward/backward tasks.
Short-term memory is assessed through the delayed recall of ﬁve
nouns. Language is assessed using naming (low familiarity animals),
sentence repetition, and the phonemic ﬂuency task. Visuospatial ability
is assessed using clock-drawing and cube-copying tasks. The MoCA has
displayed acceptable reliability in clinical groups (Bernstein, Lacritz,
Barlow, Weiner, & DeFina, 2011; Freitas, Simões, Marôco, Alves, &
Santana, 2012). Outcome measures included total MoCA score and domain subscores.
2.3.2. Clinical variables
The SDS (Gossop, Best, Marsden, & Strang, 1997) measured AOD participants' level of dependence on their primary substance of misuse. The
K10 was used to capture level of psychological distress experienced by
all participants. The K10 has been extensively used in both community
and clinical samples as an indicator of a potential psychological disorder,
and has demonstrated acceptable psychometric properties (George,
Kinner, Bruno, Degenhardt, & Dunn, 2010; Hides et al., 2007; Sunderland,
Mahoney, & Andrews, 2012). Relevant demographic and substance use
data routinely collected by WHOs were accessed, following participants
and the director of the service providing written consent.

2.1. Participants
2.4. Data analysis
The AOD group was recruited from We Help Ourselves (WHOs), a
large provider of residential AOD treatment in Australia that uses the
Therapeutic Community model of treatment. Participants were recruited across seven WHOs sites in New South Wales (Sydney, Hunter Valley) and Queensland (Sunshine Coast). The response rate was
approximately 90%. Speciﬁc inclusion and exclusion criteria were not
applied in order to capture the heterogeneous and complex presentations of residential AOD treatment populations and to increase the generalizability of results. Although there was no formal assessment of
substance use disorders using the Diagnostic and Statistical Manual of
Mental Disorders (5th ed.; DSM-5; American Psychiatric Association,
2013) criteria it was assumed that residents would meet these criteria
given their attendance at a high-intensity residential program.
A control group was recruited through the University of Wollongong
College, a provider of educational programs to persons who have not
completed high school matriculation, as an alternative pathway to tertiary study. All students were invited to participate and the response rate
was approximately 60%. Control participants, all native English speakers,
were excluded for any lifetime dependence on or treatment for alcohol
or other drugs, and any psychiatric or neurological diagnoses.

All data were analyzed using IBM Statistical Package for the Social Sciences (version 19; IBM Corp, 2010). The primary goals of the analysis were
to compare the performance of residents and controls on the MoCA and to
explore variation in MoCA scores and potential predictors (e.g., primary
substance of misuse, gender effects) within the AOD sample.
Shapiro–Wilk statistics and visual inspection of histograms and
boxplots determined that total MoCA score, MoCA domain subscores,
age, years of education, K10 and SDS scores were not normally distributed for both AOD and control groups. Consequently, nonparametric
techniques were employed for most of the analyses. Nonparametric
analysis of covariance was required for some analyses to enable covarying demographic characteristics that differed between groups. Quade's
(1967) distribution-free procedure was used as a nonparametric alternative to analysis of covariance (see Olejnik & Algina, 1985). This involved ranking the dependent variable and all covariates for all cases,
ignoring the grouping variable. Following this, the linear regression of
the ranked dependent variable on the ranked covariate measure was
calculated and the unstandardized residuals saved, again ignoring the
grouping factor. To calculate Quade's F statistic, a one-way analysis of
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variance using the residuals from the regression as the dependent variable and the grouping variable as the factor was performed.
Total MoCA score and cognitive domain subscores were the primary
dependent variables for analysis. However, factor analyses of the MoCA
have demonstrated that domains may be grouped differently
(e.g., Duro, Simões, Ponciano, & Santana, 2010; Freitas et al., 2012).
Given the multi-process nature of neuropsychological tasks, whereby
any single task may tap into a range of perceptual, cognitive and
motor abilities, and the overlapping nature of the cognitive domains
assessed by the MoCA (Freitas et al., 2012), we created an additional
score for analysis of executive function. This was of particular interest
because executive dysfunction is especially common in substance
misusing individuals (e.g., Fernández-Serrano, Pérez-García, Río-Valle,
et al., 2010; Gierski et al., 2013; Hester, Lubman, & Yϋcel, 2010; Perry
et al., 2011). As such, we utilized the standard measure of executive
function from the MoCA as well as an extended measure that included
performance on the visuospatial cube-copying and clock-drawing
tasks, with the rationale that these tasks rely on key component processes of executive function.
All AOD residents were compared to controls in the ﬁrst instance. Residents were then compared in terms of gender and primary substance of
misuse. Primary substance of misuse groupings were formed by choosing
the three largest representative groups in residence at the time of testing
(alcohol, heroin and amphetamines). A broader opiates group was then
formed by the addition of clients on methadone maintenance and
buprenorphine users. Cocaine users, minimal in Australian AOD samples
(Australian Institute of Health and Welfare, 2005), were grouped with
amphetamine users to form a stimulants group. This strategy maximized
group sizes for comparison, grouping together substances with similar
chemical properties. However, primary users of cannabis, tranquilisers
and benzodiazepines were not grouped or included in these comparisons
due to insufﬁcient sample sizes of these subgroups (see Results). Finally,
AOD users hospitalized after a head injury were compared to those without serious head injuries.

Table 1
Demographic, substance use, psychological, and clinical variables for the AOD group
(n = 128).
Age (Mdn, range)
Gender (% male)
Education (Mdn, range)
Unemployed (%)
Homelessa (%)
Arrested during last 3 monthsa (%)
Primary substance of misuseb (%)
Alcohol
Heroin
Amphetamines
Cannabis
Tranquilisers
Methadone
Buprenorphine
Cocaine
Benzodiazepines
SDSc scorea (Mdn, range)
History of overdose (%)
Injected during last 3 months (%)
K10d scorea (M, SD)
Hospitalized after head injury (%)
Lost consciousness/concussion after head injury (%)
a
b
c
d

35 (19–56)
70.3
10 (7–16)
90.5
7.4
43.2
30.4
27.7
20.5
8.9
4.5
2.7
1.8
1.8
1.8
11 (0-15)
60.2
52.6
29.2 (7.8)
50
67.2

n = 95.
n = 112.
Severity of Dependence Scale.
Kessler Psychological Distress Scale.

3. Results

distress. Despite attempts to match sample characteristics, controls
were signiﬁcantly younger (Mdn = 25 years, range 21–61) than the
AOD group (Mdn = 35 years, range 19–56), z = −5.21, p b .001, and
had signiﬁcantly more years of education (Mdn = 12 years vs. Mdn =
10 years), z = −4.26, p b .001. Gender distribution did not differ signiﬁcantly between groups (54% male in controls vs. 70.3% male in AOD). Age
and education were therefore included as covariates for group comparisons. Psychological distress was low to moderate in controls (K10 mean
17), and was signiﬁcantly higher in AOD residents (K10 mean 29), F(1,
130) = 33.33, p b .001.

3.1. Preliminary analyses

3.2. Primary analyses

MoCA data were available for 128 AOD residents and 37 controls. For
some analyses, the AOD sample was reduced to 95 due to missing data
(e.g. primary substance of misuse, n = 16; SDS and K10 scores, n = 33).
Table 1 displays demographic, substance use, psychological, and cognitive functioning variables for the AOD group. AOD residents were in
their mid-thirties on average and predominantly male. Alcohol was
the primary substance of misuse for almost one-third of the sample,
followed by heroin and amphetamine misuse, with these three substances accounting for approximately 80% of the entire AOD sample.
The mean K10 score indicated very high levels of psychological distress
and the mean SDS score indicated high levels of psychological dependence on participants' primary substance of misuse, although the
range extended to 0 in some cases, reﬂecting that some residents had
progressed further in their treatment. The prevalence of head injuries
was particularly high in the sample. Of the 67.2% who had either lost
consciousness or sustained a concussion after a head injury, the mean
number of times this had occurred was 4.98 (SD = 5.95). Half of the
total sample had been hospitalized after sustaining a head injury.
All control participants were screened to ensure that they had not
been dependent on alcohol or other substances and/or received treatment for substance use disorder in the past. No control participant currently used any substance (excluding alcohol and tobacco) on a regular
basis (i.e., greater than once a month), with minimal prior experimentation with drugs, and 76% drank alcohol less than twice per week. The
24% of control participants who drank alcohol more than once per week
were screened to ensure that their current drinking was not occurring
at a problematic level that caused clinically signiﬁcant impairment or

3.2.1. Covariates
Despite the group difference in age, age was not signiﬁcantly correlated
with total MoCA score, p = .16. It was also not correlated with any MoCA
subscores, all p N .05, in the entire sample as well as in the AOD group
alone. There were signiﬁcant correlations between years of education and
total MoCA score, r = .18, p = .02, executive function, r = .36, p b .001,
short-term memory, r = .18, p = .02, working memory, r = .21, p =
.006, and language, r = .26, p = .001. Age and education were both included as covariates in analyses, but while education was consistently signiﬁcant in the models, age was not. Age was subsequently dropped from the
analyses and results are reported here with education alone as the covariate
in analyses of MoCA outcomes for the AOD vs. control group.
3.2.2. MoCA scores
Comparison of the AOD and control group determined a signiﬁcant
difference in total MoCA score, F(1, 163) = 5.28, p = .023, the combined
executive function/visuospatial subscore, F(1, 163) = 6.91, p = .009,
and the visuospatial domain alone, z = − 2.43, p = .015, with poorer
performance in the AOD group (Table 2). None of the other cognitive
domain subscores differed between groups: short-term memory, F(1,
163) = .25, p = .62, working memory, F(1, 163) = .27, p = .60, and language, F(1, 163) = 1.04, p = .31. There was a trend toward poorer executive function in the AOD group, F(1, 163) = 3.01, p = .08.
3.2.3. Gender effects
There were no signiﬁcant differences between male and female AOD
participants in age, years of education, or SDS scores (all p N .28).
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Table 2
Comparison of MoCA scores between AOD and control groups, for entire AOD sample and
those without head injuries: mean (SD).

Total score
Executive/visuospatial
Executive
STMa
WMb
Visuospatial
Language

Head injuries
included

Head injuries
excluded

AOD group
(n = 128)

AOD group
(n = 64)

Control
(n = 37)

25.60 (3.13)⁎
5.13 (1.57)⁎⁎
2.48 (1.05)
3.63 (1.33)
5.36 (1.06)
2.64 (1.01)⁎
5.01 (0.94)

26.39 (2.56)
5.53 (1.47)
2.73 (1.03)
3.78 (1.23)
5.50 (1.04)
2.80 (0.98)
5.16 (0.88)

26.94 (3.10)
6.14 (1.64)
3.08 (0.92)
3.92 (1.23)
5.43 (0.99)
3.05 (1.13)
5.35 (0.82)

⁎ p b .05.
⁎⁎ p b .01.
a
Short-term memory.
b
Working memory.

Females tended to have higher K10 scores (M = 31.25, SD = 7.89) than
males (M = 28.21, SD = 7.60), t(93) = −1.82, p = .07. MoCA outcomes
for males vs. females were not signiﬁcantly different (all p N .10) although females tended to score slightly higher than males (Mdn 3 vs.
2) on executive subscores, z = −1.68, p = .09.
3.2.4. Primary substance of misuse
There were signiﬁcant differences between primary substance of
misuse groups in age, F(2, 92) = 8.25, p = .001, but not years of education, H(2) = 4.15, p = .13, or SDS scores, H(2) = 1.59, p = .45; age was
therefore included as a covariate in the analysis. There were no signiﬁcant differences in total MoCA score, F(2, 92) = .04, p = .96, shortterm memory, F(2, 92) = .09, p = .92, language, F(2, 92) = .15, p =
.86, executive function, F(2, 92) = 1.37, p = .26, visuospatial abilities,
F(2, 92) = 1.61, p = .21, or combined executive function/visuospatial
abilities, F(2, 92) = 1.30, p = .28, between primary substance of misuse
groups (Table 3). There was a marginally signiﬁcant difference for
working memory performance, F(2, 92) = 2.98, p = .056, with the
poorest performance in the stimulants group. K10 scores were signiﬁcantly different across substance of misuse groups, F(2, 77) = 5.96,
p = .004, being higher in the stimulant group relative to the opiate
group (p = .022) and the alcohol group (p = .07), with no difference
between alcohol and opiate groups (p = .69).

r = .18, p = .085. This pattern indicates that greater psychological distress (but not greater drug dependence) is associated with greater cognitive impairment.
3.3.2. Head injuries
Given that 50% of the AOD sample had been hospitalized for a head
injury, the impact of head injuries on cognitive function was imperative
to investigate further. There were no signiﬁcant differences in age, z =
−1.24, p = .22, education, z = −.94, p = .35, or K10 scores, t(93) =
− .23, p = .82, between AOD residents who had versus had not been
hospitalized after a head injury, but those who had not been hospitalized for head injury had higher SDS scores, z = − 2.10, p = .035,
(Mdn = 11 vs. 10). AOD participants who had been hospitalized had
lower total MoCA scores (Mdn = 25.5 vs. 26), z = − 2.59, p = .01,
than those who had not. The hospitalized group also had lower executive/visuospatial (Mdn = 5 vs. 6, z = −2.97, p = .003), working memory (mean rank = 58.38 vs. 70.62, z = −2.18, p = .03), and executive
(Mdn = 2 vs. 3, z = − 2.66, p = .008) subscores, than the nonhospitalized group, with trends toward lower language, z = − 1.67,
p = .095, and visuospatial subscores, z = −1.71, p = .088, but no difference in short-term memory subscores, z = −1.17, p = .24. Fig. 1 displays standardized (out of 6) MoCA domain scores for AOD
participants hospitalized for head injuries, non-hospitalized AOD participants and controls.
3.3.3. Analysis of sample without signiﬁcant head injuries
After exclusion of those who had been hospitalized after a head injury, the primary analyses were repeated to compare only those AOD residents who had not sustained head injures requiring hospitalization
with controls (Table 2). The AOD group in this reduced sample (n =
64) were signiﬁcantly older than controls (Mdn = 34 vs. 25, respectively), z = −4.82, p = b .001, and less educated (Mdn = 10 vs. 12), z =
− 3.65, p = b .001. With age and education included as covariates,
there were no signiﬁcant differences in total MoCA score, F(1, 99) =
.38, p = .54, or any MoCA subscores (all p N .20) between AOD residents
without signiﬁcant head injuries and controls. Signiﬁcant differences
remained for K10 scores between these AOD residents (Mdn = 29)
and controls (Mdn = 16), F(1, 82) = 33.51, p = b .001. Other than
males scoring signiﬁcantly higher (mean rank = 36.43) in working
memory subscores than females (mean rank = 25.50), z = − 2.91,
p = .004, no other effects of gender or primary substance of misuse
were found in this sample without head injuries.

3.3. Exploratory analyses
3.3.1. Psychological distress and substance dependence
There were signiﬁcant negative correlations between K10 scores and
total MoCA scores, r = −.22, p = .012, executive function/visuospatial
abilities, r = −.21, p = .015, and language scores, r = −.20, p = .021,
and a trend for working memory, r = −.16, p = .06, in the overall AOD
sample. K10 and SDS scores were positively correlated, r = .20, p =
.049, but SDS scores were not correlated with any MoCA scores (all
p N .05), other than a trend toward a correlation with executive function,

3.3.4. Clinical signiﬁcance of impairment
To investigate the clinical signiﬁcance of impairment, total MoCA
scores were recoded as a dichotomous variable to indicate either the
presence or absence of cognitive impairment according to the cut-off
score suggested by Copersino et al. (2009) as ≥26 reﬂecting no evidence
6
5
4
3

Table 3
Comparison of MoCA scores across primary substance of misuse groups: mean (SD).

Total score
Executive/visuospatial
Executive
STMa
WMb
Visuospatial
Language
a
b

Alcohol
(n = 34)

Opiates
(n = 36)

Stimulants
(n = 25)

25.85 (3.49)
5.09 (1.73)
2.26 (1.14)
3.76 (1.18)
5.53 (1.08)
2.82 (0.94)
5.12 (0.95)

25.92 (2.55)
5.14 (1.51)
2.64 (1.05)
3.69 (1.35)
5.56 (0.69)
2.50 (1.06)
4.94 (1.01)

25.88 (3.23)
5.60 (1.58)
2.68 (1.11)
3.64 (1.31)
5.00 (1.22)
2.92 (0.91)
4.96 (0.93)

Short-term memory.
Working memory; trend toward greater impairment in the stimulants group p = .056.

Hospitalised

2

Non-Hospitalised

1

Controls

0

Fig. 1. Standardized (out of 6) MoCA domain scores for the AOD patients who were hospitalized for head injuries, non-hospitalized for any head injury (includes those who
never had a head injury or may have sustained head injuries not requiring hospitalization), and control participants.
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of cognitive impairment. Within the overall AOD group, 43.8% met
criteria for cognitive impairment. After removing those hospitalized
for head injuries, 37.5% met criteria for impairment and this represented
a signiﬁcantly greater proportion than the 16.2% of controls meeting
criteria for impairment, χ 2(1, N = 101) = 5.09, p = .019. However,
after removing a further 27 participants in the AOD sample who had
sustained concussion or lost consciousness after a head injury but had
not been hospitalized, the prevalence of impairment dropped to 29.7%
and this did not represent a statistically signiﬁcant difference when
compared to the 16.2% of impaired controls (p = .13). Subsequently, it
was deemed appropriate to examine the prevalence of impairment
within the AOD group who had been hospitalized after a head injury.
Of those who had been hospitalized (n = 64), only 50% met criteria
for cognitive impairment, indicating that hospitalization for head injuries alone may not predict cognitive impairment. There was no difference in the total number of head injuries (including those that did not
require hospitalization) sustained by those who met criteria for impairment (Mdn = 3) vs. those who did not (Mdn = 3), p = .67.
4. Discussion
This study used a brief screening tool, the MoCA, to provide an overview of cognitive functioning in residents of a substance misuse TC. The
major ﬁndings were that 43.8% of the AOD group met criteria for cognitive impairment and head injuries were a signiﬁcant determinant of this
impairment. Within the AOD group, 50% had been hospitalized after a
head injury and were more cognitively impaired than those who had
not sustained head injuries requiring hospitalization. Greater psychological distress in the AOD group was also associated with greater
cognitive deﬁcits.
4.1. Neuropsychological functioning
AOD residents overall scored signiﬁcantly lower on the MoCA and
showed greater deﬁcits in executive function and visuospatial abilities
than controls. No other cognitive domains differed between residents
and controls. Within the AOD group, there were no gender effects
other than a trend toward males displaying greater executive dysfunction than females and females tended to have higher levels of psychological distress than males. MoCA outcomes did not differ according to
primary substance of misuse, other than stimulant users showing marginally poorer working memory ability and higher levels of psychological distress. The lack of observed differences in neuropsychological
outcomes between substance of misuse groups may be explained by
the prevalence of polysubstance use in clients undergoing residential
AOD treatment; differences may not be detected between groups in
which substance use has reached a level necessitating residential treatment. Generally, clients in residential AOD treatment have extensive
histories of substance use with considerable variability between individuals. Another possible explanation is that differences do exist between substance of misuse groups in residential treatment but that
the current study did not possess group sizes large enough to detect
these differences.
4.1.1. Head injuries
Half of the AOD sample in the current study had been hospitalized
after a head injury and were more cognitively impaired than those
who had not, with lower total MoCA scores, and poorer executive/visuospatial and working memory abilities. When the hospitalized
group were excluded from the analysis, there were no differences in
any neuropsychological outcomes between AOD residents and controls,
and no differences between primary substance of misuse groups, but females in this subset displayed poorer working memory performance
than males.
In general, these ﬁndings are congruent with the literature suggesting that cognitive impairments exist in AOD populations (Caplan et al.,

2007; Ersche & Sahakian, 2007; Fernández-Serrano, Pérez-García, RíoValle, et al., 2010; Gonzalez, 2007; Gruber et al., 2007; Oscar-Berman
& Marinković, 2007; Scott et al., 2007; Yücel et al., 2007; Yϋcel &
Lubman, 2007) and may be detected by a brief cognitive impairmentscreening tool (the MoCA). In assessing a residential AOD sample, arguably we accessed those most severely affected by their addiction, and
also those with a high prevalence of head injuries requiring hospitalization. The level of cognitive impairment detected in this sample, as measured by the MoCA, was not severe and was largely associated with TBI,
a factor that has not routinely been considered in previous studies
and may account for a signiﬁcant portion of the deﬁcits observed in
the literature.
4.2. Implications
This study showed that having sustained a TBI requiring hospitalization accounted for the majority of cognitive impairment detected in the
sample. There are two major implications: ﬁrst, simply asking clients
whether they have ever sustained a head injury requiring hospitalization may be the most time-efﬁcient way to informally gauge the possibility of cognitive deﬁcits. Clients may be unable, however, to provide
accurate accounts due to the high rate of TBIs occurring during intoxication that may remain undetected and receive no medical intervention.
While half of the AOD group in the current study had sustained a head
injury requiring hospitalization, 50% of this subgroup did not meet
criteria for impairment based on the MoCA score threshold. As such,
screening for head injuries alone without subsequent cognitive assessment may lead to inﬂated estimates of impairment. Furthermore, this
type of screening would not capture approximately one third of the
AOD sample that had never sustained head injuries and yet met criteria
for cognitive impairment. Thus, the second implication is that cognitive
deﬁcits may also exist independently of head injuries in AOD samples
and hence require screening in their own right.
These complex ﬁndings highlight the importance of brief cognitive
screening as a standardized assessment procedure for all clients entering residential treatment. In this way, treatment planning may account
for the presence of cognitive deﬁcits. Further neuropsychological assessment may be recommended and modiﬁcations to treatment and/
or targeted interventions may be implemented.
Regardless of the etiology of cognitive impairment, cognitive screening has the potential to inform interventions aimed at alleviating these
deﬁcits. For example, adjunct interventions to remediate cognitive deﬁcits together with better-tailored speciﬁc treatments may bolster residential services, reducing dropout rates and consequently improving
treatment outcomes. Evidence suggests that the neuropsychological deﬁcits associated with TBI can be alleviated through cognitive remediation
interventions (Maas et al., 2013; Manley & Maas, 2013; Tsaousides &
Gordon, 2009), and there is emerging evidence for the use of cognitive remediation programs in substance misuse populations as a way to improve
treatment retention (Bates, Buckman, & Nguyen, 2013; Fals-Stewart &
Lam, 2010; Rupp, Kemmler, Kurz, Hinterhuber, & Fleischhacker, 2012;
Verdejo-García, 2011; Wexler, 2011). Further research aimed at developing and trialling cognitive remediation programs for AOD populations is
required and providing these interventions within residential treatment
services would be most ideal (e.g., Gonçalves et al., 2014).
4.3. Limitations and future directions
There are several limitations of the current study. There were clear
differences between the AOD group and controls (e.g., age, education,
inferred socioeconomic status). While some of these differences were
accounted for statistically, future research would beneﬁt from the inclusion of better-matched control groups. The exploration of primary substance of misuse groups resulted in small sample sizes with reduced
statistical power for comparison; larger samples in future studies may
reveal substance-speciﬁc impairment. Another limitation of the current
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study is its failure to assess for psychiatric comorbidities, which are
common in AOD populations and add substantial complexity to the process of treatment. The current study utilized the K10 as a measure of
psychological distress and higher scores were associated with greater
cognitive impairment. Future studies should include formal psychiatric
diagnoses in order to examine their interaction with substance use disorders and head injuries in terms of cognitive outcomes. Additionally,
the current study focused on hospitalization and frequency of head injuries, but not their nature, severity or age of occurrence, which could be
further examined in future studies. Also, despite the AOD sample being
abstinent from AOD, there was no assessment of their duration of abstinence or length of stay in residential services prior to cognitive assessment; this, along with a more detailed substance use history
(including age of onset and number of years of substance use) and objective measures of abstinence (e.g. urine testing in both AOD and control samples), could have provided further information regarding the
nature and extent of the observed cognitive deﬁcits. Finally, the potential lack of sensitivity of the MoCA to more speciﬁc cognitive deﬁcits in
AOD populations cannot be underestimated; the scores observed in
this sample were not substantially below the cut-off indicative of impairment. Nevertheless, the MoCA can serve as a cost-effective screening tool that would detect severe deﬁcits in those most requiring
further neurocognitive assessment.
5. Conclusion
The current study identiﬁed that the MoCA may be usefully applied
in the AOD treatment setting as a brief screening tool. We showed in a
naturalistic snapshot of clients in AOD residential treatment that cognitive impairment is common and may be related to the effects of head injuries, which are also highly prevalent. Cognitive abilities such as
executive function and working memory are important for AOD residents to engage meaningfully in treatment and achieve successful outcomes. If these capacities are compromised, residents may be more
likely to drop out from treatment and fail to recover from their addiction. The ﬁrst step in rectifying this situation is to improve the assessment and detection of those who present with cognitive deﬁcits. This
will help to inform modiﬁcations to treatment and/or cognitive remediation interventions that may be beneﬁcial in accommodating and potentially remediating impairments in cognition, increasing the
likelihood of treatment engagement and retention, and hopefully leading to long-term recovery from addiction.
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